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SUPPLEMENT

Abstracts From the 2021 Health Care Systems Research
Network Annual Conference
The Health Care Systems Research Network (HCSRN) is comprised of 19 not-forprofit health systems with embedded research departments. The network’s annual
conference serves as a forum for member institutions to highlight research findings,
explore new collaborations, and share insights and opportunities. Abstracts accepted
for oral and poster presentation at the 2021 HCSRN Conference are published in
this supplement of Journal of Patient-Centered Research and Reviews, the official
scientific journal of the annual conference. J Patient Cent Res Rev. 2021;8:154-217.

ADDICTION SCIENCE/SUBSTANCE USE
Does the Change in Smoking and Marijuana Use
Policies Influence Adolescents’ Risky Sexual
Behaviors and Other Associated Factors?
Ruaa Al Juboori, Orlando Davy, Thembekile Shato,
Divya Subramaniam, Qiang Fu
Saint Louis University / SSM Health, St. Louis, MO
Background: Changing policies around marijuana use and
the increase in the use of e-cigarettes have affected patterns of
risky sexual behaviors (RSBs) among adolescents. Despite
a decline in some RSBs like condom non-use in previous
years, few researchers have analyzed how adolescents’ RSB
trends have been influenced by other risky behaviors such as
smoking, marijuana use, fighting, and binge drinking, which
is the objective of the current study.
Methods: A total of 61,072 students from 4 Youth Risk
Behavior Surveillance System survey years (1993, 2001,
2009, and 2017) were included. The distributions for each
outcome within each risk behavior were examined to assess
whether a trend existed. Multivariate logistic regression
models were constructed to examine the relationship
between 5 risky behaviors (suicide risk, smoking, binge
drinking, marijuana use, and physical fight) and 2 indicators
of RSBs (condom non-use and multiple sexual partners).
Interactions between survey year and risky behavior were
used to assess whether changes in the patterns of behavior
across survey years were either widening or narrowing. An
odds ratio of >1 implied divergence in the strength of the
behaviors from previous years, whereas an odds ratio of <1
implied the strength of associations were converging to a
current year with respect to the base year 1993.
Results: Although there were significant associations
between risky behaviors like suicidality and RSBs, a
narrowing in the trend of the association between some
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risky behaviors and RSBs was noticed. There was a
convergence in the trend of association between fighting in
2009, and binge drinking in 2001, with condom non-use as
compared to 1993. Also, there was a similar pattern between
fighting and suicidal risk in 2017 as compared to 1993 for
multiple sexual partners. However, there were no consistent
decreasing changes in associations across time in marijuana
use and smoking with RSBs.
Conclusion: Further longitudinal studies are needed to
clarify directionality and policy recommendations for
substance use as proxy to reduce the growing burden of
sexually transmitted infections among the adolescent
population.
Association Between Pharmacotherapy for
Opioid Use Disorder and Counseling in OfficeBased Versus Specialty Substance Use Disorder
Treatment Settings
Richard Grucza, Ned Presnall, Kevin Xu, Carrie Mintz
Saint Louis University / SSM Health, St. Louis, MO
Background: Expanding pharmacotherapy for opioid
use disorder (OUD) in the United States is a high priority
for public health officials. Buprenorphine, a partial opioid
agonist, was approved by the U.S. Food and Drug Association
in 2002 for the maintenance treatment of OUD. Office-based
opioid therapy with buprenorphine expanded rapidly, but
specialty substance use disorder (SSUD) settings have been
slower to universally adopt buprenorphine therapy. To our
knowledge, no literature has directly reported the likelihood
of receiving medication in these two settings among people
in treatment for OUD. The analyses presented here examine
the association between receipt of counseling services for
OUD and receipt of medication in both office-based and
SSUD treatment settings.

Methods: We identified 234,804 Medicaid- and
commercially insured individuals in the IBM MarketScan
database who utilized OUD counseling services from 2006 to
2016. For these individuals, we identified pharmacy claims
for buprenorphine, oral naltrexone, and extended-release
naltrexone and used the “days supply” variable to identify
co-prescription of OUD pharmacotherapy on counseling
days. We identified 34.1 counseling service days per
individual, on average. Individuals averaged 34.1 counseling
service days. Using procedure codes to differentiate officebased individual and group psychotherapy (CPT codes)
from comparable services in SSUD settings (HCPCS-H
codes), we examined the association between counseling
services and pharmacotherapy in each setting. We examined
3 outcomes: 1) coverage with any medication on counseling
days; 2) coverage with buprenorphine on counseling days;
and 3) coverage with naltrexone (oral or extended-release)
on counseling days.
Results: Depending on the type of counseling received
(individual, group-based, or intensive), patients had 2.7 to
4.2 times higher odds of being treated with medication on
counseling days in office-based vs SSUD settings. Odds
ratios for buprenorphine receipt ranged from 3.7 to 7.3 for
office-based vs SSUD settings. In contrast, naltrexone was
more likely to used be in SSUD settings (odds ratios ranging
from 0.3 to 0.5 for office-based vs SSUD).
Conclusion: The disparity in pharmacotherapy practices
between office-based and SSUD care is large and
consistent with documented biases against agonist OUD
pharmacotherapy in SSUD settings.
Medication Storage and Disposal Among OpioidNaïve Patients in Primary Care
Mia Lussier, Lorraine Tusing, Jove Graham, Alanna
Kulchak Rahm, Christina Gregor, Eric Wright
Geisinger Research, Forty Fort, PA
Background: Prescription opioids in the home are a
potential contributor to opioid-related deaths. Proper opioid
storage and disposal is known to reduce medication misuse.
Prior studies supporting safe storage and disposal practices
largely focus on postsurgery patients, demonstrating
improved storage and disposal with education and supply of
a disposal mechanism. We aimed to implement and evaluate
a safe medication storage and disposal program for patients
newly prescribed opioid medications in primary care.
Herein, we report baseline storage and disposal practices
among patients newly prescribed opioids in primary care.
Methods: We developed a best practice alert for patients
newly prescribed an opioid medication across 12 primary
care locations. The initial best practice alert was silent,
allowing us to determine baseline storage and disposal
patterns. A telephone survey was conducted among all

eligible subjects 30–45 days after encounter. The survey was
adapted from previously used surveys and included storage
and disposal questions targeted at the prescribed opioid
medication. Household information, such as the presence
of children in the home, someone living with chronic pain,
health literacy, education, and income, were collected in
order to evaluate factors that may influence storage and
disposal behaviors.
Results: Of 307 eligible participants, 208 (68%) completed
the survey; 47 participants (23%) indicated that their doctor
talked to them about disposal, and 60 (29%) indicated that
their doctor talked to them about storage. Of the orders
placed, 71 (34%) were written for CII medications, and 203
(96%) were written for as-needed use; 14 participants (7%)
did not fill their prescription, and 145 (70%) had medication
remaining at the time of the survey. Four participants (2%)
reported their medication was stored in a locked location.
Among those who had leftover opioid, 13 participants (8%)
disposed of their medication, of whom 5 (38%) did so by a
Centers for Disease Control and Prevention-recommended
method.
Conclusion: In a survey of participants without any
intervention to improve storage and disposal methods, we
found few stored medications safely or disposed leftover
medications properly. Future analysis will evaluate how
interventions (ie, active best practice alert, education,
reminder call, and disposal bag mailed to home) affected
participants’ storage and disposal of opioid medications.

CANCER
Treatment Decision-Making in Multiple Myeloma: A
Pilot Study
Mara Epstein, Joann Wagner, Jill Zitzewitz, Kathleen
M. Mazor
Meyers Primary Care Institute, Worcester, MA
Background: There is no single standard of care for treating
multiple myeloma (MM). The choice of potential treatment
options, including autologous stem cell transplantation
and newer, less intensive therapies, makes it important to
understand how patients with MM are informed about
treatment options. In this pilot study, we examined patients’
perceptions of treatment decisions and the factors they
considered important when selecting first-line treatment for
MM.
Methods: We developed a 60-item questionnaire combining
an existing measure of communication in cancer care
with new items. Participants were recruited through
ResearchMatch, an online, volunteer-based research
platform, and additionally through a local multiple myeloma
support group. Responses were scored on a Likert scale, with
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some open-ended questions. Eligible participants were men
and women 18–80 years of age who had been previously
diagnosed with MM.
Results: 12 participants (50% male gender; 92% White
race; median age: 65.5 years) responded to the survey, and
75% were diagnosed with MM more than 3 years prior. Twothirds received chemotherapy as primary treatment, and 50%
had an autologous stem cell transplantation. All participants
reported having a provider available to answer questions
soon after diagnosis. However, 4 participants (33%)
disagreed with the statement “I knew what would happen
next, and what decisions I would face” after diagnosis,
suggesting communication gaps. Comments included “I
wasn’t given much information about my prognosis” and
“could have explained more fully the benefits and drawbacks
of each treatment.” The majority (83%) reported “always”
being involved in treatment decisions, and 92% understood
why decisions were made. However, only 42% “always”
understood the risks of different treatment choices. Patients
sought information on MM from varied and multiple
sources, including their doctor (75%), the internet (67%),
nurses (42%), cancer societies (42%), and friends/family
(17%). Participants identified “overall survival” (50%),
and “cost” (25%) as the most important factors in treatment
decisions.
Conclusion: Most MM patients responding to this pilot
survey were involved in treatment decision-making, although
the risks and benefits of each treatment were not always well
understood. These preliminary results reveal gaps in patientprovider communication around MM treatment and a need
to more fully elucidate barriers to ensure all MM patients
receive care that aligns with their goals and preferences.
Determinants of Urologists’ Adherence to Active
Surveillance Follow-Up Guideline for Low-Risk
Prostate Cancer

surveillance follow-up guideline. Guided by the combined
use of the Consolidated Framework for Implementation
Research, which focuses on organization-level determinants,
and the Theoretical Domains Framework, which focuses on
provider-level determinants, we used template analysis to
identify multilevel determinants of urologists’ adherence to
guideline-recommended active surveillance follow-up care.
Results: Relevant determinants were comfort with varied
utilization behaviors of the guideline, perspectives on
the prostate biopsy procedure, and the degree of structure
within the practice setting. At the provider level, there was
variation in how urologists provided active surveillance
follow-up care. All urologists referred to the NCCN
guidelines; however, most urologists adapted the guidelines
to their needs and/or comfort level (eg, following a subset
of recommendations, adapting the interval/frequency of
serial tests). Most providers felt that strictly adhering to
the repeated biopsy aspect of the guideline was difficult
because of concerns about fitting everybody to one type
of frequency that does not stratify patients by risk. Others
reflected on patients expressing physical discomfort and
concerns of infection stemming from the biopsy procedure.
At the organization level, urologists in a structured practice
environment had the tendency toward providing NCCN
guideline-adherent care, whereas urologists practicing in
settings with less organization relied more on individual
discretion, which created room for flexibility with the care
that they provide.
Conclusion: Both provider- and organization-level
determinants affected urologists’ provision of follow-up
care, which may partially explain why patients eventually
fail to receive NCCN guideline-adherent active surveillance
follow-up care. Findings call on the need for multilevel
strategies to increase adherence or to modify existing
guidelines to reflect the need at multiple levels.

Soohyun Hwang, Sarah Birken

Electronic Patient-Reported Outcome Measures in
Head and Neck Cancer

University of North Carolina at Chapel Hill, Chapel
Hill, NC

Jeewanjot Grewal, Theresa Zatirka, Amy Williams,
Steven Chang, Samantha Tam

Background: The National Comprehensive Cancer Network
(NCCN) guidelines offer guidance for follow-up care for
patients with low-risk prostate cancer on active surveillance.
However, in practice, 70% of patients receive follow-up care
that is not guideline-adherent, characterized by insufficient
or excessive surveillance testing, potentially diminishing
active surveillance effectiveness and contributing to poor
patient outcomes. The objective of this study is to identify
provider- and organization-level determinants of guidelineadherent active surveillance follow-up care.
Methods: We used in-depth semi-structured qualitative
interviews with 12 U.S.-based urologists to examine
determinants of urologists’ adherence to the active

Henry Ford Health System, Detroit, MI
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Background: Electronic patient-reported outcome
measures (ePROMs) represent a patient-centric essential
representation of the patient experience. While traditional
assessments have relied on provider-generated data, these
data correlate poorly with ePROMs as indicators of outcome.
Implementation of ePROMs alone in a medical oncology
setting has improved the length of systemic treatment and
overall survival, decreased acute care visits and emergency
department visits, and improved patient-reported quality
of life. Thus far, the application of ePROMs has mainly
been limited to clinical trial settings. This study presents
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preliminary results from patients with head and neck cancer
in a systemwide implementation of ePROMs.
Methods: The institution implemented ePROMs throughout
the health system, including the multidisciplinary head and
neck surgical/medical/radiation oncology clinics, beginning
in fall 2020. The National Institutes of Health’s validated
and standardized Patient-Reported Outcomes Measurement
Information System (PROMIS) was utilized to capture
4 core oncology domains: fatigue, pain interference,
physical function, and depression. ePROMs were recorded
before, during, and after treatment. Questionnaires were
administered prior to patient appointments via MyChart,
and an iPad was given to the patients at the time of check-in
should the questionnaires be incomplete before each visit.
Results: In all, 106 patients successfully completed
PROMIS questionnaires from September to October 2020.
Mean PROMIS scores were 51.4 (standard deviation [SD]:
8.8) for the depression scale, 52.4 (SD: 10.0) for fatigue,
56.7 (SD: 10.4) for pain, and 43.7 (SD: 9.6) for physical
function. Physical function scores were the only subscale
to vary significantly within the cohort. Patients scored 0.22
points less on the physical function subscale with each
year of increasing age (P=0.004). As well, patients with
oropharyngeal primaries had significantly higher physical
function subscores (mean: 48.7, 95% CI: 44.9–52.5)
compared to patients with laryngeal primaries (mean: 39.7,
95% CI: 35.8–43.5; P=0.003).
Conclusion: ePROMs can be successfully implemented
as a part of a routine multidisciplinary head and neck
cancer practice. ePROMs have previously been shown to
yield clinically meaningful patient-centric data to drive
intervention and may improve quality of life, patient
satisfaction, and overall survival. In patients with head
and neck cancer, physical function varied most, with older
patients and those with laryngeal primaries reporting worse
physical function-related quality of life.
Impact of Definitive and Timely Diagnosis on
Survival of Metastatic Pancreatic Cancer in
Patients With Initial Diagnosis of Cancer of
Unknown Primary

assess the impact of definitive and timely diagnosis (DTD)
on survival of patients initially diagnosed with CUP. We
examined how DTD of metastatic PC affects survival in
older patients who initially present with CUP compared to
those diagnosed with metastatic PC only.
Methods: This study used 2010–2016 Surveillance,
Epidemiology, and End Results (SEER)-Medicare data.
Logistic regression models compared patient characteristics
who received DTD in two subsets: CUP-PC and PC-only.
The impact of DTD on patient survival in CUP-PC was
analyzed using Cox proportional hazards regression. All
models were adjusted for gender, age, race, ethnicity, area of
residence, histology, and Charlson comorbidity score.
Results: The adjusted odds of DTD in CUP-PC were 15%
lower for those with a comorbidity score of 0 (adjusted
odds ratio: 0.85 [0.79, 0.91]) and 24% lower for epithelial/
unspecified histology (adjusted odds ratio: 0.76 [0.71, 0.82]).
DTD in CUP-PC was associated with a 72% reduction in
hazard of death (hazard ratio: 0.28 [0.25, 0.31]). Patients
who are Black were associated with a 15% increase (hazard
ratio: 1.15 [1.08, 1.23]), Latino with a 19% increase (hazard
ratio: 1.19 [1.10, 1.29]), and epithelial/unspecified histology
with an 85% increase (hazard ratio: 1.85 [1.76, 1.95]).
Conclusion: DTD of CUP-PC was favorable in patients
who were a race other than White or Black with fewer or no
comorbidities. Unfavorable characteristics included older
patients and epithelial/unspecified histology. Results indicate
transition in diagnosis from CUP to metastatic cancer of a
known site and diagnosis within 3 months has a significant
impact on the life of the patient. Our findings reflect the
importance of DTD in CUP patient survival, especially for
older, female, Black, Latino, and rural-residing patients with
multiple comorbidities.
Patient Self-Reported Experience of Serious Illness
Communication and Care Among Individuals With
Advanced Cancer
Ellis C. Dillon, Martina Li, Amandeep Mann, Amaka
Agodi, Alyssa Hernandez, Hal S. Luft, Natalia Colocci,
Steve Lai, Manali Patel

Larissa White, Julie Smith-Gagen

Sutter Health, Palo Alto, CA

Kaiser Permanente Colorado, Aurora, CO

Background: For individuals with advanced cancer, careful
communication and early conversations regarding patients’
goals, values, and preferences for care (ie, goals of care)
can improve patient experiences and care at the end of life.
Yet, many patients lack understanding of their diagnosis and
prognosis and do not receive goal-aligned care.
Methods: A health care organization in Northern California
adopted patient experience surveys as part of a quality
improvement program on August 12, 2019. Individuals
with advanced cancer (stage IV, recurrence with distant
metastases or glioblastoma) were surveyed by mail, email,

Background: Cancer of unknown primary (CUP) accounts
for 3%–5% of all cancers and is the fourth most common
cause of cancer mortality in the United States. Median
survival after CUP diagnosis is 3–4 months. Pancreatic
cancer (PC) accounts for 3% of all cancers and is the third
most common cause of cancer mortality in the United
States. Median survival after stage III/IV PC diagnosis is
2–3 months. As CUP and metastatic PC are comparable in
prevalence and survival, PC diagnosis is a useful endpoint to
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or phone at 1, 4, and 8 months after they were identified.
Descriptive statistics and qualitative thematic analysis of
open-ended questions are reported.
Results: 546 patients were identified and 403 surveys were
completed at 1 (n=162), 4 (n=147), and 8 months (n=94).
By 1 month, 48 of 150 patients (32.0%) reported discussing
palliative care with their care team and 13 patients (8.7%)
were already receiving specialty palliative care. At 1 month,
102 of 156 (65.4%) rated the quality of information received
about treatment and treatment choices as “excellent” vs
59.7% at 4 months and 63.4% at 8 months. Meanwhile, 46 of
154 (29.9%) at 1 month, 32 of 143 (22.4%) at 4 months, and
16 of 91 (17.6%) at 8 months responded “I wish I had more
information about my prognosis” (vs, at 8 months, 74.7%
responding “right amount of information,” 0% “wished they
had less information,” and 7.7% “not sure about wanting
more information.” Participants provided 233 responses to
the open-ended question: “What could be done to improve
your experience?” The most common theme was a desire
for improved communication about diagnosis, prognosis, or
treatment, for example, “I haven’t been given how long I’ll
live. It would be good to have an idea.” and “Discussion of
what my options are. This thing happened so fast that I had
radiation and didn’t know what was happening.”
Conclusion: For individuals with advanced cancer, these
surveys suggest the biggest potential to improve experience
is to improve communication, specifically discussion of
treatment choices, palliative care, and prognosis. Feedback
from surveys was relayed to local clinical teams, who then
responded to identified concerns. Continued longitudinal
surveys may reveal how patients’ needs change as their
illness progresses.
Patients Deciding on Cancer Screening and
Prevention Using Clinical Decision Support: “I
Wouldn’t Have Thought About Getting Screened
Without It”
Melissa Harry, Daniel Saman, Laura Freitag, Clayton
Allen, Patrick J. O’Connor, JoAnn Sperl-Hillen, Joseph
Bianco, Anjali Truitt, Thomas Elliott
Essentia Health, Duluth, MN
Background: Clinical decision support (CDS) designed to
encourage discussions between patients and their primary
care providers may help improve cancer screening and
prevention rates. Our objective was to understand patients’
perspectives on both cancer prevention and screening and
a personalized CDS tool among those exposed to the CDS
tool because they were due or overdue for cancer screening
(breast, colon, lung, cervical) or prevention (human
papillomavirus vaccination, tobacco, overweight).
Methods: We conducted semi-structured, qualitative
interviews with 37 adult patients due or overdue for cancer
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prevention and screening services in 10 primary care clinics
within intervention arms of a randomized control trial in a
health care system serving a largely rural population. We
conducted interviews immediately following a visit with
a primary care provider. We thematically segmented and
coded transcribed interview data using qualitative content
analysis.
Results: We identified 3 overarching themes: 1) the CDS had
more strengths than weaknesses, with the latter providing
areas for improvement; 2) cancer prevention and screening
facilitators and barriers identified were mainly at the patient
level, but lack of using the CDS by some providers was
the only provider-level barrier noted; and 3) discussions
and decision-making varied by type of cancer prevention
and screening. Almost all participants made positive
comments regarding the CDS. Some participants learned
new information, reported the CDS helped them make a
decision they otherwise would not have made, and found
the recommendations helpful in making a decision with
their provider. Only 1 of the patients eligible for lung cancer
screening reported speaking with their provider about it.
Participants who described using the tool with their provider
did have higher self-reported rates of making a choice than
those who did not.
Conclusion: Participants generally approved of a
personalized CDS tool for cancer screening and prevention
in primary care, finding it useful and a welcome addition to
their visit. However, we found some providers did not use
the CDS with eligible patients, suggesting adoption issues
that future research should assess, along with the impact of
the CDS on screening rates. Other researchers could also
apply the patient interview framework we developed in
understanding patient perspectives and care needs.
Identifying Individuals With Advanced Cancer:
Assessing a Real-Time Alternative to Retrospective
Tumor Registry Data
Ellis C. Dillon, Amandeep Mann, Kevin Hays, Martina
Li, Natalia Colocci, Manali Patel, Steve Lai, Hal S. Luft
Sutter Health, Palo Alto, CA
Background: Tumor registry data are the gold standard
for cancer surveillance, but registries only report cancers
at diagnosis and have long lags. Easily accessible real-time
data on current cancer stage and recurrent advanced disease
are needed for clinical and research initiatives. The growing
use of electronic chemotherapy pathways decision support
tools may help to meet this need.
Methods: ClinicalPath (formerly Via Oncology: https://
www.elsevier.com/solutions/clinicalpath) was launched
at a health care organization in Northern California on
February 1, 2019. This tool is designed to assist oncologists
in choosing a prioritized evidence-based chemotherapy
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regimen. Oncologists input certain patient information,
including stage of disease and presence of distant metastases.
To understand how well data input to ClinicalPath identify
patients with advanced stages of cancer, we selected all
patient records in ClinicalPath consistent with advanced
cancer (stage IV or distant metastases) from February 1,
2019, to September 30, 2019, to compare with organizational
tumor registry (TR) data for those patients. The goal was
to assess whether ClinicalPath was accurately capturing
instances of advanced cancer, ie, stage IV cancer or earlier
stage cancer with recurrence and distant metastases.
Results: Of 101 patients with advanced cancer identified
from ClinicalPath, 85 (84.2%) were found in TR data.
Overall, 84 of those 85 (98.8%) had the same cancer
diagnosis; 56 (65.9%) were reported in both data sources as
having stage IV cancer, 20 (23.5%) in the TR had an earlier
stage cancer, and 9 in the TR (10.6%) were missing staging
information. One individual (1.2%) had discrepant diagnosis
(ie, TR showed prostate cancer while ClinicalPath showed
non-small cell lung cancer). This patient was diagnosed
with prostate cancer, which was reported in TR, and was
later (>20 years) diagnosed with non-small cell lung cancer,
which was noted in ClinicalPath. There were 16 patients
not in TR data, likely because they came to the organization
after being diagnosed elsewhere.
Conclusion: Information in ClinicalPath is consistent with
the TR for the majority of patients with advanced cancer
and captures patients whose TR data is submitted from other
organizations. Being embedded in the clinical workflow,
ClinicalPath offers reliable and faster evidence-based data
for research and clinical quality improvement efforts.
Improving Access to Specialty Radiotherapy for
Patients With Resectable Brain Tumors
Mehee Choi, Brian Martin, Joseph Zabramski, Lisa
Misell, David Brachman
GT Medical Technologies, Tempe, AZ
Background: Many patients with brain tumors face
challenges with access to care. For rural patients, prolonged
travel times may limit access to appropriate radiotherapy.
Radiation centers offering specialized brain radiotherapy, eg,
stereotactic radiosurgery (SRS), are geographically limited.
Utilization of brain brachytherapy, localized radiation
undertaken at the time and place of resection, could help
lessen this access-to-care disparity. Until recently, technical
challenges have limited the adoption of brachytherapy,
but the U.S. Food and Drug Association recently cleared
an easier-to-use permanently implanted, bioresorbable
collagen square embedded with Cesium-131 sources
(GammaTile, GT Medical Technologies) for implantation at
surgery for all recurrent intracranial tumors and for newly
diagnosed malignant intracranial neoplasms. To investigate
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if wider availability of this treatment could possibly lower
the geographic barrier to access to care, we mapped the
U.S. population against existing radiation centers with
brain tumor treatment expertise and neurosurgery centers
performing craniotomies.
Methods: We analyzed 2018 Centers for Medicare &
Medicaid Services claims data using CPT codes for singleand multifraction SRS to identify radiation centers with
brain tumor treatment expertise and mapped these against
the population. Using similar methodology, using CPT codes
for craniotomies, we identified neurosurgery centers, as any
facility performing craniotomies is potentially eligible to
implant GammaTile.
Results: A total of 135 radiation centers used CPT codes for
SRS; 193 million, 119 million, 82 million, and 52 million
Americans lived >30, >60, >90, and >120 minutes from one
of these centers, respectively. A total of 530 neurosurgery
centers perform craniotomies, including 1 or more in every
state, a 4-fold increase over the number of radiation centers
offering SRS.
Conclusion: For many patients, substantial travel distances
limit their access to radiation centers with brain tumor
treatment expertise. In contrast, the 530 craniotomyperforming neurosurgery centers have far greater geographic
dispersion. The option of undergoing brain radiation
with GammaTile implantation at the time of brain tumor
craniotomy brings treatment closer to millions, ensures
compliance, and reduces additional travel for follow-up
radiation treatment.
Diffusion of Newly Recommended Annual
Colorectal Cancer Screening Among African
Americans 45–49 Years Old
Gloria Coronado, Andrea N. Burnett-Hartman, Jeff
Lee, Carmit McMullen, Carolyn Rutter, Caitlin Murphy,
Mary Ann McBurnie, John M. Caruthers, Amanda
Petrik, Samantha Hendren
Kaiser Permanente Northwest, Portland, OR
Background: Over the past two decades, there has been an
unexplained rise in colorectal cancer incidence in individuals
younger than age 50. In response to this rise, in 2020, the
U.S. Preventive Services Task Force (USPSTF) updated
its colorectal cancer screening recommendations; the new
draft recommendations call for screening initiation among
average-risk individuals to begin at age 45, instead of 50.
Since 2016, Kaiser Permanente Northwest has recommended
colorectal cancer screening for African Americans who
are 45–49 years old, and these patients are included in
an annual centralized mailed fecal immunochemical test
(FIT) outreach program. Little is known about the uptake
of colorectal cancer screening in this population subgroup.
This information can provide important clues about how
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quickly screening recommendations are implemented in
delivery systems.
Methods: Patients were 45–49-year-old African Americans
members of Kaiser Permanente Northwest identified from
2016 through 2020. We report the proportion of eligible
patients who completed a FIT each year and the proportion
that completed 1, 2, 3, and 4 FITs over the 4-year evaluation
interval.
Results: Our study sample included 923 African Americans
in the 45–49 age range; 41% of the sample completed at
least one FIT over the 4-year interval. This included 22.3%
who screened only once, 11.9% who screened twice, 5.7%
who screened 3 times, and less than 2% who screened each
of the 4 years.
Conclusion: Despite the annual promotion of FIT among
African Americans 45–49 years of age, only 41% completed
at least one FIT over the 4-year interval. Additional efforts are
needed to successfully promote colorectal cancer screening
initiation in this group. Given the pending changes to
USPSTF guidelines to drop the age of screening initiation to
45 years, our findings may inform the diffusion of colorectal
cancer screening in the context of new screening guidelines.

CARDIOVASCULAR DISEASE
Comparing Change in Systolic Blood Pressure
With Clinic-Based Care Versus Telehealth Care in a
Pragmatic Cluster-Randomized Trial (Hyperlink 3)
Karen L. Margolis, JoAnn Sperl-Hillen, A. Lauren
Crain, Jeffrey Anderson, Anna Bergdall, Leif I. Solberg,
MarySue Beran, Beverly B. Green, Pamala A. Pawloski,
Jeanette Y. Ziegenfuss, Amy Kodet, Daniel Rehrauer,
Meghan JaKa, Christine Norton, Patricia Haugen,
Benjamin Crabt, Nicole Trower, Deepika Appana,
Rashmi Sharma, Sarah Norman, Patrick J. O’Connor
HealthPartners, Minneapolis, MN
Background: Uncontrolled hypertension is the largest
contributor to all-cause and cardiovascular mortality. Nurseand pharmacist-led telehealth care (TC) interventions have
resulted in large, lasting improvements in blood pressure
compared with clinic-based care (CC) under controlled
research conditions but have not been studied at scale under
real-world conditions.
Methods: This cluster-randomized trial in 21 primary care
clinics used electronic health record algorithms triggered
during primary care encounters to enroll patients 18–85
years old with hypertension and blood pressure of >150/95
mmHg. TC patients (n=1424) were recommended to follow
up with a pharmacist in 2 weeks to obtain home blood
pressure telemonitoring and telephone management visits.
CC patients (n=1648) were recommended to follow up
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with a medical assistant for a blood pressure check in 2
weeks. The primary outcome was the difference in change
in systolic blood pressure (SBP) between groups over 12
months using blood pressure data from the electronic health
record. A secondary per protocol analysis among patients
who enrolled and adhered to recommended follow-up within
6 weeks used inverse probability weighting to account for
potential bias.
Results: Enrolled patients had a mean age of 60 years and
were 47% male, 7% Asian, 19% Black, 69% White, and
2% Hispanic. Mean enrollment blood pressure was 164/94
mmHg. Within 6 weeks, 27% of TC patients had a pharmacist
visit (of whom 80% began telemonitoring) and 32% of CC
patients had a medical assistant visit. Change in SBP was
similar in TC (-18.7 mmHg) and CC (-17.5 mmHg) patients
(difference of -1.2 mmHg [95% CI: -2.9, 0.6]). However, in
the per protocol analysis, TC patients had greater decrease
in SBP than CC patients (-4.6 mmHg [95% CI: -7.7, -1.5]).
Patient surveys showed higher ratings of care, more frequent
self-monitoring, and greater use of home blood pressure for
treatment changes in TC.
Conclusion: Patient engagement in the TC intervention
was much lower in this pragmatic trial than in a previous
explanatory trial, and the primary analysis showed equivalent
decrease in SBP in both groups. However, among those who
engaged in follow-up care, TC patients had a larger decrease
in SBP. Additional research is needed to study effects of
strategies to encourage uptake of telehealth care in realworld patients with hypertension.
Blood
Pressure
Checks
and
Diagnosing
Hypertension: Provider Knowledge, Practices, and
Beliefs
Beverly B. Green, Melissa Anderson, Andrea Cook,
Kelly Ehrlich, Yoshio Hall, Clarissa Hsu, Dwayne
Joseph, Karen L. Margolis, Jennifer McClure, Sean
Munson, Matthew Thompson
Kaiser Permanente Washington Health Research
Institute, Seattle, WA
Background: The U.S. Preventive Services Task Force
recommends out-of-office blood pressure (BP) measurement,
using 24-hour ambulatory (ABPM) or home BP monitoring,
before making a new diagnosis of hypertension. However,
this approach is not common in routine practice. This study’s
objective was to evaluate provider knowledge, beliefs, and
practices about BP diagnostic tests.
Methods: The setting was 10 primary care medical centers
in a single health care system. Emails with a link to a survey
were sent to 420 providers, with 282 (67%) responding,
including 102 medical assistants (MA), 28 licensed practical
nurses (LPN), 33 registered nurses (RN), 86 primary care
physicians (physician), and 33 advanced practitioners
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(AP). Outcomes were a descriptive analysis of provider
BP measurement and hypertension-diagnosis knowledge,
beliefs, and practices.
Results: Most providers (78.8%) believed that BP measured
manually with a stethoscope and ABPM was a very or
highly accurate way to measure BP when making a new
diagnosis of hypertension. In contrast, most providers did
not believe that automated clinic BP, home BP, or kiosk
BP measurements were very or highly accurate. Almost all
providers reported that they always or almost always relied
on clinic BP measurements in making a new diagnosis
of hypertension (95.7%), but the majority of physicians/
APs would prefer using ABPM (60.5%) if it was readily
available. Providers were mixed as to whether patients
received home BP training and whether home BP monitors
were checked for accuracy. Physicians/APs reported
varying home BP schedules, with no schedule the most
common response (37.3%), followed by 14 days (19.1%)
and 7 days (10.9%). Almost all physicians/APs reported
using a clinic BP threshold of 140/90 mmHg for making
a new diagnosis, but a few reported 130/80 mmHg. Very
few physicians/APs reported guideline-concordant home
or ABPM diagnostic thresholds, with 140/90 mmHg the
most common response.
Conclusion: In our study, providers did not report following
evidence-based guidelines for making a new diagnosis of
hypertension and appeared to have substantial gaps in
knowledge, beliefs, and use of recommended practices.
Interventions to increase use of evidence-based practices for
diagnosing hypertension are needed.
Blood
Pressure
Checks
and
Hypertension
(BP-CHECK):
A
Controlled Trial

Diagnosing
Randomized

Beverly B. Green, Melissa Anderson, Andrea Cook,
Kelly Ehrlich, Yoshio Hall, Clarissa Hsu, Dwayne
Joseph, Predrag Klasnja, Karen L. Margolis, Jennifer
McClure, Sean Munson, Matthew Thompson
Kaiser Permanente Washington Health Research
Institute, Seattle, WA
Background: The U.S. Preventive Services Task Force
recommends out-of-office blood pressure (BP) measurement,
using 24-hour ambulatory (ABPM) or home BP monitoring,
before making a new diagnosis of hypertension. However,
this approach is not common in routine practice. The
objective of this randomized controlled trial was to compare
the performance and acceptability of clinic, home, and
kiosk-based BP monitoring to ABPM for making a new
diagnosis of hypertension.
Methods: The setting was 12 Kaiser Permanente Washington
primary care medical centers. The population was 510 adults
18–84 years old without diagnosed hypertension and on no
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antihypertensive medications who registered elevated BP
in clinic and at a baseline research visit. Participants were
randomized to 1 of 3 regimens for diagnosing hypertension
— 1) Clinic BP (at follow-up clinic appointment), 2) Home
BP (duplicate BP measurements twice a day for 5 days),
or 3) Kiosk BP (triplicate BP measurements over 3 days)
— at any time over 3 weeks. All participants subsequently
completed ABPM. All BP data were collected electronically.
The primary outcome was the diagnostic performance of
each method as compared to ABPM. Secondary outcomes
include adherence to the assigned protocol and patientreported outcomes. Linear regression models were used to
estimate the mean difference in systolic BP and diastolic
BP between the diagnostic and ABPM reference standard
measures for each group.
Results: Overall, 78.8% (402 of 510) of the participants
completed the prespecified minimum number of BP
measurements needed for diagnostic assessments. Clinic,
Home, and Kiosk BP monitoring adherence was 87.2%,
90.6%, and 67.9%, respectively, with 91.6% completing
ABPM. Compared to mean daytime ABPM, difference in
adjusted mean systolic BP for Clinic was -4.7 mmHg (95%
CI: -7.2 -2.1; P<0.001), for Home was -0.1 mmHg (95% CI:
-1.6, 1.5; P=0.92), and for Kiosk was 9.0 mmHg (95% CI:
7.0, 11.1; P<0.001). Difference in adjusted mean diastolic
BP for Clinic was -6.7 mmHg (95% CI: -8.2, -5.1; P<0.001),
for Home was -0.3 mmHg (95% CI: -1.3, 0.8; P=0.81),
and for Kiosk was 3.9 mmHg (95% CI: 2.6, 5.3; P<0.001).
Sensitivity of Clinic, Home, and Kiosk for detecting
hypertension was 31.1%, 81.7%, and 95.1%, and specificity
was 79.5%, 53.2%, and 26.7%, respectively. Home BP was
preferred. ABPM was more likely to disturb sleep and be
uncomfortable, but participants perceived it as accurate.
Conclusion: Home BP had better diagnostic performance,
adherence, and acceptability than clinic or kiosk.
Telehealth
Versus
Self-Directed
Lifestyle
Intervention to Promote Healthy Blood Pressure:
Study Design and Rationale
Alex Chang, Christina Yule, Sara Kwiecien, Charlotte
Collins, Allison Naylor, Stephen Juraschek, Lisa
Bailey-Davis
Geisinger Research, Danville, PA
Background: Weight loss, consumption of a Dietary
Approaches to Stop Hypertension (DASH) dietary pattern,
reduced sodium intake, and increased physical activity have
been shown to lower blood pressure (BP). Use of webbased tools and telehealth to deliver lifestyle counseling
could yield potentially scalable solutions to improve blood
pressure through behavioral modification, though limited
data exist to support these approaches in clinical practice.
Methods: This randomized controlled trial is designed to
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compare the efficacy of a telehealth vs self-directed lifestyle
intervention in lowering 24-hour systolic BP in patients with
overweight/obesity (body mass index of ≥25 kg/m2) and 24hour systolic BP of 120–160 mmHg. All participants are to
receive personalized recommendations to improve dietary
quality based on a web-based food frequency questionnaire,
access to an online comprehensive weight management
program, and a smartphone dietary app. The telehealth arm
additionally includes weekly calls with registered dietitian
nutritionists who use motivational interviewing. The
primary outcome is change from baseline to 12 weeks in
24-hour systolic BP. Secondary outcomes include changes
from baseline in 24-hour diastolic BP, daytime systolic
BP, nighttime systolic BP, daytime diastolic BP, nighttime
diastolic BP, total Healthy Eating Index-2015 (HEI)
score, weight, waist circumference, and physical activity.
Other prespecified outcomes include change in individual
components of the HEI score and satisfaction with the
Healthy BP research study, measured on a 5-point Likert
scale. Exploratory analyses are designed to test whether
outcomes differed before and after the pandemic.
Results: Out of 210 participants who were consented for the
first study visit, 169 have completed the run-in period and
have been randomized into the trial. Recruitment and trial
enrollment continued during the pandemic with conversion
to remote study visits. In a preplanned interim analysis of
the first 34 randomized patients, 28 (82%) completed the
3-month study visit. Mean (standard deviation) changes
from baseline to 3 months were -8.0 mmHg (9.9) for 24hour systolic BP, -5.4 kg (4.5) for weight, -6.1 cm (7.4) for
waist circumference, and 11.2 units (12.0) for HEI score.
Conclusion: Completion of the study is expected by summer
of 2021 and will determine the comparative effectiveness
of a telehealth vs self-directed approach to lower 24-hour
systolic BP using web-based tools.

medicine/internal medicine, nephrology, cardiology, and
endocrinology. The survey consisted of 31 questions about
provider characteristics, knowledge of BP measurement, use
of out-of-office BP measurement, and practice patterns for
hypertension management. Practice patterns were assessed
based on responses to questions about BP goals in various
clinical scenarios (eg, younger/older, no comorbidity/
various comorbidities, good/poor functional status).
Results: Out of a total of 584 health care providers, 173
providers (35% attending physicians, 28% advanced
practitioners, 20% pharmacists, 18% residents/fellows)
completed the survey, a 29.6% response rate. The
majority (53%) of providers reported repeating office BP
measurements 75%–100% of the time if BP was above their
target goal. Nearly all (99%) providers reported using home
BP monitoring in patients with uncontrolled BP; the most
common way of receiving BP results was having the patient
bring results to clinic (52%). Only 42% correctly answered
that mineralocorticoid receptor antagonists were the drug
of choice for uncontrolled BP after maximum doses of
angiotensin-converting enzyme inhibitors, dihydropyridine
calcium channel blockers, and thiazide diuretic. In most
patient scenarios for which treatment to <130/80 mmHg is
recommended by the AHA, the majority of providers did not
report typically treating to that level. For example, providers
reported treating a hypothetical 85-year-old healthy patient
with good functional status less aggressively (47% to
<150/90, 45% to <140/90, and 8% to <130/80 mmHg) than
an 85-year-old patient with diabetes (8% to <150/90, 65%
to <140/90, and 26% to <130/80 mmHg). Family medicine
providers were more likely to choose higher BP targets.
Conclusion: Health care providers’ clinical practices play
a crucial role in achieving adequate BP control in the
population. Additional work is needed to enhance capture
of home BP measurements and address challenges to
implementing lower BP goals.

Provider Knowledge and Practice Patterns
Regarding the Measurement and Management of
Hypertension

Blood Pressure Control and Practice Patterns
During the COVID-19 Pandemic

Ahana Bhan, Kathryn Foti, Jamie Green, Cybele
Pacheco, Ion Dan Bucaloiu, Alex Chang

Alex Chang, Ahana Bhan, Kathryn Foti, Jamie Green,
Cybele Pacheco, Ion Dan Bucaloiu

Geisinger Research, Danville, PA

Geisinger Research, Danville, PA

Background: Studies show that blood pressure (BP) control
has worsened in recent years despite 2017 American College
of Cardiology (ACC)/American Heart Association (AHA)
guidelines recommending lower BP targets (<130/80
mmHg) for many adults with hypertension. Little data exist
on provider knowledge and consistency of practice patterns
with ACC/AHA guidelines.
Methods: A 31-item hypertension survey was emailed
in January 2021 to providers involved in hypertension
care at Geisinger, including those practicing in family

Background: Recent data suggest worsening blood pressure
(BP) control in U.S. adults with hypertension. The impact of the
COVID-19 pandemic on BP control has not been well studied.
Methods: We used electronic health record (EHR) data to
examine trends in BP control and adherence to hypertension
guidelines among adults 18 years of age or older with
hypertension diagnosis codes who received care at Geisinger
from January 1, 2018, to October 12, 2020. BP control of
<140/90 mmHg was defined by averaging all outpatient BP
values in the EHR over each calendar year for each patient.
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Trends in BP control were examined overall and stratified
by the prior year’s mean BP as ≥140/90, <140/90, or
unavailable.
Results: There were 127,362, 132,780, and 109,589 patients
with hypertension and outpatient BP measurements in
2018, 2019, and 2020, respectively. Patient characteristics
were similar for each calendar year (mean age of 62.9
years, 50.8% female, 35.6% with diabetes, 29.1% with
chronic kidney disease, 5.5% with myocardial infarction,
and 12.5% with heart failure). Prevalence of uncontrolled
BP of >140/90 mmHg was 25.1% in 2018, 24.9% in 2019,
and worsened to 27.2% (P<0.001) in 2020. The prevalence
of uncontrolled BP was higher in 2020 compared to earlier
years regardless of the prior year’s mean BP classification
(prior BP of ≥140/90: 48.2% remained uncontrolled
in 2019 vs 50.7% in 2020; prior BP of <140/90: 13.9%
became uncontrolled in 2019 vs 15.2% uncontrolled in
2020; no BP in prior year: 37.5% were uncontrolled in
2019 vs 39.6% uncontrolled in 2020). Among patients with
hypertension seen during the study period, 74.5% were
on first-line antihypertensive drugs (renin-angiotensinaldosterone system inhibitor: 61.9%; thiazides: 27.7%;
calcium channel blockers: 25.0%), while 34.2% were on
beta blockers; the mean number of antihypertensive classes
was 1.83 (standard deviation: 1.3). In 2020, 12.5% of visits
were conducted by telehealth, and <1% of these telehealth
visits had BP values recorded in structured EHR fields.
Conclusion: BP control worsened slightly in a large
health system during the COVID-19 pandemic. Further
investigation is needed to understand how unknown BP
measurements may have impacted hypertension care.
Opportunities to improve BP control include enhancing
capture of home BP measurements to enable appropriate
titration and addition of BP medication classes.
The Impact of the COVID-19 Pandemic on
Cardiovascular Hospitalizations
Suma Vupputuri, Kevin B. Rubenstein, Celeena R.
Jefferson, Sadiya S. Khan
Kaiser Permanente Mid-Atlantic States, Rockville, MD
Background: During the early phases of the COVID-19
pandemic, significant declines in hospitalizations for
cardiovascular disease (CVD) were observed. Potential
explanations for this phenomenon include health systemlevel factors (eg, limiting elective procedures) as well as
individual-level factors (eg, avoidance of health care due
to fear). These may have led to delays in care, and it is not
known if a “rebound” effect resulting in greater than normal
CVD hospitalizations may have occurred. Therefore, we
aimed to examine rates of CVD hospitalization following
the onset of the COVID-19 pandemic compared to rates of
CVD hospitalization prior to the pandemic.
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Methods: We conducted a retrospective, serial crosssectional study among adults (≥18 years old) with CVD
hospitalization during two periods: 1) following the onset
of the COVID-19 pandemic (March 1, 2020, to November
30, 2020); and 2) the prepandemic period (March 1, 2019,
to November 30, 2019). CVD events were defined by
emergency department or inpatient primary diagnoses for
ischemic heart disease, stroke, and peripheral vascular
disease. Rates of CVD hospitalization were reported for
3-month intervals within the pandemic and prepandemic
periods per 100 members.
Results: During the COVID-19 and prepandemic periods,
2503 and 2864 patients were hospitalized for CVD,
respectively. Patients hospitalized during the pandemic
had a mean (standard deviation) age of 67 (14) years, were
predominantly Black (45%) and White (35%), and the
majority were male (58%). There were no differences in
demographic characteristics between patients hospitalized
for CVD in the COVID-19 pandemic and prepandemic
periods. Rates of CVD hospitalization were lower during
the COVID-19 period (12.1, 13.1, and 14.3 per 100
members for time intervals with midpoints at April 15,
2020, July 15, 2020, and October 15, 2020, respectively)
than the prepandemic period (15.4, 16.1, 14.3 per 100
members for time intervals with midpoints at April 15,
2019, July 15, 2019, and October 15, 2019, respectively).
Conclusion: Rates of CVD hospitalization were
significantly lower following the onset of the COVID-19
pandemic and did not normalize until late in 2020. No
rebound effect of increased CVD hospitalization was
noted during our study period. Future efforts should
investigate whether the severity of outcomes due to CVD
hospitalization differ during the pandemic relative to the
prepandemic period, following potential delays in health
care utilization.

CHRONIC CONDITIONS, MULTIMORBIDITY,
AND AGING POPULATIONS
Association Between Spiritual Distress With
Symptoms and Quality of Life in Patients
Receiving Home-Based Palliative Care
Ellie Fratt, Andre Cipta, Bethany Turner, Eric Haupt,
Emily Rozema, Huong Nguyen
Kaiser Permanente Southern California, Pasadena, CA
Background: Spiritual distress may exacerbate other
symptoms and negatively affect quality of life. The purpose
of this analysis is to determine the association between
spiritual distress with symptoms and quality of life in
patients receiving home-based palliative care (HBPC).

aah.org/jpcrr

163

Methods: Data for this analysis were drawn from a
comparative effectiveness trial of two HBPC models
(standard vs tech-supported) for patients with serious
illness and their caregivers. Research staff contacted
patients and caregivers via phone within 14 days from
the patient’s admission to HBPC. Survey responses on
the Edmonton Symptom Assessment Scale (ESAS) and
PROMIS-10 tool for measuring quality of life were either
obtained directly from the patient or via the caregiver
(assisted or proxy report). Spiritual distress was assessed
with a validated question using the following anchors: 0
= no spiritual pain/at peace to 10 = worst spiritual pain/
not at peace; patients were categorized as having no (0),
mild (1–5), or moderate/severe (6–10) spiritual distress.
Sociodemographic characteristics were extracted from the
patient’s electronic medical record.
Results: The sample included 658 patients (mean age: 78 ± 13
years; 60% female; 50% White). The Charlson comorbidity
index was 8.3 ± 3.3. Over one-quarter of the sample (n=181)
had moderate to severe spiritual distress, and 48% endorsed
some level of spiritual distress upon admission to HBPC.
There were no differences in sociodemographics or religious
affiliation across spiritual distress groups except for race/
ethnicity. Patients who were identified as belonging to
Hispanic, Black/African American, or Other racial/ethnic
groups more often reported moderate to severe spiritual
distress than non-Hispanic Whites (32% vs 32% vs 43%
vs 21%, respectively; P=0.02). Symptom burden per ESAS
(29.8 ± 14.9 vs 35.5 ± 15.0 vs 42.5 ± 14.5) and qualify of life
per PROMIS-10 (physical: 32.3 ± 7.1 vs 30.6 ± 5.9 vs 28.6
± 6.0; mental: 41.2 ± 9.1 vs 38.4 ± 8.3 vs 34.8 ± 7.3) were
significantly worse with increasing spiritual distress from
none, mild, and moderate/severe, respectively (P<0.001 for
all). Results of the adjusted analyses will be presented at the
meeting.
Conclusion: Spiritual distress is correlated with
significantly worse symptoms and quality of life.
Prevalence of moderate to severe spiritual distress varies
by race/ethnicity. It is important to assess for and address
spiritual distress when optimizing symptom management
and quality of life, particularly within vulnerable
sociodemographic groups.
Time-Series Analysis of Recent Antidiabetic
Medication Prescribing Trends Among Medicare
Enrollees in an Integrated Health System
Michael Miller, Anna DiNucci, Rabia Jalalzai, Nonna
Rabinovich, Douglas Roblin
Kaiser Permanente Mid-Atlantic States, Rockville, MD
Background: As prevalence of type 2 diabetes mellitus
(T2DM) has grown, numerous therapeutic options
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have emerged with new evidence and revised treatment
guidelines. Despite high T2DM prevalence in Medicare
enrollees (31.6% in 2015), recent U.S. prescribing
trends (post-2015) for antidiabetic medications remain
unreported. Therefore, this research describes recent
monthly prescribing trends for antidiabetic medications
in a large, diverse population of Medicare enrollees from
Mid-Atlantic states.
Methods: Demographic, diagnostic, clinical encounter,
and prescribing data between July 2018 and July 2020
for Medicare enrollees 65 years of age or older with a
prescription drug benefit and T2DM were extracted from
the electronic health record in a large integrated health
system. The total number of unique prescription orders for
antidiabetic medications was summed and reported as the
monthly prescribing rate per 100 eligible plan members.
Cross-sectional time-series regression models with NeweyWest standard errors and up to a 6-lag order were estimated
for the 25-month observation period to describe the
monthly prescribing trends overall and by pharmaceutical
subclasses: first-generation (biguanides, thiazolidinediones,
sulfonylureas, alpha-glucosidase inhibitors, dopamine
receptor agonists, meglitinide analogs), second-generation
(glucagon-like peptide-1 agonists, sodium glucose
cotransporter-2 inhibitors, dipeptidyl peptidase-4 inhibitors),
human insulins, insulin analogs, and combination
medications. Separate models were constructed for all
monthly-eligible cross-sectional samples and continuouslyeligible samples.
Results: For all monthly-eligible members (n>22,000),
the time-series model estimated the overall baseline month
prescribing rate as β < sub > 0 < /sub ≥ 23.88 T2DM
medication orders per 100 members, with a significant
positive monthly trend (β < sub > 1 < /sub ≥ 0.12); P<0.05.
At baseline, first-generation antidiabetic medication orders
were most common (β < sub > 0 < /sub ≥ 16.28 medication
orders per 100 eligible members), followed by human
insulins (β < sub > 0 < /sub ≥ 3.87), insulin analogs (β < sub >
0 < /sub ≥ 3.04), second-generation antidiabetic medications
(β < sub > 0 < /sub ≥ 0.58), and combination medications (β
< sub > 0 < /sub ≥ 0.11). Significant positive monthly trends
were observed for human insulins, insulin analogs, and
second-generation pharmaceutical subclasses (P<0.05). For
continuously-eligible members (n=19,185), no significant
monthly trend for overall antidiabetic medication orders
was observed. However, similar significant positive monthly
prescribing trends were observed for human insulins, insulin
analogs, and second-generation pharmaceutical subclasses
(P<0.05).
Conclusion: Increasing monthly T2DM antidiabetic
medication prescribing trends were observed for some
pharmaceutical subclasses. Future work will focus on
patient-level impact with respect to T2DM management and
subsequent treatment outcomes.
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Experiences of Caregivers of Persons Living With
Dementia Receiving Home-Based Primary Care
Jessica D. Vallejo, Mayra Macias
Kaiser Permanente Southern California, Pasadena, CA
Background: Home-based primary care (HBPC) services
are essential to the care of homebound persons living with
advanced dementia (PLWD). We sought to describe the
experience of family caregivers receiving HBPC services
within an integrated health system to identify improvement
opportunities.
Methods: Using email and phone outreach, we recruited
family caregivers of PLWD who were actively receiving
care (n=129) from October 6, 2020, to November 20, 2020,
oversampling underrepresented groups. Semi-structured
interview questions probed the following domains prioritized
by the program leaders: satisfaction with HBPC services,
areas for improvement or unmet needs, and experience
with virtual care during the pandemic. Interviews were
conducted in English or Spanish and were audio-recorded
and transcribed. Transcripts were imported to NVivo where
an iterative process, informed by grounded theory, was used
to identify emergent themes.
Results: A total of 16 caregivers (81% female, 63%
Hispanic, 19% spoke Spanish) were interviewed. Most
caregivers were 50 years or older (69%) and adult
children or other family members (88%); approximately
one-third reported receiving minimal to no caregiving
help from others (32%). Caregivers reported that HBPC
met (31%) or exceeded (56%) their expectations. The
interviews highlighted 4 important themes: caregivers’
appreciation for the coordinated, continuous, convenient,
and affordable care provided by HBPC; informational and
emotional support for the caregiver; desire for additional
assistance with personal care needs and costs of medical
supplies and equipment; and areas for improvement
related to better communications around program
expectations, after-hours support, and quality of care
with contracted home health staff. Caregivers felt there
should be a balance between virtual care and necessary
in‐person visits due to the complexity of patient needs
and technology challenges.
Conclusion: Similar to previous reports, we also found that
for most family caregivers of PLWD, HBPC was effective
in providing coordinated, continuous, and convenient
care aligned with families’ priorities. However, caregivers
also expressed unmet service and financial needs and
desired improved communications and quality oversight
for other contract services. Expansion of HBPC services
will be contingent on not only improving care experience
for patients and families but also more effective resource
utilization for health systems and payers.
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IMPACT Learning Health Network: Transforming
Care Through Embedded Pragmatic Clinical Trials
in Health Care Settings That Serve People With
Dementia
Leah Tuzzio, Leah Hanson, Ula Hwang, Rosa Baier,
Rachel Hays, Eric Larson
Kaiser Permanente Washington, Seattle, WA
Background: More than 5 million Americans are living
with Alzheimer’s disease or a related dementia, which is
expected to triple in the next 30 years. People living with
dementia (PLWD) have higher rates of hospital stays,
emergency room visits, skilled nursing facility stays, and
overall health care utilization. Care partners experience
increased anxiety, depression, and stress. The disconnect
between health care settings and evidence-based care for
PLWD has stymied the real-world health care setting from
adoption of promising interventions. Care settings that
embrace a culture of continuous learning are ideal settings
for embedded pragmatic clinical trials (ePCTs), which
can accelerate evidence generation in a cycle that creates
sustainable improvements in clinical practice.
Methods: The mission of the NIA IMPACT Collaboratory
is to build the nation’s capacity to conduct ePCTs of
nonpharmacologic interventions embedded within health
systems for PLWD and their care partners. Over the past
year, IMPACT developed a learning health network (LHN),
a consortium of individuals representing care settings and
organizations joined by the common goal of improving
care quality, equity, and accessibility for PLWD and
their care partners. The LHN is intended to comprise 4
communities, bringing together stakeholders and catalyzing
collaboration to build capacity for ePCT research: 1) longterm care (nursing homes, assisted living facilities); 2)
health care settings (ambulatory care clinics, Accountable
Care Organizations, Medicare Advantage plans, integrated
delivery systems); 3) hospitals/emergency departments
(inpatient, hospital at home, prehospital); and 4) communitybased organizations (Meals on Wheels, hospice, senior
centers, adult day centers).
Results: Thus far, 3 communities have formed within
the LHN. Topics discussed have included setting-specific
priorities for dementia care, common interests in dementia
research, challenges within each setting to implement ePCTs
with this population, and how to collaborate. Currently,
there are multiple IMPACT funding opportunities to support
research collaboration in this area.
Conclusion: This LHN is building a national resource
devoted to the intersections between ePCTs for persons with
dementia and the setting in which they receive health care.
The LHN seeks to engage investigators and sites within
the HCSRN and other health care settings to establish a
collaborative to support and facilitate the conduct of ePCTs
among PLWD and their care partners.
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Multimorbidity Among Nursing Home Residents
With Obesity
Ning Zhang, Yanhua Zhang, Junkai Xie, Chongli Yuan,
Danni Liu, John Zeber, Arlene Ash, Min Zhang
Meyers Primary Care Institute, Worcester, MA
Background: A steady increase has occurred in the
prevalence of obesity among nursing home residents, from
22% in 2005 to 28% in 2015; meanwhile, the prevalences
of other weight categories have all decreased. Obesity
develops frequently in the presence of other chronic
conditions or cognitive impairment. Thus, nursing home
care providers must manage obesity, comorbidities, and
functional limitations. The objectives of this project are to
characterize constellations of multimorbidity among nursing
home residents with obesity.
Methods: This study is a secondary data analysis based on
the Minimum Data Set in 2014. The study sample includes
residents with a body mass index (BMI, defined as weight
in kilograms divided by height in meters squared) of ≥30.
Residents were categorized as having class I (30 ≤ BMI <
35), class II (35 ≤ BMI < 40), or class III (BMI ≥ 40) obesity.
Multimorbidity represents if a resident had any chronic
conditions, functional limitations, and geriatric conditions
(ie, conditions commonly experienced by older adults that
are not included in the chronic disease paradigm). Other
variables of interest included age, sex, race, and ethnicity.
We used association rule mining to identify the most
common monads, dyads, triads, quadriads, and pentads.
In addition, we identified the association between the cooccurring conditions.
Results: Among nursing home residents with obesity,
the most common condition was hypertension (75%)
presenting with or without the co-occurrence of any other
conditions. The most common dyad was hypertension and
urinary incontinence (52%). The most common triads were
hypertension, urinary incontinence, and bowel incontinence
(37%). The most common quadriads were hypertension,
urinary incontinence, bowel incontinence, and moderate
to severe cognitive impairment (23%). The most common
pennads were hypertension, urinary incontinence, bowel
incontinence, moderate to severe cognitive impairment, and
depression (37%). Class III obesity has a slightly different
combination of multimorbidity than the other two groups.
Bowel incontinence and urine incontinence have a strong
correlation.
Conclusion: Nursing home residents with obesity
frequently have hypertension, depression, moderate
physical dependence, and some geriatric conditions. Clinical
practice guidelines should address how these conditions
in combination impact care processes and contribute to
undesirable outcomes such as hospitalization and mortality.
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Examining Long-Term Weight Loss Surgery
Success in a National Electronic Health Record
Dataset
Megan Ferriby Ferber, Timothy Chrusciel, Joanne
Salas, Jeffrey Scherrer
Saint Louis University / SSM Health, St. Louis, MO
Background: As rates of obesity continue to rise, so do
the number of patients seeking weight loss surgery (WLS).
This study utilized a private sector electronic health record
(EHR) database to determine if patients’ sex, racial identity,
and presurgical comorbidities were associated with postWLS success (ie, losing ≥50% excess weight) out to 4 years
postsurgery.
Methods: We used a national EHR database of 5 million
adults. Our study cohort was created using ICD-9 and ICD10 codes to identify patients who had WLS in 2012 to 2015.
Additional inclusion criteria were baseline body mass index
(BMI) of 35 or greater and a valid BMI for at least 1 followup period. Successful weight loss was defined as the loss
of at least 50% of the weight needed to reach a BMI of 25.
Patient characteristics were compared at 4 follow-up periods:
1, 2, 3, and 4 years postsurgery. Data were analyzed using
chi-squared tests for categorical variables and independent
t-tests for continuous variables.
Results: Results indicated 66.2% of patients experienced
successful weight loss at 1 year post-WLS. Significant
differences (P<0.05) were associated with female sex,
White race, younger age, lower baseline BMI, and 8 of the
15 comorbidities examined. At 2 years post-WLS, 59.4%
of patients experienced successful weight loss, with White
race, younger age, lower baseline BMI, and 5 comorbidities
(diabetes, hypertension, hyperlipidemia, hypertensive
heard disease, other heart disease) significantly associated
with successful weight loss. At 3 years post-WLS, 49.9%
of patients had successful weight loss. Hypertension,
anxiety disorders, and nonalcoholic steatohepatitis were
significantly associated with successful weight loss. At 4
years post-WLS, 48.7% of patients experienced successful
weight loss, with race, age, and nonalcoholic steatohepatitis
significantly associated with success (P<0.05).
Conclusion: Our results suggest that a larger number
of patient characteristics are associated with successful
weight loss at 1 year post-WLS as compared to success
at 2 to 4 years post-WLS. The percentage of successful
weight loss decreases with time after surgery. These results
support the efficacy of WLS in the general population and
that there may be a need for sustained support out to 2
years post-WLS to help patients experience optimal postWLS outcomes.
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Symptom Burden Is Lower in Asian and Pacific
Islander Patients Admitted to Home-Based
Palliative Care but Similar Among Other Racial/
Ethnic Groups

Challenges
of
Comparative
Effectiveness
Research in Palliative Care: Lessons From a
Pragmatic Trial of Video Consultations in HomeBased Palliative Care

Emily Rozema, Eric Haupt, Richard Mularski, Huong
Nguyen

Carmit McMullen, Huong Nguyen, Susan Wang, Henry
Werch, Paula Edwards, Gina Andres, Brian Mittman,
Ernest Shen, Lynn Reinke, Richard Mularski

Kaiser Permanente Southern California, Pasadena, CA
Background: Prior studies suggest that, among patients
admitted to home-based palliative care (HBPC), patientreported pain, depression, and overall symptom burden are
higher among Black and Hispanic patients. However, these
studies were mostly descriptive in nature and did not account
for other relevant covariates. The purpose of this analysis is to
add to existing knowledge by determining if symptom burden
differs between seriously ill White patients and patients of
color in a large, ethnically diverse HBPC cohort.
Methods: We drew from baseline data (2019) collected
as part of a comparative effectiveness trial of two models
of HBPC for patients with serious illness and their family
caregivers across two Kaiser Permanente regions. The
Edmonton Symptom Assessment Scale (ESAS) was
administered to patients or proxy caregivers by research staff
or HBPC clinicians. To assess for differences in ESAS total
scores at admission to HBPC, we performed a univariate
analysis of differences in mean scores and a multivariate
median regression analysis across all race/ethnicity
groups. Covariates included age, gender, insurance type,
income, receipt of medical financial assistance, Charlson
comorbidity score, admitting diagnosis, impairment with
activities of daily living, do-not-resuscitate code status,
hospital utilization in the prior 7 days, treatment arm, proxy
response, whether the ESAS was administered by research
staff or clinicians, and site.
Results: Characteristics of the 2245 patients were mean age of
78 ± 13 years, 52.7% female, 54.2% White, 23.4% Hispanic,
13.5% Black, 8.4% Asian/Pacific Islander (PI), and 0.6%
multiracial/other/unknown. In the univariate analysis, mean
baseline ESAS scores were comparable across White (29.4
± 14.35), Black (29.7 ± 15.14), and Hispanic (29.3 ± 15.75)
groups but lower among Asian/PIs (25.4 ± 13.6) (P=0.002).
In the multivariate analysis, mean baseline ESAS score for
the Asian/PI group was lower (-3.5 [-6.2, -0.8]; P=0.01)
compared to the White group. There were no significant
differences across other race/ethnicity categories.
Conclusion: These findings indicate that, in this integrated
health system cohort, while symptom burden was not
higher in Black and Hispanic groups, it was lower among
Asian/PI patients admitted to HBPC compared to Whites.
More research is needed to assess whether access to care,
health system factors, geographic factors, or other factors
may contribute to previous findings of disparities in
symptom burden.
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Kaiser Permanente Northwest, Portland, OR
Background: Comparative effectiveness studies using
pragmatic trial designs offer opportunities to generate robust
evidence that health systems need about interventions and
innovations tested in real-world settings. In palliative care,
evidence-based interventions are needed to identify practice
innovations for ameliorating the unmet demand for services.
Telemedicine has the potential to enhance access, but there is
little evidence about telehealth interventions in this setting.
Methods: We conducted a pragmatic, cluster-randomized
noninferiority trial in two large integrated health systems
(HomePal Study). Registered nurses (n=111) at 14 sites
were randomized to standard in-person care vs videovisit supported care. Patients and caregivers were enrolled
in the study, which included mixed-methods process
evaluation using the NASSS (nonadoption, abandonment,
scale-up, spread, sustainability) framework of technology
nonadoption. Primary outcomes included symptom burden
and caregiving preparedness at 1–2 months.
Results: The study was stopped early due to low video-visit
uptake and the health system’s decision to expand telehealth
to both study arms, the latter of which was incompatible
with the randomized design. Maintaining static comparators
and randomization of nurses ultimately proved unfeasible.
Funding specifications precluded adaptations that we
proposed in response to health system needs and constraints.
Pivoting to a cluster-randomized step-wedge design would
have allowed a staggered rollout of video-enabled care, an
approach that is more familiar and amenable to health systems
and clinicians. Shifting to an adaptive trial design would
have enabled iterative improvements of our intervention as
we gained experience with video visits and the technology
platforms and incentives for telehealth delivery evolved.
Conclusion: The success of large, multisite pragmatic trials
testing complex interventions depends on continued support
and engagement of health system stakeholders, ranging
from frontline clinicians to executives. Multiyear palliative
care trials must do so while serving severely ill patients
with acute needs in a rapidly shifting landscape of market
pressures and regulatory/payment changes. Our experience
offers important lessons, particularly with the unprecedented
COVID-19 pandemic — the need to be flexible and nimble
with study designs and methodology and the need to
implement changes in the face of imperfect or incomplete
evidence, as was the case with telehealth.
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COVID-19
“Home a-Lonely”: Understanding Emotional and
Social Complexities of Remote Work During the
COVID Pandemic
Heather R. Walker, Isaac Holyoak
University of Utah Health, Salt Lake City, UT
Background: As the infection and death rates for
COVID-19 continue to soar on a global scale, researchers
around the world are coming forward to measure,
evaluate, and understand the impacts of this virus. For
example, the White House issued a Call to Action on
March 16, 2020, to bring forward technology researchers
to analyze COVID-19 data. Likewise, academic
journals like The Lancet, Global Heart, Journal of
Medical Internet Research, and others put out calls for
COVID-19–centered research. To meet the increased call
for expansive research on the impacts of COVID-19, this
research sets out to understand how the shift from oncampus to remote work has been impacting work culture
at two University of Utah Health teams.
Methods: This mixed-methods study aims to understand the
social and emotional complexities of forced remote work
experienced during the COVID-19 pandemic. To do this, a
SenseMaker® project was developed and deployed via social
media and through two institutional employee lists from
University of Utah Health. SenseMaker® is a sensemaking
tool that captures both widespread patterns and weak
signals in attitudes and mindsets. It requires respondents to
visually weigh various relational elements to interpret their
experiences around a given topic or phenomenon (Van der
Merwe et al, 2019).
Results: Findings reveal a resource-based discrepancy
between individuals’ coping behaviors and strategies, a
distinct polarization in outlook toward remote work, and
a feeling of productivity based more on meeting basic
demands than on set work hours. Also, this study finds that
conversations about mental health are not being had to the
extent they are perceived to be needed.
Conclusion: When the Work-Home Resources Model (Ten
Brummelhuis, 2012) is applied to contextualize experiences
with forced remote work during a pandemic for health
teams, it becomes evident that mental health needs to be
strongly emphasized. Findings from this study complicate
understandings of productivity and provoke further
discussion of how health systems might best approach
employee work and health in the future.
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Disparity of Seroprevalence of SARS-CoV-2 IgG
Antibodies in a Large Midwestern Health System
Veronica Fitzpatrick, Anne Rivelli, Jon Richards
Advocate Aurora Health, Downers Grove, IL
Background: Recent research has suggested widespread
disparity in COVID-19 distribution among racial and ethnic
minorities, especially Black and Hispanic populations.
In all cases, Black persons are more likely to contract
COVID-19 and are twice as likely as White persons to
die of related complications. Black and Hispanic persons
may be at greater risk of exposure to COVID-19 because
they are more likely to be essential workers and also tend
to live in densely populated areas and multigenerational
households The objective of the study was to contribute to
current research on distribution of exposure to SARS-CoV-2
immunoglobulin G (IgG) by describing disparities across
baseline demographic and clinical role factors among a large
cohort of health care workers employed by one of the largest
Midwestern health systems in the United States.
Methods: This cross-sectional study collected 16,233
SARS-CoV-2 IgG serum samples between June 8, 2020,
and July 10, 2020, from a convenience sample of Illinoisand Wisconsin-based adult health care workers. Positive
presence of SARS-CoV-2 IgG antibodies was detected
using the ARCHITECT assay (“SARS-CoV-2 IgG assay”),
developed in collaboration with Abbott Laboratories and
approved for use by the U.S. Food and Drug Administration.
Study data included SARS-CoV-2 IgG assay result and
baseline factors of interest (age, sex, race, ethnicity, clinical
role category, zip code). Crude and adjusted relative odds
were generated to describe disparities.
Results: Among the 16,233 total participants, 622 (3.83%)
had positive SARS-CoV-2 IgG. Crude and adjusted odds
revealed age, race, ethnicity, and clinical role disparities
at P<0.0001. Participants 32–82 years old (vs age 18–31)
had lesser adjusted odds of positive IgG (0.54–0.66). Black,
Asian, and mixed-race participants (vs White participants)
had greater adjusted odds of positive IgG (3.86, 1.87, and
1.99, respectively). Hispanic (vs non-Hispanic) participants
had 1.80 times greater adjusted odds of positive IgG.
COVID-clinical (vs nonclinical) participants had 1.86 times
greater odds of positive IgG.
Conclusion: This study highlights the disparity in
distribution of the SARS-CoV-2 virus by age, race, ethnicity,
and clinical role category. Generally, positive SARS-CoV-2
IgG was detected more among health care workers who were
youngest, non-White, Hispanic, and working in COVIDdesignated clinical units.
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Widening Cancer Care Disparities in the Adoption
of Telemedicine During COVID-19: Who Is Left
Behind?

Disparities in Outpatient and Telehealth Visits
During the COVID-19 Pandemic in a Large
Integrated Health Care Organization

Su-Ying Liang, Michael Richardson, Monique de Bruin,
Tony Chen, Natalia Colocci, Allison Kurian, John Chan

Lei Qian, Stanley Xu, Lina Sy, Sungching Glenn,
Vennis Hong, Denison Ryan

Sutter Health, Palo Alto, CA

Kaiser Permanente Southern California, Pasadena, CA

Background: COVID-19 has reshaped how care is delivered
— in person, virtually, or postponed. While telemedicine
has served as an alternative way to access care since the
beginning of the pandemic, relatively little is known about
its utility in cancer care and possible disparities in care
delivery. We examined the impact of COVID-19 on volume
of oncology services and adoption of telemedicine across
patient subgroups.
Methods: Data were obtained from the electronic health
record of a multispecialty health system serving a
racially/ethnically diverse patient population in Northern
California. The study cohort included 52,985 patients
who had at least 1 oncology encounter from January
2019 to August 2020. To compare COVID-19–related
changes in volume of encounters, we assessed the yearto-year variability for appointment cancellation, office
visits, and cancer screening procedures. Multivariate
logistic regression was performed to examine variability
in use of telemedicine (video visits) by specific patient
characteristics (sex, age, race/ethnicity, and language),
controlling for comorbidity, insurance type, and preCOVID-19 health care utilization.
Results: Compared to the pre-COVID-19 monthly averages
in 2019, oncology appointment cancellation rates increased
by 73% in March 2020. Volume of services substantially
declined in 2020 (by 66% for oncology office visits, by
92% for mammograms, and by 95% for colonoscopies in
April). Use of telemedicine for oncology started in midMarch 2020, grew to 55% of all scheduled visits in April,
and remained at 38% in August. We focused on variability
by specific patient subgroups when telemedicine was
used prevalently in April 2020. On regression analysis,
Hispanics were significantly less likely to use telemedicine
than Whites (odds ratio: 0.62, 95% CI: 0.51–0.76). Patients
who were older (odds ratio: 0.62, 95% CI: 0.49–0.78)
or who required interpreting services (odds ratio: 0.44,
95% CI: 0.32–0.61) were significantly less likely to use
telemedicine than patients who were younger or did not
need an interpreter.
Conclusion: Overall office visits decreased significantly
during the COVID-19 pandemic. Uptake of video visits
was uneven across patient subgroups and lowest among
older, Hispanic patients and those who required interpreting
services. Future studies are needed to better understand the
barriers to and preferences for transition to telemedicine.

Background: Dramatic decreases in outpatient visits and
sudden increases in telehealth visits were observed after
the start of the COVID-19 pandemic. But it is unclear
whether these changes differed by patients’ demographics
and socioeconomic status. The objective of this study was
to assess the impact of the pandemic on outpatient and
telehealth visits by demographics and household income
level in a diverse patient population.
Methods: We calculated weekly rates of outpatient and
telehealth visits (telephone or video) by age, sex, race/
ethnicity, and neighborhood household income among
members of Kaiser Permanente Southern California
(KPSC) during January 5, 2020–October 31, 2020, and the
corresponding period in 2019. We estimated the percent
change by comparing visit rates during the pandemic period
to the prepandemic period (January 1–March 7, 2020) using
Poisson regression models, adjusting for seasonality. We
examined if the changes differed by age, sex, race/ethnicity,
and household income level.
Results: Among 4.55 million KPSC members enrolled in
January 2020, about 15% were ≥65 years old, 49% were
female, 39% were Hispanic, and 8% lived in an area of
median household income less than $40,000. Across all
subgroups, outpatient visit rates decreased while telehealth
visit rates increased due to the pandemic. Among age
groups, the 65 and older population had the smallest
increase in telehealth visits: 1.5/person-year during the
prepandemic period vs 3.9/person-year in October 2020
(a 161% jump, 95% CI: 158%–164%). During the same
periods, across racial/ethnic groups, Hispanic individuals
had the largest increase in telehealth visits (220%, 95%
CI: 217%–223%); across income levels, telehealth visits
in the low-income group increased the most (220%, 95%
CI: 214%–227%). The rate of combined outpatient and
telehealth visits in the low-income group returned to
prepandemic levels (0.7%, 95% CI: -0.2%–1.6%) by
October 2020.
Conclusion: While the 65 years and older population had the
smallest increase in telehealth visits, the Hispanic group and
the low-income group had the largest increase in telehealth
utilization possibly due to the low cost and flexibility of
location and time.
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Impact of the COVID-19 Pandemic on Hepatitis C
Screening in Kaiser Permanente Mid-Atlantic States
Cabell Jonas, Michael Horberg, Eric Watson, Aniecia
Gunn, Jared Williamson, Anna Dinucci
Kaiser Permanente Mid-Atlantic States, Rockville, MD
Background: Hepatitis C virus (HCV) is a bloodborne
infectious disease. An estimated 2.4 million Americans are
living with HCV; half of these individuals may not know
they are infected. In 2014, the U.S. Preventive Services
Task Force (USPSTF) recommended individuals of babyboomer age (born 1945–1965) and those otherwise at risk
be screened one time for HCV. In March 2020, the USPSTF
expanded its recommendation to include all patients 18–79
years of age. In Maryland, Virginia, and Washington, DC,
COVID-19 cases began to rise beginning in March 2020.
In the months following, Kaiser Permanente Mid-Atlantic
States (KPMAS) clinics began to reduce services and
limit hours, and patients began delaying nonurgent care.
COVID-19 cases persisted in the region throughout 2020
and into the present. Herein, we describe the resulting
impact of the first year of the COVID-19 pandemic on HCV
screening in the KPMAS health system.
Methods: The HCV Pathway is a standardized HCV
screening program designed to improve screening rates.
The HCV Pathway became the standard for adult HCV
screening in March 2019. Hepatitis C screening through the
HCV Pathway, facility closures, and COVID-19 infection
rates were examined during the time periods of March 2019
to February 2020 (pre-COVID-19 pandemic) and March
2020 to February 2021 (during COVID-19 pandemic).
Tested patients were examined by age, sex, race/ethnicity,
service area, insurance type, and documented social history
(intravenous drug use, men having sex with men).
Results: HCV testing rates were significantly reduced
during key months of the COVID-19 pandemic in 2020.
The downward trend in HCV testing seen from March to
July 2020 was reversed by an operational change in August
2020 that expanded HCV testing to patients 18–79 years
old via electronic health record-based health maintenance
topics and best practice alerts. As a result of the operational
change, HCV screening rates increased above 2019 rates
temporarily. The deactivation of the best practice alerts in
December 2020 resulted in a stabilization of HCV testing
into 2021 to pre-COVID 2020 levels.
Conclusion: HCV screening rates were significantly
reduced during key months of the COVID-19 pandemic;
however, the implementation of electronic health recordbased alerts stabilized testing rates to at or above preCOVID-19 pandemic levels.
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Medication Adherence During the COVID-19
Pandemic: Preliminary Data From the Patient
Perspective
JoAnn Sperl-Hillen, Lilian N. Chumba, Patrick J.
O’Connor, Pamala A. Pawloski, Jeanette Y. Ziegenfuss
HealthPartners, Bloomington, MN
Background: This study aimed to share preliminary
descriptive survey results from patients with potential
medication adherence issues on how they changed taking or
filling medications during the COVID-19 pandemic.
Methods: As part of a larger trial of a clinical decision
support intervention, patients identified as potentially
nonadherent to medications were contacted by telephone to
complete a survey in the weeks after a clinical encounter.
The 10-minute survey asked patients about their recent
experiences with taking and filling medications during the
COVID-19 pandemic. Responders received a $10 thank
you incentive. Patients surveyed met criteria at a clinical
encounter for not being at clinical goal for either glycated
hemoglobin or blood pressure or if they were on a statin and
had a low adherence score (<80%) to a medication in that
domain. The adherence scores were Epic-derived proportion
of days covered (PDC) calculations using Surescripts
dispense data in the last 6 months, and only scores rated with
high data confidence were included.
Results: The survey is currently in the field, with a
50% anticipated response rate after all reach attempts
are completed. To date, a total of 123 individuals have
completed the survey; 13% of respondents noted that
they had changed how they take or fill prescriptions for
medicines due to the COVID-19 pandemic. Of these
patients, 53% indicated they were taking their medication
more regularly than before and 27% indicated they were
taking medication less regularly or having difficulty taking
their medication as prescribed. None of the individuals
reported having trouble refilling their medication, 27%
refilled their medicine sooner or more often to make sure
they didn’t run out, 27% changed to refill their prescription
by mail order, and 20% indicated they were more concerned
about the cost of their medications.
Conclusion: Of patients not achieving care goals and
identified with potential adherence issues, less than onefifth reported that the COVID-19 pandemic changed how
they took or refilled their medication. Of patients who did
make changes, more than half reported taking medications
more regularly than before. They reported no trouble
obtaining refills, but cost was a concern for some.
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Influenza and COVID-19 Vaccination Intent,
Knowledge, and Attitudes in Symptomatic Patients

How Can Artificial Intelligence Be Leveraged to
Effectively Manage Pandemics? A Scoping Review

Michelle Henninger, S. Bianca Salas, Phil Crawford,
Judy Donald, Holly Groom, Allison Naleway

Ania Syrowatka, Masha Kuznetsova, Ava Alsubai,
Adam L. Beckman, Paul A. Bain, Kelly J. Thomas
Craig, Jianying Hu, Gretchen P. Jackson, Kyu Rhee,
David W. Bates

Kaiser Permanente Northwest, Portland, OR
Background: The COVID-19 pandemic has led to an
increased emphasis on seasonal influenza (flu) vaccination
with the goal of alleviating strain on stretched health
systems. It is unknown how the pandemic has impacted flu
vaccination intention and coverage during the 2020–2021
flu season. Further, with COVID-19 vaccines now being
administered, more data is needed on people’s intent to
be vaccinated and their knowledge and attitudes about the
COVID-19 vaccines.
Methods: As part of a larger study on SARS-CoV-2 and flu
testing, we identified adult members of Kaiser Permanente
Northwest, living in the Portland-Vancouver metropolitan
area, with a recent telehealth visit consistent with COVID-19
or flu symptoms and an incomplete laboratory order for
flu or SARS-CoV-2 testing. Participants completed an
eligibility survey assessing intention to vaccinate for flu and
COVID-19 and an enrollment survey assessing knowledge
and attitudes about the COVID-19 vaccine.
Results: Since September 2020, we have invited 3762
members to participate; 647 (17%) completed the
eligibility survey and 368 (10%) completed the enrollment
survey. Most (62%) reported receiving the flu vaccine
during the previous (2019–2020) season. As of January
23, 2021, 46% reported having already received the flu
vaccine during the current (2020–2021) season. Of those
not vaccinated, 67% reported at least moderate intent to
receive the flu vaccine. Only 2% reported having already
received the COVID-19 vaccine. Of those who had
not, 86% reported at least moderate intent of receiving
the COVID-19 vaccine. Those who did not plan to get
vaccinated for COVID-19 (14%) were significantly more
likely than those who did to be concerned about vaccine
side effects and to believe the vaccine could give them
COVID-19. They were significantly less likely to believe
they were at risk of getting COVID-19, that their primary
care provider would recommend the vaccine, or to trust
federal vaccination recommendations.
Conclusion: Most participants reported receipt or intent
to receive the 2020–2021 flu vaccine, and intent to receive
the COVID-19 vaccine was even higher than that for the
flu vaccine. Patient education focusing on the safety of the
COVID-19 vaccine, and risks of not being vaccinated, are
needed to address vaccine hesitancy.
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Brigham and Women's Hospital / Harvard Medical
School, Boston, MA
Background: COVID-19 has had a profound impact on all
aspects of society, and future pandemics are sure to follow.
Artificial intelligence represents a valuable tool that could
be used to effectively manage pandemics. The objective of
this scoping review was to identify use cases for involving
artificial intelligence for pandemic preparedness and response
from the peer-reviewed, preprint, and grey literature.
Methods: We identified studies by searching 5 databases
(PubMed, Embase, Web of Science, IEEE Xplore, ACM
Guide to Computing Literature) and 2 preprint servers
(medRxiv, bioRxiv). We used a structured Google search to
identify grey literature. The data synthesis had two parts: an
in-depth review of studies that leveraged machine learning,
and a limited review of studies that applied traditional
modeling approaches such as compartmental models.
Machine learning applications from the in-depth review
were categorized into use cases related to public health and
clinical practice and narratively synthesized. Data sources
used for model development and types of machine learning
well suited for each use case were summarized.
Results: 183 articles met the inclusion criteria for the indepth review and reported on the development of machine
learning algorithms or tools in response to COVID-19, the
2009 H1N1 pandemic influenza, severe acute respiratory
syndrome (SARS), or hypothetical pandemics. Six key use
cases were identified: forecasting infectious disease dynamics
and effects of interventions; surveillance and outbreak
detection; real-time monitoring of adherence to public
health recommendations; real-time detection of influenzalike illness; triage and timely diagnosis of infections; and
prognosis of illness and response to treatment. Data sources
and types of machine learning that were useful varied by
use case. Application of machine learning was still at the
research or developmental stage for most use cases. Overall,
1173 articles reported on traditional modeling approaches
and were included in the limited review, which served to
highlight additional areas where machine learning could be
leveraged for pandemic preparedness and response.
Conclusion: Important machine learning-based solutions
have been developed in response to pandemics, but few were
optimized for practical application early in the COVID-19
pandemic. These findings can support policymakers,
clinicians, and other stakeholders in prioritizing research
and development to support operationalization of artificial
intelligence for future pandemics.
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Characteristics, Clinical Care, and SARS-CoV-2
Testing of Patients Utilizing e-Visit Encounters for
COVID-19-Like Illness, March–October 2020

Heterogeneity in COVID-19 Patients at Multiple
Levels of Granularity: From Biclusters to Clinical
Interventions

Holly Groom, Phil Crawford, Michelle Henninger, S.
Bianca Salas, Judy Donald, Lenee Blanton, Eduardo
Azziz-Baumgartner, Allison Naleway

Suresh K. Bhavnani, Erich Kummerfeld,
Radhakrishnan, Christopher Tignanelli

Kaiser Permanente Northwest, Portland, OR
Background: Kaiser Permanente Northwest (KPNW) health
system implemented an online COVID-19 electronic visit
(e-visit) in February 2020. This self-administered screening
tool allows patients to report COVID-19-like illness (CLI)
symptoms and exposures; providers review information
and recommend a clinical course of action within 24 hours.
We describe the demographics of members using the e-visit
tool and subsequent clinical care recommendations and
laboratory outcomes.
Methods: Using KPNW electronic health records, we
identified CLI e-visits among adult members from March
through October 2020. We calculated the proportion of
e-visits associated with subsequent health care visits
(categorized by most intensive care type received: inpatient/
emergency room (ER), ambulatory in-person, virtual, labonly); SARS-CoV-2 lab orders; and positive SARS-CoV-2
test results. We compared demographics and prevalence
of conditions established as increasing the severity of
COVID-19 illness (eg, body mass index [BMI] of ≥40, type
2 diabetes) between those with e-visits to general KPNW
members (with 1 or more health system encounters from
November 1, 2019, through October 31, 2020) and between
those who were and were not referred for SARS-CoV-2
testing following a CLI e-visit.
Results: We identified 24,674 CLI e-visits. The rate of
e-visits was highest among members 25–34 years of age
(294 e-visit encounters per 1000 members), double that of
non-CLI encounters in this age group in the prior 12 months
(143 per 1000). Of all CLI e-visits, 86% (n=21,162) led
to subsequent encounters, among those were inpatient/ER
(2%), ambulatory in-person (65%), virtual telephone/video
(31%), and lab-only (2%). From May through October
(when SARS-CoV-2 testing was consistently available),
77% of e-visits resulted in lab orders. Overall, 4.3% of tests
were positive for SARS-CoV-2 (weekly range: 0%–10.3%).
Demographics of members with and without test orders
were similar, as was the prevalence of high-risk conditions
such as BMI ≥ 40 (6.3% vs 7.6%, respectively) and type 2
diabetes (6.3% in both groups).
Conclusion: Many KPNW members, especially those 25–
35 years old, made use of the CLI e-visit. Most were referred
for subsequent care and/or SARS-CoV-2 testing, although
only a small proportion of tests were positive. Although
symptom severity was not obtained, similar rates of highrisk conditions were observed between those who did and
did not receive lab orders.
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University of Texas Medical Branch, Galveston, TX
Background: Several studies have shown that COVID-19
patients with prior comorbidities have a higher risk
for adverse outcomes, resulting in a disproportionate
impact on older adults and minorities that fit that profile.
However, although there is considerable heterogeneity in
the comorbidity profiles of these populations, not much
is known about how prior comorbidities co-occur to form
COVID-19 patient subgroups and their implications for
targeted care.
Methods: We used bipartite networks to quantitatively and
visually analyze heterogeneity in the comorbidity profiles
of COVID-19 inpatients, based on electronic health records
from 12 hospitals and 60 clinics in the greater Minneapolis
region. This approach enabled the analysis and interpretation
of heterogeneity at 3 levels of granularity: 1) cohort level
to identify commonly occurring phenotypes in COVID-19
patients; 2) subgroup level to measure the risk of each
phenotype; and 3) patient level to examine which patients
can use interventions designed for the subgroup and which
require individualized interventions.
Results: The results revealed statistically and clinically
significant results at each level of granularity. 1) Cohort:
The algorithm identified 4 biclusters consisting of
patient subgroups and their most frequently co-occurring
comorbidities, which was statistically significant compared
to 1000 random permutations of the data (COVID-19 Q:
0.22, random median Q: 0.19; P<0.001). The 4 biclusters
were qualitatively inferred as representing distinct
phenotypes: cardio-renal, coagulapathy liver disease,
diabetes-obesity-psychosis, and hypertensive-electrolyte. 2)
Subgroup: Each patient subgroup had different combinations
of significant associations with adverse outcomes compared
to the controls. For example, the cardio-renal had significant
odds ratios for all 3 adverse outcomes. These associations
to adverse outcomes enabled the clinicians to design triage
strategies targeted to each phenotype. 3) Patient: A majority
of the outlier patients in each subgroup had comorbidities
within their biclusters. However, the generic treatment
plans for the entire subgroup were often not appropriate,
suggesting customization of treatment for such patients.
Conclusion: The results suggest that each level of
granularity in the bipartite network analysis provided
distinct treatment and triage insights based on the cooccurrence of comorbidities. A critical limitation of the
current research is that we analyzed only one dataset, and
our future research will test the replicability of these results
in another COVID-19 dataset.
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Impacts of COVID-19 on the Peer Recovery
Specialist Role

Impact of Health Care Provider Recommendations
on COVID-19 Vaccination Intent

Morgan Anvari, CJ Seitz-Brown, Jessie Spencer, Sara
Abdelwahab, Megan Mulheron, Jessica Magidson,
Julia Felton

Kimberly A. Fisher, Ngoc Nguyen, Hassan Fouayzi,
Sonal Singh, Sybil Crawford, Kathleen M. Mazor

University of Maryland, College Park, College Park, MD
Background: The opioid epidemic and COVID-19 have
both disproportionally affected underserved minority
communities. Peer recovery specialists (PRSs), individuals
who have lived substance use experience, are uniquely
equipped to serve low-income, ethnoracial minority clients
who have been doubly burdened by a lack of access to
substance use and COVID-19 treatment and resources.
As the health system relies on PRSs in a variety of
departments, it is important to understand how they are
navigating the pandemic. This research aimed to learn 1)
the impact of COVID-19 on the PRS role/experience, and
2) how experience, training, and supervision have or have
not prepared PRSs for these challenges.
Methods: PRSs (n=15) from Maryland and New Jersey
were recruited via snowball sampling for semi-structured,
qualitative interviews. Thematic, rapid qualitative analysis
was conducted to examine themes related to the study
objectives.
Results: PRSs described numerous challenges and shifts
in their role in face of the pandemic. These included
logistic challenges, such as an inability to refer clients
to usual resource centers, assistance programs, and
treatment programs due to COVID-19-related closures
and policies. PRSs also described a shift in their role, with
an increased focus on patient basic needs, and an increase
in communication and follow-up with clients to combat a
perceived loss of interpersonal connection. Many PRSs
explained that while their training did not prepare them
for a pandemic, their shared substance use experience,
empathy, and flexibility uniquely prepared them to support
their clients. Additionally, participants noted that a key
part of the PRS role is helping clients overcome barriers to
treatment, making PRSs well equipped to assist clients as
the pandemic creates novel treatment barriers.
Conclusion: COVID-19 has posed unique challenges to and
brought on shifts in the PRS role. However, factors unique
to the PRS role, such as shared experience and helping
clients overcome barriers to treatment, have prepared PRSs
to assist clients during the pandemic. Further research may
look into how COVID-19 has affected the PRS role over
time and how novel trainings may support PRSs during
the pandemic. Lessons learned during the pandemic can
inform future developments regarding the PRS role.
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Meyers Primary Care Institute, Worcester, MA
Background: A substantial proportion of the U.S.
population is hesitant to be vaccinated against COVID-19.
The importance of a health care provider recommendation in
promoting vaccination is well established for the influenza
and human papillomavirus vaccines. We tested a series of
health care provider recommendations among COVID-19
vaccine-hesitant individuals to identify elements that
increase intent to be vaccinated.
Methods: We conducted an online survey using the Prolific
panel in January 2021, oversampling Black and Latino panel
members. Participants were classified as vaccine-hesitant
if they responded “no” or “not sure” to the question “Do
you intend to be vaccinated against COVID-19?” Vaccinehesitant participants were asked to imagine they were seeing
their doctor for an annual exam, at the end of which the
doctor states that the COVID-19 vaccine is available and that
the patient is eligible to receive it at that visit. Participants
were randomly assigned to receive either an “elective”
recommendation (control) or 1 of 4 strong recommendations
(intervention), followed by reassessment of vaccination
intent. All messages included a statement that the vaccine
is very safe and very effective. In the control message, this
was followed by “What do you think?” (ie, an elective
recommendation), whereas the intervention messages
included an explicit recommendation (ie, “I recommend
that you get it”). The intervention messages differed in the
strategy used to encourage vaccination (personal physician
review of safety data, comparison to the flu shot, statement
that millions of people have already received it, emphasis on
protecting others).
Results: The 756 vaccine-hesitant respondents were 60.2%
female, 44.2% Black, 22.4% Latino, and 33.4% White,
with a mean age of 35.6 years (range: 18–73). Vaccinehesitant participants were significantly more likely to accept
vaccination after receiving a strong health care provider
recommendation than participants who received an elective
recommendation (19.3% vs 9.9%; P<0.015). There were
no statistically significant differences between the 4 strong
recommendations.
Conclusion: A strong explicit recommendation from a
health care provider significantly increases the likelihood
that a COVID-19 vaccine-hesitant individual will
accept vaccination compared with an elective-style
recommendation. This finding highlights the importance
of health care provider outreach and delivery of strong
recommendations to foster COVID-19 vaccine acceptance.
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Reasons for COVID-19 Vaccine Hesitancy and
Conditions for Acceptance

DATA SCIENCE, INFORMATICS, AND DATA
MODELS

Kimberly A. Fisher, Ngoc Nguyen, Hassan Fouayzi,
Sonal Singh, Sybil Crawford, Kathleen M. Mazor

Computerized
Ejection
Fraction
Extraction
Algorithm Development and Validation

Meyers Primary Care Institute, Worcester, MA

Xiangyi Xu, Xiaowei (Sherry) Yan, Wendi Knapp,
Souvik Das, Anthony Sturzu, Kimberly Buss

Background: The severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) and associated coronavirus
disease 2019 (COVID-19) pandemic have been devastating.
In the United States, more than 28 million people have
been infected, resulting in more than 500,000 deaths.
The approval of effective COVID-19 vaccines is reason
for optimism, but realizing the full benefits of vaccines
will require widespread uptake. Overlap between factors
associated with COVID-19 disease and COVID-19 vaccine
hesitancy threaten to exacerbate existing health disparities.
We investigated reasons for and associations with vaccine
hesitancy to inform strategies for promoting COVID-19
vaccination among vulnerable populations.
Methods: In January 2021, we conducted an online survey
using the Prolific panel, oversampling Black and Latino
panel members. Respondents received ~$1.50 consistent
with Prolific recommendations. This abstract describes
reasons for vaccine hesitancy and the relationship between
vaccine hesitancy, vaccine knowledge, and numeracy.
Results: The analytic sample included 1706 respondents;
53.3% identified as female; 30.2% identified as Latino,
32.5% as Black, and 34.8% as White; 24.4% reported a
high school education or less; and the mean age was 34.5
years (range: 18–76). Asked if they would be vaccinated
for COVID-19, 24.3% responded “no” and 20% responded
“not sure.” We categorized both responses as vaccinehesitant. The most common reasons for vaccine hesitancy
were concern about vaccine safety (34.3%), speed of
vaccine development (20.2%), insufficient testing (14.7%),
and distrust of COVID-19 vaccines (10.2%). A majority
of hesitant respondents (54.3%) reported they would get
vaccinated if the vaccine was in widespread use; 50.2%
would get vaccinated if the COVID-19 vaccine was as safe
as the flu shot; and 47.2% would get vaccinated if someone
in their household was at risk. Vaccine-hesitant respondents
scored lower than nonhesitant respondents on vaccine
knowledge (4.8 of 7 vs 5.6 of 7 correct; P<0.001) and relied
less on numbers when making health decisions (64% vs
84%; P<0.001).
Conclusion: Overall, respondents who intend to get
vaccinated had more accurate vaccine-related knowledge
and reported greater reliance on numbers in making health
decisions. These findings suggest that messaging to vaccinehesitant adults should provide evidence of vaccine safety
using narrative and comparisons to familiar, accepted health
practices (ie, flu shots) rather than statistics.
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Sutter Health, Walnut Creek, CA
Background: Left ventricular ejection fraction (EF) is a
diagnostic indicator for the classification of heart failure
and is used in treatment. However, EF is documented with
variations in free-text reports, which hinders its utilization.
We developed a regular-expression-based algorithm
to extract EF values from echocardiogram reports and
conducted validation.
Methods: We conducted 3 phases of chart review to
validate the algorithm. The extracted EF value and EF
quality referred to domains where EF was extracted from,
and the algorithm was refined based on validation findings.
In the first phase, 112 randomly selected echocardiogram
reports were reviewed by a physician and compared to
algorithm-retrieved EF. In the second phase, 512 randomly
selected reports, stratified by departments, were reviewed
by physicians (n=7). Each report was reviewed by 2
physicians. In the final validation phase, we trained 10
physicians in charting review results, and they reviewed
1001 randomly selected reports from January 1, 2019,
to December 31, 2019. We evaluated the interreviewer
agreement on outcomes and also compared the algorithmderived values with the “gold standard,” defined as the
agreed-upon EF value between reviewers.
Results: A regular-expression algorithm was developed
based on keywords list provided by clinicians and initial
mining of 280,000 echocardiogram reports. In phase 1, both
the physician and the algorithm identified EF values from
88 of 112 reports (78.6%), showing 100% consistency of
EF-value identification fidelity. Among those 88 reports,
the accuracy of EF value extracted by the algorithm was
97.5%. In phase 2, interreviewer consistency was 93.9%
for EF value and 82.5% for EF quality. Compared to gold
standard on 499 reports, the algorithm accuracy of EF value
was 97.2%. In the final phase, interreviewer consistency for
EF value remained high (97.2%) and was improved for EF
quality (92.7%). Algorithm accuracy improved to 98.8%.
Conclusion: Cardiovascular domain knowledge is crucial
in developing algorithms for extracting EF values. The
3-phase validation has ensured the algorithm’s accuracy and
validity. The algorithm was implemented to extract EF from
all historical echocardiogram reports, and discrete EF will
be available in electronic health records for use in the system
going forward from April 2021.

Supplement

Updating Out-of-Date Virtual Data Warehouse
Tumor Variables to Align With Current AJCC8
Standards

Generating an Observational Health Data Sciences
and Informatics OMOP Data Model from HCSRN's
Virtual Data Warehouse

Rick Krajenta, Lois E. Lamerato

John Weeks

Henry Ford Health System, Detroit, MI

Kaiser Permanente Washington, Seattle, WA

Background: AJCC Cancer Staging Manuel, 8th Edition
was released in October 2016 to be implemented for cases
diagnosed on or after January 2018. This new version
had its companion data transmission system upgraded to
Version 18 of the North American Association of Central
Cancer Registries (NAACCR) standards (NAACCR is now
on Version 21). While the AJCC manual establishes rules
and data elements for staging, prognostic indicators, and
treatment, NAACCR creates format for data transmission to
central registries and regulatory agencies. We describe the
changes associated with the release of AJCC8 and suggest
a data strategy for updating HCSRN’s current Virtual Data
Warehouse (VDW).
Methods: The new NAACCR has 11 fields retired, 579
fields revised, and 223 new fields. The retired category
doesn’t include the revisions when data were maintained; 25
site-specific factor (SSF1–SSF25) fields were exploded out
to individual columns and no longer populated. The current
VDW will need to include STORE fields while maintaining
FORDS fields SSF1–25 for historic data. Prognostic factors
and posttherapy fields have been added to some topological
and/or histologic types as components of staging. Radiation
treatment has been completely revised. The new data are
very difficult to use for populating current VDW, as neither
the NAACCR extract nor local tumor registry conform to
VDW definitions. Similarly, current fields will need to hold
historic data while new fields should be added. Consequently,
the existing VDW has missing data due to not being updated
to current national data standards.
Results: Currently at Henry Ford Health, new data items that
don’t have VDW definition are stored in an ancillary table.
This could be a possible template for expanding variables to
contain these 802 NAACCR variables. The ancillary tables
could link to a core table in a star data architecture. No
attempt to recode new radiation treatment to current VDW
specs was done at Henry Ford Health, though a similar
process as to that for SSF can be implemented.
Conclusion: Although the TUMOR work group has been
on hiatus during implementation of this standards upgrade,
we need to do something to keep this dataset up to date. This
ancillary table has the potential for storage of the existing
SSF while providing a flexible structure for additional
factors as they are developed.

Background: Over the last 5 years, hundreds of millions
of dollars have been granted to research programs that use
the Observational Health Data Sciences and Informatics
(OHDSI) OMOP common data model. Kaiser Permanente
Washington Health Research Institute (KPWHRI) now
has a process for generating an OHDSI implementation
from our research data warehouse for any given cohort of
patients. In 2015, the Precision Medicine Initiative (All of
Us) Program was passed by U.S. Congress with an initial
funding of $130 million; the project decided to harmonize
data for analyses across health care organizations using
the OHDSI OMOP common data model. KPWHRI used
HCSRN’s Virtual Data Warehouse (VDW) to create a
limited version of OHDSI OMOP for the eMERGE project.
That project was improved and moved into a GitHub
project that is now available to everyone.
Methods: We created an SAS data file that contained
the VDW standard codes and code descriptions. Then,
by leveraging the OHDSI OMOP Standard Vocabularies
data, we created a mapping from HCSRN VDW codes into
OHDSI OMOP standard codes. At KPWHRI we call the
tables that provide VDW codes and descriptions Research
Code Management tables. We use these code management
tables to generate the selected patient data needed to
generate the OHDSI OMOP database.
Results: We tested the results of the OHDSI OMOP that we
generated by leveraging the cohort definitions generated
for the OHDSI OMOP as part of the eMERGE project.
The code generated by the OHDSI Atlas application and
stored in the PheKB cohort definitions ran without error
in our OHDSI OMOP data model. We compared the
results of a previously defined VDW cohort with the same
requirements, and the patient list was the same for both
independently defined cohorts.
Conclusion: The HCSRN is in a great position to
leverage the data that they have been curating for almost 2
decades in large National Institute of Health and National
Cancer Institute grants that require the use of OHDSI
OMOP. KPWHRI is offering a solution through GitHub
and welcoming the community to use the software and
participate in improving it for our entire network.
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Large Variation in Utilizing Electronic Health
Records for Clinicians During Video Visits
Xiaowei (Sherry) Yan, Zijun Shen, Hannah Husby, J.B.
Jones
Sutter Health, Walnut Creek, CA
Background: Measuring how the electronic health record
(EHR) is used for clinic visits has led to insights about
how to reduce EHR burden and improve workflow, user
interface, and experience. During the COVID-19 pandemic,
video visits (VV) have seen rapid adoption across almost all
specialties as an alternative to in-person visits (IPV). It is
unknown if and how EHR use by clinicians differs during
VV and how this varies by specialty.
Methods: We randomly selected 5 individual days from
March 1 to April 30 in 2020 and extracted EHR audit
logs for all completed outpatient visits. We analyzed
clinicians’ EHR utilization time by aggregating time
spent in EHR activities for each encounter and estimated
each clinician’s total EHR time and time before and after
check-in. We compared clinician’s mean EHR time for
VV by specialty and compared EHR time for VV to IPV
for the same specialty.
Results: Audit log data for 17,369 completed VV and
53,223 IPV were extracted and analyzed. Clinicians
accessed the EHR before patient check-in significantly more
for VV than IPV (50.9% of the time vs 23.7%). On average,
clinician’s EHR time per encounter was similar between
VV (32.9 minutes, standard deviation [SD]: 28.3) and IPV
(32.9 minutes, SD: 31.6). However, clinician’s EHR per
encounter varied significantly by specialty for VV, from
19 minutes (SD: 18.9) in nephrology to 60.1 minutes (SD:
44.7) in integrative medicine. Clinician’s EHR time differed
significantly between VV and IPV for some specialties: in
rheumatology and psychiatry, EHR time for IPV was 17.2
minutes longer than VV; and it differed by 7.1 minutes in
internal and family medicine, which account for 42% of VV.
In contrast, in integrated medicine, EHR time was twice as
long for VV (mean: 60.1 minutes) than IPV.
Conclusion: EHR use during VV varies significantly
across specialties. There is a significant difference in
duration of EHR use between VV and IPV within the
same specialty. EHR time for clinicians is significantly
longer for IPV than for VV in primary care encounters.
Incorporating VV into a primary care provider’s daily
schedule might be an opportunity to address clinician
burnout by reducing EHR work.
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Can Claims Data Accurately Predict Preoperative
Body Mass Index Among Bariatric Surgery
Patients? A Comparison of Machine Learning
Approaches
Jenna Wong, Xiaojuan Li, David Arterburn, Adee
Kennedy, Dongdong Li, Rui Wang, Sengwee Toh
Harvard Medical School and Harvard Pilgrim Health
Care Institute, Boston, MA
Background: Lack of body mass index (BMI) measurements
hinders use of claims databases in obesity research. In
bariatric surgery populations, the ability of claims data to
accurately predict preoperative BMI, a potential confounder
of surgical outcomes, could further facilitate use of claims
data in comparative effectiveness and safety studies of
bariatric procedures.
Methods: We used the OptumLabs® data warehouse (January
2011–June 2018), containing linked de‐identified claims
and electronic health record (EHR) data, to identify patients
≥18 years of age who underwent a new bariatric surgery.
Eligible patients had a preoperative BMI recorded in the
EHR ≤30 days before the index procedure. We constructed
72 features describing patients’ demographics, diagnoses,
medications, and previous hospitalizations based on linked
claims data ≤6 months before surgery and applied 6 machine
learning techniques using minimal human guidance to predict
preoperative BMI as a continuous value (kg/m2). We tuned and
trained the models on 90% of patients whose index procedure
occurred in 2011–2017. We assessed model performance on
the remaining 10% of patients in 2011–2017 (concurrent) and
all patients with an index procedure in 2018 (prospective).
Results: Among 3226 eligible patients, 1877 (58%) had
sleeve gastrectomy, 1136 (35%) had Roux‐en‐Y gastric
bypass, and 213 (7%) had adjusted gastric banding. Most
patients were female (76%), and the mean age was 48 years.
Median (interquartile range) preoperative BMI measured in
the EHR was 44.8 (40.5–50.6) kg/m2. Using claims-based
features to predict preoperative BMI, algorithms capable of
automatically performing variable selection and automatically
modeling interactions and nonlinear relationships (random
forest, XGBoost, and feedforward neural network) achieved
an R2 of 0.862–0.874 and mean absolute error of 2.2–2.3 in
the concurrent testing set. Other algorithms (linear regression,
elastic net, and support vector machine) had lower but still
decent performance, with an R2 of 0.747–0.755 and mean
absolute error of 3.1–3.3 in the concurrent testing set. Similar
performance was observed in the prospective testing set.
Conclusion: In the absence of BMI measurements,
claims-based models — especially models automatically
implementing variable selection, interactions, and nonlinear
relationships — can accurately predict preoperative BMI
in bariatric surgery patients, thus facilitating confounding
control by baseline severity of obesity in claims-based
studies evaluating bariatric procedure outcomes.
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A Natural Language Processing Approach to
Improving the Use of Electronic Health Records
for Identification of Patients With Social Risks and
Needs
Christopher Rouillard, Mahmoud Nasser, Haihong Hu,
Kevin Rubenstein, Douglas Roblin
University of California, Berkeley, Oakland, CA
Background: Health systems are committed to addressing
the impacts of social determinants of health (SDoH) on
patients’ health and well-being. Advances in electronic
health record (EHR) systems provide opportunities for
systematic documentation and surveillance of historically
undetected patient SDoH. Natural language processing
(NLP) developments create a unique opportunity to generate
a machine learning approach to identify patient SDoH.
Methods: We developed an open-source NLP approach to
identify patient SDoH from unstructured free-text provider
notes. This generalizable approach enables implementation
across multiple EHR systems, geographic regions, and SDoH
categories. Patient self-reported SDoH status (recorded by Your
Current Life Situation [YCLS] survey) and associated provider
notes recorded between March 2017 and June 2020 were
extracted (32,261 beneficiaries; 50,722 YCLS surveys; 485,425
provider notes). Machine learning test statistic Term FrequencyInverse Document Frequency was used for NLP pattern
generation. Patterns were developed and assessed in a training,
training validation, and final validation dataset (64%, 16%, and
20% of total data, respectively). NLP models analyzed 3 SDoH
categories: housing instability and utilities payment (Housing),
medical services payment (Medicine), and transportation
assistance (Transportation). We also assessed model ability
to identify a combined SDoH metric. Model performance
was analyzed using sensitivity, specificity, and Cohen’s kappa
statistic, assuming the YCLS survey to be the gold standard.
Results: Within the training validation dataset, SDoHspecific NLP models showed strong sensitivity and specificity,
with moderate agreement with the YCLS survey (Housing:
sensitivity of 0.67, specificity of 0.89, Kappa of 0.51;
Medicine: sensitivity of 0.55, specificity of 0.73, Kappa of
0.20; Transportation: sensitivity of 0.79, specificity of 0.87,
Kappa of 0.58). Model performance in the training dataset
was comparable to the training validation dataset. In the final
validation dataset, a combined SDoH prediction metric showed
sensitivity of 0.77, specificity of 0.69, and Kappa of 0.45.
Conclusion: Our NLP algorithm demonstrated moderate
performance in identification of overall SDoH status and
specific unmet SDoH from digitized EHR provider notes
compared to patient self-reports of SDoH. An NLP approach
will enable improved surveillance of SDoH and, therefore,
support delivery of interventions to patients unidentified by
existing survey methods (nonrespondents, not in sample).
NLP offers a novel approach for identifying unmet SDoH,
improving resource allocation, monitoring SDoH goals, and
ultimately improving patient health.
Supplement

Development and Testing of a Risk-Standardized
Inpatient Respiratory Depression Electronic
Clinical Quality Measure for Orthopedic Practice
Ania Syrowatka, Avery Pullman, Woongki Kim, Stuart R.
Lipsitz, Michael Sainlaire, Tien Thai, Wenyu Song, Troy
Li, Alexandra Businger, David W. Bates, Patricia C. Dykes
Brigham and Women's Hospital / Harvard Medical
School, Boston, MA
Background: Postoperative respiratory depression is a
serious event that places patients at risk for hypoxia, anoxia,
severe brain damage, cardiac arrest, and death. Key challenges
to accurate and comparable measurement are lack of a
universal definition, variability in measurement approaches,
and heterogeneous populations. The objective of this work
was to develop and test an electronic clinical quality measure
(eCQM) that reports the inpatient respiratory depression rate
following total hip arthroplasty and total knee arthroplasty.
Methods: Measure specifications were informed by a review
of the literature, existing clinical quality measures as well as
those under development, and consultations with a technical
expert panel. Respiratory depression was measured using
information routinely documented in electronic health records:
respiratory depression-related diagnoses (eg, hypoxemia)
or respiratory failure; mechanical ventilation or intubation
procedure codes; and oxygen saturation (ie, SpO2) levels.
Testing was conducted using data captured in the Mass General
Brigham (MGB) electronic health record. The percentage of
patients who experienced postoperative respiratory depression
during the inpatient stay was calculated (unadjusted and riskstandardized), both overall and stratified by clinician group.
Results: At MGB, 16,474 patients received an inpatient
elective primary total hip arthroplasty or total knee
arthroplasty in 2016–2019 and were included for measure
testing. Most patients were White (90%), female (58%),
over the age of 65 years (58%), and spoke English as their
primary language (96%). Overall, 545 patients experienced
respiratory depression during the inpatient stay for an
unadjusted rate of 3.3%. Respiratory depression was
identified based on documented diagnostic or procedure
codes for 252 patients. An additional 293 patients (~50% of
cases) were identified using documented oxygen saturation
levels. There were 6 orthopedic clinician groups at MGB,
and inpatient respiratory depression rates ranged from
2.5% to 6.7% (unadjusted). The overall risk-standardized
inpatient respiratory depression rate at MGB was 2.7%, with
clinician-group rates ranging from 2.3% to 3.7%.
Conclusion: Development of this eCQM addressed
challenges associated with measurement of respiratory
depression by leveraging data elements (specifically vital
signs) routinely documented in electronic health records but
not available in administrative health data. This approach
allowed for more accurate estimates of inpatient respiratory
depression and fair comparisons of performance between
orthopedic clinician groups.
aah.org/jpcrr
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Use of Natural Language Processing to Ascertain
Suicide Ideation/Attempt From Clinical Notes
Within a Large Integrated Health System

Maximizing Use of Chronic Disease Clinical
Decision Support in Primary Care Clinics: Lessons
Learned From Randomized Trials

Fagen Xie, Deborah S. Ling Grant, John Chang, Britta
I. Amundsen, Rulin C. Hechter

JoAnn Sperl-Hillen, Heidi L. Ekstrom, Kris A. Ohnsorg,
Daniel Saman, Stephen Waring, Thomas Elliott,
Clayton Allen, Deepika Appana, Patrick J. O’Connor

Kaiser Permanente Southern California, Pasadena, CA
Background: Identifying risk factors for suicide using
clinical notes is time-consuming and usually requires
manual case review. This study aims to develop and validate
a natural language processing computerized algorithm
to automatically ascertain suicide ideation/attempt from
clinical notes in a large integrated health system, Kaiser
Permanente Southern California (KPSC).
Methods: Clinical notes containing prespecified relevant
keywords and phrases related to suicidal ideation/attempt
between 2010 and 2018 were extracted from KPSC
electronic health record system. A random sample of
864 clinical notes was selected and equally divided into
4 subsets. These subsets were reviewed and classified as
1 of 3 suicide ideation/attempt categories — “Current,”
“Historical,” and “No” — for each note by experienced
research chart abstractors. The first 3 subsets were used
as training datasets to develop the computerized algorithm
sequentially, and the fourth was used as a validation dataset
to evaluate the algorithm performance. The validated
algorithm was then applied to the entire study sample of
clinical notes.
Results: The computerized algorithm ascertained 23 of the
26 confirmed Current suicide ideation/attempt events and
all 10 confirmed Historical suicide ideation/attempt events
in the validation dataset. This algorithm produced 88.5%
sensitivity and 100.0% positive predictive value (PPV) for
Current suicide ideation/attempt and 100.0% sensitivity and
100.0% PPV for Historical suicide ideation/attempt. A total
of 1,050,289 Current ideation/attempt events and 293,038
Historical ideation/attempt events were identified after the
computerized algorithm was applied to the entire study
population sample. Among the 400,436 individuals who
were identified as having a Current suicide ideation/attempt
event, 115,197 (28.8%) were 15–24 years old at the first
event during the study period, 234,924 (58.7%) were female,
165,084 (41.7%) were Hispanic, and 150,645 (37.6%) had 2
or more events in the study period.
Conclusion: Our study showed that a natural language
processing computerized algorithm can effectively ascertain
suicide ideation/attempt from the free-text clinical notes in
the electronic health record of a diverse patient population.
This algorithm can be utilized in support of suicide
prevention programs and patient care management.
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HealthPartners, Bloomington, MN
Background: High and sustained clinical decision
support (CDS) use rates are a necessary precondition for
CDS success, because CDS systems that are not used are
unlikely to improve care. In this comparative case report,
we describe various strategies used for CDS training,
financial incentives, feedback of CDS use rates, and other
factors associated with both high and low CDS use rates in
primary care clinics.
Methods: Comparative case report of 3 National Institutes
of Health-funded CDS implementation projects that address
cardiovascular risk factor control in primary care settings.
These studies were conducted in 3 large multispecialty
medical groups over a 10-year period of time.
Results: In Project A, CDS use rates rose to 60% at
targeted primary care encounters over a 6-month period
of time using in-clinic training and financial incentives
to clinicians and office staff. In Project B, CDS use rates
rose to 70% using in-clinic training, feedback of CDS
use rates (at targeted encounters) to clinic leaders and
individual clinicians, but with no financial incentives. In
Project C, CDS use rates rose to 50%–60% after virtual
CDS training, with feedback of CDS use rates and no
financial incentives, subsequently fell when the proportion
of targeted encounters was increased, but rose again after
face-to-face in-clinic refresher training. For CDS aimed
only at diabetes patients, clinicians could accurately
identify target patients, but when targeting was based on
less obvious measures of cardiovascular risk, algorithmic
identification of targeted patients was required.
Conclusion: These case studies suggest that training
delivered using existing local medical group training
procedures or customs is less effective than face-to-face
training in clinic settings. We found little to support the use
of financial incentives to providers as an effective strategy
to achieve or maintain high CDS use rates, although
incentives to clinic “pools” was effective. We found strong
evidence that monitoring and feedback of primary care
provider-specific and clinic-specific CDS use rates by
name is an effective strategy to initiate and sustain desired
levels of CDS use in primary care clinics.
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EPIDEMIOLOGY AND SURVEILLANCE
Review of Factors Associated With Number
Needed to Screen for Revised World Health
Organization Principles and Recommendations
for Systemic Screening of Active Tuberculosis
Rabia Jalalzai
Johns Hopkins School of Public Health, Baltimore, MD
Background: As part of the larger systematic review of
number needed to screen (NNS) to detect 1 case of active
tuberculosis (TB) per the revised World Health Organization
(WHO) principles and recommendations for systematic
screening of active TB, this paper’s main objective is to
determine factors that affected NNS to detect a single case
of TB among 21 studies emerging from WHO’s Eastern
Mediterranean Region.
Methods: We first calculated TB prevalence by dividing the
number of confirmed active TB cases by the total number
of people screened in each study. NNS counts to find 1
case of active TB were then calculated as the inverse of TB
prevalence. Results were obtained using Stata® software.
Results: The overall NNS count to detect 1 case of active
TB was 98. Within screening strategies, screening based
on TB symptoms yielded NNS of 186, chest X-ray 38, and
sputum smear 21. Among the diagnosis strategies, culture as
a method of TB ascertainment had NNS of 200 and Xpert
yielded NNS of 42.
Conclusion: NNS calculations vary depending on screening
strategies, diagnostic methods, and the risk groups included
in each study but can help guide decisions when planning
and carrying out active case finding. Among the screening
strategies, chest X-ray and smear may be high yield with
comparatively smaller NNS than symptom screening.
Among diagnostic tactics, Xpert resulted in a much smaller
mean NNS compared to culture, suggesting that it may
be valuable to include Xpert as a way of TB confirmation
when planning for active case finding. Studies that screened
children had a much smaller mean NNS compared to those
that screened adults, indicating the need to set a higher
NNS threshold when screening adults. Clinical diagnosis
for populations of children yielded NNS of 32, proposing
that it may be worthwhile to include clinical diagnosis as an
active TB confirmation method for this age group. Within
the risk groups, persons with diabetes and HIV resulted in
much smaller NNS compared to those with opioid drug use
disorder. An arbitrary threshold of the number needed to
screen set at 105 or above will result in all 3 risk groups
included as a priority group for active case finding.
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Emergency Room Utilization and Hospital
Admissions Among Patients With Monoclonal
Gammopathy of Undetermined Significance
Maira A. Castaneda Avila, Kate Lapane, Sharina
Person, Yanhua Zhou, Bill Jesdale, Kathleen M. Mazor,
Mara Epstein
University of
Worcester, MA

Massachusetts

Medical

School,

Background: Monoclonal gammopathy of undetermined
significance (MGUS) is an understudied premalignant
disorder. Patients with MGUS progress to multiple
myeloma at a rate of 1% per year and undergo regular
clinical surveillance with associated anxiety. We examined
differences in emergency department visits (ER) and hospital
admissions in patients with and without MGUS to evaluate
the impact of receiving an MGUS diagnosis on health care
utilization.
Methods: This matched cohort study included 429 patients
with MGUS diagnosed in central Massachusetts from 2007
to 2015 and 1286 patients without MGUS matched on
sex, age (± 2 years) and length of enrollment in the health
system. Frequency of ER visits and hospital admissions
were assessed in 3 time frames: 1) 1 year before diagnosis/
index date; 2) 1 month before and after diagnosis/index
date; and 3) 1 year after diagnosis/index date. Multivariable
conditional Poisson models were used to evaluate the
magnitude of change in health care utilization in patients
with MGUS as compared to patients without MGUS.
Results: Half the population was female, with a mean age
at diagnosis/index date of 75 years. The majority was nonHispanic White (MGUS: 85% vs non-MGUS: 81%), and
the mean Charlson comorbidity index score was higher
for patients with MGUS (2.3) than those without (1.6).
The rate of ER visits was 73% (95% CI: 1.1–2.8) higher
for those with MGUS than patients without MGUS in
the month before and after diagnosis/index date and 51%
higher for the year after diagnosis (95% CI: 1.25–1.82).
The rate of hospital admissions was 4 times higher (95%
CI: 2.8–7.8) for those with MGUS than for patients without
MGUS in the period around diagnosis. The association was
attenuated, although still elevated, in the year following
diagnosis (incidence rate ratio: 1.67, 95% CI: 1.4–2.00).
Conclusion: Our study suggests that MGUS diagnosis
is associated with a higher increased utilization of ER
visits and hospitalizations, especially during the month
surrounding the diagnosis date. Further studies are warranted
to examine the reason behind this increased utilization.
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A Spatial Analysis of Mental Health Disorder and
Crime Rates in St. Louis, Missouri
Ness Sandoval, Ruaa Al Juboori, Shreya Nagendra
Saint Louis University / SSM Health, St. Louis, MO
Background: Urban mental health remains an important
dimension in the study of neighborhood inequality. Yet,
few studies have examined the relationship between
neighborhood mental health and crime.
Methods: The 4 data sources used in this study were American
Community Survey 2018 5-Year, PolicyMap database, St.
Louis Metropolitan Police, and TIGER shapefiles from the
U.S. Census. Using a geospatial methodological framework,
this study explored the spatial relationship of neighborhood
mental health disorder and crime rates for 106 census tracts in
St. Louis. Missouri. This study operationalized mental health
disorder using 3 variables: 1) self-report depression; 2) selfreport of days of mental distress disorder; and 3) a depression
index. Analyses were done using ArcGis and GeoDa.
Results: The Moran’s I analysis confirmed that all 3 mental
health disorder measures had spatial autocorrelation and
that they were all significant. Self-report depression had the
highest Moran’s I value. The Moran’s I analysis also showed
that neighborhood crime rate had moderate but statistically
significant spatial autocorrelation. The spatial autoregressive
model (SAR) showed conflicting results. The SAR model
found no evidence that neighborhood crime rates were
associated with days of mental distress. However, the SAR
model did find weak evidence that neighborhood self-report
depression and the depression index were associated with
crime rates; this was an unexpected direction (ie, associations
opposite to our expectations).
Conclusion: While our results overall suggest that crime
minimally influenced depression, additional research is
needed, including to understand results in the unexpected
direction.
Accuracy of Tumor Registry Data for Capturing
Endocrine Therapy Treatment Compared to
Pharmacy Data Among Women With Breast Cancer
From an Integrated Health Care Delivery System
Cameron Haas, Erin Bowles, Janie Lee, Jennifer
Specht, Diana Buist
Kaiser Permanente Washington, Seattle, WA
Background: Accurately accounting for adjuvant breast
cancer treatment is important for studies evaluating
surveillance effectiveness and second events following initial
treatment. Previous studies have documented incomplete
endocrine therapy ascertainment in the population-based
Surveillance, Epidemiology, and End Results (SEER)
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registry based on Medicare claims data for breast cancer. We
evaluated the accuracy of SEER treatment data for endocrine
therapy in women with breast cancer using pharmacy data
from our Virtual Data Warehouse.
Methods: We included 6925 women with a primary breast
cancer diagnosis during 1995–2017 enrolled in Kaiser
Permanente Washington. We used pharmacy data as our
gold standard and included any prescription dispensings
for aromatase inhibitors, selective estrogen-receptor (ER)
modulators, and GnRH agonists following diagnosis dates.
We calculated kappa (concordance), positive predictive
value (PPV), and negative predictive value (NPV) overall
and within patient and tumor characteristics of interest.
We calculated time to first prescription dispensing as the
difference in days between diagnosis and date of first fill in
our claims data.
Results: Our cohort had a median age of 62 years; 84%
were ER+/progesterone receptor (PR)+, 45% localized
stage, just over half received lumpectomy with radiation
(54%), and only 29% received chemotherapy. Among the
5098 women with ER+/PR+ breast cancer, SEER data
identified 67% as having received endocrine therapy. This
increased to 77% when we added pharmacy dispensing data.
In the 566 cases for which receipt of endocrine therapy was
not recorded by SEER, most (76%) had their first fill within
12 months of diagnosis whereas 15% had their first fill
more than 2 years postdiagnosis. SEER’s concordance with
pharmacy dispensings was 0.76, with PPV of 95% and NPV
of 81%. PPV did not vary across most patient and tumor
characteristics; however, NPV declined with younger age at
diagnosis (75% for age of <45 years vs 87% for age of 75+
years), increasing tumor stage (71% for regional stage vs
93% for in situ), and chemotherapy treatment (72% for those
with chemotherapy vs 84% for those without chemotherapy).
Conclusion: Claims and pharmacy data enable more
complete capture of endocrine therapy data, increasing
accuracy of treatment data compared with SEER data alone.

GENOMICS AND PRECISION MEDICINE
Prospects of the Global Precision Medicine Market
Muge Yang, Bin Li
Washington Institute for Health Sciences, Arlington, VA
Background: With the rapid development of next-generation
gene sequencing technology and information technology,
the medical model is changing from the traditional “onesize-fits-all” model to the precision medical model, which is
based on the specificity of individual genetics, environment,
and lifestyle to develop individualized treatment and
prevention plans.
Methods: We used “precision medicine market'” as the
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keyword to search the literature on ProQuest Central and
downloaded the 200 most relevant articles. Based on the
data in the literature, we estimated the value of the current
global precision medicine market, including ecosystems,
end users, therapies, and geographic regions, as well as the
global market value in the next 10 years, in U.S. dollars.
Results: The factors that promote the development of
precision medicine include technological progress, market
demand, changes in medical models, public attention, and
government action. The factors hindering the development
of precision medicine include high price, technical
limitations, scarcity of professionals, and lack of appropriate
policies and regulations. The global precision medicine
market size is estimated at $53.7 billion–$87.2 billion in
2019, and it is expected to reach $146.8 billion–$278.6
billion by 2030. The compound annual growth rate from
2020 to 2030 is 11.13%. The precision medicine market
can be segmented by ecosystem, end user, treatment, and
geography. By ecosystem and end user, diagnostic-related
segments occupy the main part of the precision medicine
market. By therapeutics, the oncology segment dominates
the precision medicine market with an estimated market
share of more than 30%. North America is the largest and
most potential regional precision medicine market; in 2019,
its market was $31.4 billion–$54.6 billion and contributed
approximately 35.0%–46.8% of the global market values.
Europe is the second-largest market with a market size of
$15.1 billion–$34.3 billion in 2019. The Asia-Pacific region
is the fastest-growing precision medicine market with a
compound annual growth rate of 14.4%–16.6% in the next
few years. It is foreseeable that precision medicine will be
one of the fastest-growing industries in the world over the
next 10 years.
Conclusion: It is foreseeable that precision medicine will
be one of the fastest-growing industries in the world over
the next 10 years, and the growth rate will remain over 10%.
Genetic Risk Factors for Suicidal Behaviors Among
Community-Based Veterans: Exploratory Results
From the Veterans’ Health Study
Joseph A. Boscarino, Richard E. Adams, Joseph J.
Boscarino, Thomas G. Urosevich, Stuart N. Hoffman,
H. Lester Kirchner, Ryan J. Dugan, Carrie A. Withey,
Charles R. Figley
Geisinger Research, Danville, PA
Background: Since suicide among veterans is a concern
among health care providers and our genetic knowledge
of this outcome is still limited, our objective was to assess
genetic risk factors for suicide among community-based
veterans. We studied a random sample of veterans who
were outpatients in a non-Veterans Affairs (VA), large
multihospital system in central/northeastern Pennsylvania.
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Methods: Using diagnostic surveys, we interviewed 1072
veterans by phone, 62.3% of which were deployed to
Vietnam and 37.7% deployed to post-Vietnam War conflicts.
The interviews took ~65 minutes to complete and collected
data on suicide, posttraumatic streess disorder (PTSD),
depression, combat and trauma exposures, and demographic
and psychosocial factors. DNA was collected via Oragene
saliva kits (DNA Genotek Inc.), which were returned by
mail following the survey. The genetic risk variants studied
were within loci previously associated with PTSD, including
CRHR1, CHRNA5, RORA, and FKBP5 genetic variants,
which were used to calculate a polygenic risk score (range:
0–8, mean: 3.6, standard deviation [SD]: 1.4) (https://
pubmed.ncbi.nlm.nih.gov/32021198/). Non-Whites (n=43)
were excluded from these analyses.
Results: Among those who ever attempted suicide or had a
suicide plan, the PTSD genetic risk score was significantly
higher (3.96 vs 3.55; F=4.54; P=0.033). The mean number
of lifetime trauma exposures among veterans was 3.5
(SD: 2.1). In multivariable logistic regressions, significant
predictors of attempting suicide or having a suicide plan
were history of depression (odds ratio [OR]: 7.4; P<0.001),
PTSD risk score (OR: 1.3; P=0.017), and lifetime trauma
exposures (OR: 1.2; P=0.010). Significant predictors for
developing a suicide plan were history of depression (OR:
8.8; P<0.001), PTSD risk score (OR: 1.2; P=0.045), lifetime
trauma exposures (OR: 1.2; P=0.035), and serving on
multiple combat tours (OR: 0.49; P=0.038).
Conclusion: In this study, we identified novel genetic
risk variants for suicidal behaviors among veterans that
may have implications for future genomics and precision
medicine. These exploratory findings may be relevant for
health care providers and others working in both VA and
non-VA facilities in the future. Further research is advised.
The Kaiser Permanente Northwest Biorepository:
A Valuable Resource for Collaborative Research
Joanna Bulkley, Jessica Hunter, Allison Naleway,
Shawn Westaway, Yolanda Prado, Alan Bauck, Sarah
Vertrees, Charisma Jenkins, Sheila Weinmann
Kaiser Permanente Northwest, Portland, OR
Background: The Center for Health Research (CHR)
at Kaiser Permanente Northwest (KPNW) provides
researchers access to a unique collection of blood and tissue
specimens for use in research studies in collaboration with
CHR investigators. Specimens are linked to each patient’s
electronic health record, which documents the full scope of
our members’ medical care, including data from encounters,
pharmacy, and laboratory testing. Survey and/or genomic
data are available for some participants and tumor registry
data for members with cancer. Specimens from participants
who now have COVID-19 test results also are available.
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Methods: Specimens were gathered for research studies
and by retaining specimens after usual clinical care. Bloodderived specimens include plasma, DNA extracted from
whole blood, and buffy coat that can be used to obtain
genomic data. Tissue specimens include individual formalinfixed paraffin-embedded (FFPE) normal and tumor tissue
blocks dating back to 1971 and associated hematoxylin and
eosin (H&E)-stained slides.
Results: The KPNW biorepository contains over 60,000
blood-derived specimens from more than 40,000 individuals.
The majority are female (59%), <70 years old (57%), and
non-Hispanic White (89%). Large disease cohorts include
diabetes (>5000), cardiovascular disease (>3000), cancer
(>2800 breast, prostate, and lung), and clinical depression
(>1300). Specimens from participants with other diseases,
including hypertension, hemochromatosis, hip fracture,
and cervical dysplasia, are available, as are specimens from
volunteers without a specific disease (>2000). There are
more than 3.5 million normal and tumor tissue blocks and
H&E slides. Of the more than 95,000 tumors in the library,
tissue is available from more than 15,000 breast, 10,000
prostate, 7500 cervical, 7500 colon and rectum, 6000 lung,
and 6000 urinary system cancer patients.
Conclusion: Linking KPNW’s clinical data with DNA
and other biological specimens creates a powerful research
resource. Our specimens can be used for a wide range of
studies: studies of molecular and genetic factors associated
with disease incidence and progression; pharmacogenetic
studies; and disease detection, prevention, and treatment
studies. To date, our biospecimens have been used to predict
response to tamoxifen in breast cancer treatment, evaluate the
pharmacogenetics of CYP2C19 in proton pump inhibitor use,
and identify genetic risk factors for aggressive prostate cancer.

HEALTH CARE DELIVERY AND
COVERAGE
A Mixed-Methods Evaluation of Medication
Reconciliation Using Interviews and Surveys in
Primary Care Practices
Michael Gionfriddo, Vanessa Duboski, Jove Graham,
Melissa Kern, Eric Wright
Geisinger Research, Forty Fort, PA
Background: Failure to conduct proper medication
reconciliation results in inaccurate medication lists,
leading to avoidable health care utilization and costs. To
better understand the factors that contribute to inaccurate
medication lists, we conducted a mixed-methods evaluation
as part of a quality improvement project to improve
medication reconciliation in our primary care practices.
Methods: We conducted a mixed-methods study consisting
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of semi-structured interviews and surveys of both patients
and staff within ambulatory care at a large integrated
health care delivery system. Interviews were conducted
telephonically throughout 2019 and 2020 using semistructured interview guides informed by findings from clinic
observations and peer-reviewed literature. Interviews were
recorded and analyzed thematically using a codebook and
Atlas.ti 8. Surveys, developed based on clinic observations,
staff interviews, and existing literature, were administered
electronically utilizing REDCap during the summer of
2020. Surveys were analyzed using descriptive statistics
completed in SAS and R software.
Results: We conducted 48 staff and 10 patient semi-structured
interviews. Surveys were sent to 2541 eligible staff, of
which 616 responded (24% response rate), and 5132 eligible
patients, of which 577 responded (11% response rate). Both
patients and staff felt having an accurate medication list
was important (96%); however, several factors influenced
the collection of a patient’s medication list. These factors
included the lack of a standardized process (and subsequently
a lack of clarity around responsibility for and comfort with
the process), a lower level of concern for nonprescription
medications, a lack of awareness and comfort with available
tools to facilitate medication reconciliation, a lack of time,
inadequate staff training for conducting proper medication
reconciliation, poor communication within and across sites
of care, and a lack of knowledge of medications by both
patients and staff.
Conclusion: Using a thorough mixed-methods evaluation
of the process involved in collecting an accurate medication
list in ambulatory care, we have identified several barriers
impacting the process of medication reconciliation.
Future work has the potential to reduce medication list
discrepancies, improve outcomes, and reduce avoidable
health care utilization costs.
Factors Associated With Preferences for Continued
Video Visit Use During the COVID-19 Pandemic
Xiaowei (Sherry) Yan, Sien Deng, Su-Ying Liang,
Cheryl Stults, J.B. Jones, Ellis C. Dillion, Dominick
Frosch
Sutter Health, Walnut Creek, CA
Background: Use of video visits (VV) skyrocketed during
the first wave of the COVID-19 pandemic, as in-person
visits were canceled to minimize exposure risk. Little is
known about which VV users are most likely to prefer a
VV in the future and why. We combined a population-based
survey with electronic health records to identify patient
characteristics and other factors affecting VV preferences.
Methods: In August 2020, we invited a stratified random
sample of 20,000 active patients at Sutter Health to complete
an email survey on patient health care-seeking preferences
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and VV experiences during COVID-19. We combined
survey and electronic health record data and applied a
weighted logistic regression model, adjusting for sampling
frame and response bias, to identify patient characteristics,
clinical factors, VV experience, and other factors associated
with preferences for future VV use.
Results: A total of 3351 patients completed the survey (18%
response rate), among which 1208 (37.4%) reported having
at least one VV. Among 5 dimensions for assessing VV
experience, 49% were very satisfied with the length of time
with the doctor, and 40% were very happy using VV to talk
to their doctor. Fewer patients (~36%) reported being “very
happy” with the overall quality of the visit or scheduling
experience. Among 1208 patients who reported having
VV before, 38% (n=460) would prefer a VV in the future.
Satisfaction with using a VV to interact with their doctor and
overall VV quality were the strongest factors associated with
a preference for a future VV (odds ratio [OR]: 5.30, 95% CI:
3.57–7.85 and OR: 3.94, 95% CI: 2.66–5.86, respectively).
Hispanic ethnicity (OR: 0.52, 95% CI: 0.30–0.92, compared
to White race) and older (65–79 and 80+ years) age (OR
ranges: 0.26–0.50, compared to 18–49 years of age) were
less likely to prefer a future VV.
Conclusion: More than one-third of surveyed patients
participated in a VV during the COVID-19 pandemic, and
patients’ perception of overall VV quality is significantly
associated with preference to use VVs in the future.
As COVID changes health care delivery, it is critical to
understand who, when, and how to deliver telemedicine
options that meet patient’s needs and to optimize the value
of telemedicine in the overall care delivery landscape.
Replacement of Electrolyte in the Intensive Care
Unit: Study of Pattern in MIMICS III Database
Parasteh Malihi, Mousa Ghannam, Krzysztof Laudanski
University of Pennsylvania, Philadelphia, PA
Background: Electrolyte repletion is a ubiquitous routine
intervention aimed at maintaining the homeostatic range
in serum. However, variations in the replacement practices
and belief systems surrounding the clinical effectiveness
of electrolyte repletion may be resulting in substandard
care. While low electrolyte levels are associated with poor
outcomes, higher levels are not always considered protective
— even more, they can be harmful. Current patterns of
electrolyte repletion in the intensive care unit (ICU) suggest
overrepletion, with significant percentage being dosed when
the levels are therapeutic.
Methods: Herein, we analyzed ICU electrolyte replacement
patterns using the MIMICS III database to determine
the threshold governing replacement decisions and their
efficiency. We evaluated the data for serum values for
potassium magnesium, calcium, and phosphate before and
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after repletion events. We identified the thresholds for when
repletion was administered for the mentioned electrolytes.
Additionally, we were able to identify temporal patterns in
repletion behaviors of ICU health care providers.
Results: While a majority of replacements for potassium,
magnesium, calcium, and phosphate occurred at levels
below or within reference ranges, the percentage of repletion
events that fell above the reference ranges for potassium,
calcium, and phosphate was 0.79%, 0.34%, and 0.46%,
respectively. Interestingly, occurrence of replacements
for magnesium above reference ranges was 3.37% of the
events. The electrolyte repletion resulted in mainly small to
modest postreplacement changes in electrolytes serum level.
Repletion behavior patterns were associated with hospital
workflow more so than with clinical indication.
Conclusion: This pattern of behavior found in this study
supports a wasteful and ineffective electrolyte replacement
practice in a different medical system, pointing to the
universality of the problem.
Demographic and Clinical Differences in Achieving
Guideline-Recommended
Cardiometabolic
Screening for Youth Prescribed Antipsychotic
Medications
Loretta Hsueh, Natalie Slama, Scott Spalding, Stacy
Sterling, Esti Iturralde
Kaiser Permanente Northern California, Oakland, CA
Background: Antipsychotic medications are used to treat
various mental health conditions in youth but are associated
with metabolic disturbances that elevate cardiovascular
health risks and guideline-recommended cardiometabolic
screening of these youth remains low. We examined
demographic and clinical predictors of cardiometabolic
screening for this population in a large integrated health
system to inform understanding of screening facilitators and
barriers.
Methods: In this serial cross-sectional study, we assessed
cardiometabolic screening (glucose or lipid test) from
health record data for 4568 youth (10–21 years of age)
starting antipsychotic treatment in Kaiser Permanente
Northern California during 2013–2017. Using logistic
regression, we assessed demographic and clinical predictors
of cardiometabolic screening within 2 years of medication
start. We examined whether distinct characteristics predicted
screening for boys versus girls using gender-stratified
models, confirming statistical significance of differences
via gender interaction terms added to the original model.
Below, we report adjusted metabolic screening frequencies
generated from model coefficients.
Results: Participants were of mean age 17 (standard
deviation: 3.0) years; 52% were boys. Half were racial/
ethnic minorities (22% Hispanic/Latino; 13% Black; 12%
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Asian/Nat. Hawaiian/Pac. Islander [ANHPI]). Almost 1
in 5 youth (18%) had age-adjusted obesity at baseline.
On average, 54% of youth were screened within 2 years
of starting an antipsychotic. Younger participants, girls,
Hispanic/Latino participants, and those with a diagnosis
of attention-deficit/hyperactivity disorder, bipolar disorder,
or psychotic disorder had higher screening rates, whereas
participants with a diagnosis of substance use disorder had
lower screening rates overall (P<0.05 for all). Adjusting for
mental health and primary care utilization had negligible
effects on these associations, although girls were no longer
more likely than boys to be screened after adjustment. Girls
with obesity were more likely to be screened than boys with
obesity (63% vs 53%). ANHPI race/ethnicity predicted
higher screening only in boys (61%) relative to White race/
ethnicity (51%).
Conclusion: In this diverse sample of youth treated with
antipsychotic medications, a marker of cardiometabolic
health risk (obesity) predicted glucose or lipid screening only
in girls. Screening prevalence was especially high among
ANHPI boys. Future research should examine processes
contributing to these differences to inform strategies seeking
to increase health-protective screening.
Association Between Palliative Care Consultation,
Hospital Length of Stay, and In-Hospital Charges
Among Women With Metastatic Breast Cancer in
the United States
Divya Subramaniam, Noor Al-Hammadi, Alexandria
Jenkins, Leslie Hinyard
Saint Louis University / SSM Health, St. Louis, MO
Background: There is limited research about the utilization
of palliative care services for women with metastatic breast
cancer, particularly at the end of life. The purpose of this
study was to determine the incidence of inpatient palliative
care consultation (PCC) in women with metastatic breast
cancer and to examine the association between PCC,
hospital length of stay, and in-hospital charges in a nationally
representative sample.
Methods: Women with a metastatic breast cancer-related
hospitalization in the Healthcare Cost and Utilization
Project Nationwide Inpatient Database (NIS) during 1998–
2017 were included in the study. Multivariable logistic
and linear regression analyses were used to examine the
effects of patient and hospital characteristics on the receipt
of inpatient PCC, length of stay, and total hospital charges.
SAS software was used for all analyses.
Results: Average age of the patient sample (N=513,509)
was 63 years; 73.2% of women were White, received
governmental types of insurance. Older women (60–69
years) had higher odds of getting PCC. Women of races
other than White, and patients from zip codes with lower
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household income levels were more likely to receive PCC.
This finding was evident among women who received other
types of insurance as compared to private insurance. Women
receiving governmental insurance had slightly lower odds
of receiving palliative care compared to women receiving
commercial types of insurance. Small and medium-sized
hospitals were less likely to offer the service to admitted
women. Rural and urban nonteaching hospitals were
associated with lower odds of providing PCC to their
admitted patients. A woman with comorbidity had higher
odds of receiving PCC during their hospital admission.
Hospitals were likely to charge patients receiving palliative
care services less compared to patients who did not have a
PCC encounter despite being associated with higher odds of
a longer hospital stay.
Conclusion: We found that inpatient PCC for women with
metastatic breast cancer increased hospital length of stay
and reduced hospital total charges. We also found racial
differences in inpatient palliative care consultation, with
it being restricted to older and sicker patients. Targeted
interventions must be implemented to increase PCC for
patients with metastatic breast cancer in the United States.
Palliative Care Among Patients With Metastatic
Breast Cancer in the End-of-Life Period in the
United States
Divya Subramaniam, Zidong
Jenkins, Leslie Hinyard

Zhang, Alexandria

Saint Louis University / SSM Health, St. Louis, MO
Background: Palliative care improves the quality of an
individual’s end of life. The purpose of this study was to
determine utilization of palliative care consult (PCC) on or
after date of metastasis to date of death and the association
of emergency department (ED), intensive care unit (ICU),
and chemotherapies among patients with metastatic breast
cancer in the United States.
Methods: We conducted a retrospective study using the
de-identified electronic medical record data from a national
health care informatics provider and insurer from January 1,
2000, to December 31, 2018. Adult patients (≥18 years old)
with breast cancer who were diagnosed with a secondary
neoplasm after the index diagnosis of breast cancer and
deceased in the period of data capture were included. The
cohort was split into a PCC group — patients who had
received at least one PCC on or after the date of metastasis
through date of death — and a non-PCC group consisting
of patients who not did not receive any PCC. The ED, ICU,
and chemotherapy encounters since metastasis were defined
by ICD-9/10, HCPCS or CPT codes per encounter records.
We quantified the ED and ICU visits within 2 months of
death and the antineoplastic chemotherapies within 1 and
2 months of death. Time from metastasis to death and
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utilization of services were compared between the PCC and
non-PCC groups using Whitney U-test and chi-squared test.
Results: Overall, 979 deceased patients with metastatic
breast cancer had at least one PCC. Average patient age at the
last admission was 68 years. Median time from metastasis to
death was 9 years. Most were Caucasian (79.8%) and from
the U.S. Midwest (47.1%). PCC patients had a shorter time
to death and were more likely to be African American, reside
in the Midwest, and have experienced complications since
metastasis (except for acute cerebrovascular events). PCC
patients were more likely to have used the ED or ICU within
2 months of death and to receive chemotherapy within 1 and
2 months of death.
Conclusion: Only 38% of patients with breast cancer
received at least one PCC following date of metastatic
diagnosis. Our findings highlight the need to increase PCC
among patients with breast cancer immediately following
metastasis diagnosis to ensure appropriate care is provided
and utilized.

positive. Among the quantitative results, 98% of participants
said they would recommend the tour to a colleague and 100%
of participants ranked the tour “very good” or “excellent.”
Qualitative findings included, but were not limited to,
relevance and applicability to patient and team member
experiences, the necessity of using history to inform how
we make equitable decisions in the present and future, and
making the tour an onboarding standard for all employees.
Conclusion: The VHET has provided an increasingly
accessible way for providers to interactively learn about
SDoH within the context of communal history. By the end
of the tour, many participants were inspired to action, with
some stating: “This tour motivated me to learn more about
the history of St. Louis and continue to advocate;” and “It lit
a fire inside of me to do more for our communities.”

HEALTH EQUITY AND SOCIAL NEEDS

Loretta Hsueh, Jie Huang, Anjali Gopalan, Mary Reed

Virtual Health Equity Tours as an Education Tool in
Health Care Institutions

Kaiser Permanente Northern California, Oakland, CA

Jaqui Melton
BJC HealthCare, St. Louis, MO
Background: Prior to the onset of the COVID-19
pandemic, our health care institution engaged in community
tours that explored the social determinants of health
(SDoH) within the context of St. Louis health disparities,
history, and geography. Further, it offered an opportunity
for participants to better understand historical mistrust
that members of marginalized communities hold when it
comes to expectations of care in institutional spaces. While
the experience was hailed as a staple diversity, equity, and
inclusion effort, two paramount limitations were that the
tour was limited to leadership participation and that it could
only be experienced by up to 8 people at a time.
Methods: Amid COVID-19, we were provided the
opportunity to reimagine the tour. In doing so, we explored
what it would look like to expand capacity and accessibility.
Further, we investigated and tested a variety of mediums —
including videos and interactive map technology — to create
an experience that fosters and leverages community voice,
activates and draws on participant wisdom, and provides a
relevant background and framework to help inform how we
move forward in caring for communities placed most at risk.
Results: To date, a virtual health equity tour (VHET) has
been piloted with 5 different groups comprised of team
members from a variety of different ranks and roles within
our organization. The feedback has been overwhelmingly
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Patient
Characteristics
Associated
With
Telemedicine Choice During the COVID-19
Pandemic Among Patients With Limited English
Proficiency

Background: Dramatic increases in telemedicine during
the COVID-19 pandemic have made addressing disparities
in telemedicine use a high priority. Patients with limited
English proficiency (LEP) face significant barriers to care
and to telemedicine, particularly video-based telemedicine.
Understanding patient characteristics associated with
telemedicine choice (video vs phone) can inform
interventions to reduce disparities in video telemedicine use.
Methods: Cross-sectional analysis of 22,476 primary care
telemedicine visits initiated by patients with LEP scheduled
through the Kaiser Permanente Northern California patient
portal from March 16, 2020, to October 31, 2020. Using
multivariable logistic regression, we identified correlates
of choosing video vs phone visit, including patient
language, race/ethnicity, gender, age, neighborhood-level
socioeconomic status (SES), technology access (mobile
portal use in past 12 months, neighborhood-level internet),
past video visit experience (in past 12 months), and visit
provider (eg, patient’s own primary care provider).
Results: Video visits accounted for 34.6% (n=7,765) of
all telemedicine visits initiated by patients with LEP; the
most common languages spoken included Spanish (42%),
Cantonese (16.8%), Mandarin (10.3%), Vietnamese (8%),
Punjabi (3.3%), and Russian (2.3%). Compared to Spanishspeaking patients, Mandarin-speaking patients had higher
odds of choosing video vs phone (odds ratio [OR]: 1.34)
whereas Punjabi-speaking patients had lower odds (OR:
0.66). In addition, odds of choosing video were higher
among adults younger than 18 years old (OR: 1.67) or older
than 65 (OR: 1.24), those who previously accessed the
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mobile portal (OR: 1.17), and those with prior video visits
(OR: 2.37). Odds of choosing video were lower among
patients who lived in a low-SES neighborhood (OR: 0.89)
or lived in a neighborhood with low internet connectivity
(OR: 0.83; P<0.05 for all).
Conclusion: During the ongoing COVID-19 pandemic, the
majority of telemedicine visits scheduled by adults with
LEP were conducted via telephone. Telemedicine choice
differed by specific Asian languages, underscoring the need
to disaggregate data by Asian ethnic groups. Technology
access factors, such as internet connectivity, may remain
substantial barriers to video telemedicine use. In contrast
to prepandemic studies in general patient populations,
adults 65+ years old with LEP had higher odds of video
telemedicine use compared to adults 18–64 years old. Future
research should investigate mechanisms leading to higher
video use among older patients with LEP, such as the role of
family support in using video telemedicine.
Identifying Social Needs Among Patients Referred
to an Opioid-Tapering Program in a Large Integrated
Health Care Delivery System
Dea Papajorgji-Taylor, Phillip Crawford, Katherine
Reese, Mary Ann McBurnie
Kaiser Permanente Northwest, Portland, OR
Background: Due to a significant number of patients
receiving high-dose opioid prescriptions, an integrated
health system implemented a phone-based, pharmacistled program to support primary care physicians and assist
patients in tapering. Prevalence of screening patients for
unmet basic needs among this population has not been
explored, and much less is known about how pharmacists
view the role of identified social needs into their opioidtapering plans.
Methods: We reviewed electronic health records of patients
referred to the tapering program and either were screened
for socioeconomic needs, had a community resource referral
placed on their behalf, or both, January 1, 2017–December
31, 2019. Referrals were identified by the community
referral code in the electronic health records. Descriptive
analysis was applied to identify associations among patient
characteristics, unmet basic needs, and frequency of referrals
via clinical screening. Qualitative data from the pharmacists
facilitating the opioid tapers was collected and analyzed
regarding the role that screening for socioeconomic needs
can play among patients referred to the opioid-tapering
program.
Results: Initial findings indicate 3369 patients were referred
to the tapering program during the time frame examined.
A total of 870 patients referred completed the Your Current
Life Situation questionnaire, and 330 identified at least 1
unmet need. Community resource referrals were made for
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427 patients. A total of 1222 referrals (multiple referrals
per patient) identified transportation as the most prevalent
need (21.9%), followed by government assistance programs
(14.3%), and housing and shelter (11.4%). Qualitative
data from the pharmacists emphasized the value placed on
patient-reported unmet needs when formulating a taper plan.
Participants noted that various socioeconomic unmet needs
have played a role in their patients’ abilities to successfully
adhere to a developed tapering plan or pain management.
Conclusion: Findings suggest unmet basic needs and
community referrals are frequent among insured patients
referred to an opioid-tapering program. We will describe
associations between social needs status and patient
demographics as well as the role of social needs screening
among pharmacists facilitating patient tapers. Future
research should consider identifying and addressing unmet
socioeconomic needs among patients participating in the
opioid-tapering program and develop a tapering plan that
incorporates underlying social determinants of health.
Development and Validity of 1- and 2-Item
Screeners for Identifying Social Needs in a Health
Care Setting
Alicia L. Salvatore, Michelle Axe, Richard J. Caplan,
Jacqueline Ortiz, Mitchell R. Fawcett, Diane C. Bohner,
Linda Brittingham, Matthew Hoffman, Nora Katurakes,
Mia Papas
ChristianaCare Value Institute, Wilmington, DE
Background: Addressing patients’ social needs is critical
for improving health equity. Many health systems are
adopting integrative approaches that include screening for
and addressing social needs. While acceptance of social
needs screening has increased, concerns about time added
to clinical workflows persist. Thus, our collaborative
of system stakeholders at a Mid-Atlantic health system
conducted a study to 1) develop a screener to identify
individuals with social needs, and 2) evaluate the sensitivity
and specificity of 1- and 2-item screeners in detecting
patients with social needs.
Methods: We selected 10 validated screening questions
that measured 9 social needs: housing quality, utility needs,
housing insecurity, transportation needs, food insecurity,
interpersonal violence, health literacy, limited health care
access due to cost, and urgent needs. A financial insecurity
question was selected as the validation item; this was
evaluated alone and in combination with Medicaid status.
Data were collected in 1) Complex Care Community, a
care coordination service for high-risk patients; 2) obstetric
triage (ObTriage); and 3) the Healthy Latinx Families
Program (HLFP) and the Latin American Community Center
(LACC), two community health worker programs serving
the Latinx community. Analyses and validation diagnostics
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were calculated by program.
Results: Complex Care Community (n=944) and ObTriage
(n=317) patients were largely female, non-Hispanic,
English-speaking, White or African American, and Medicaid
beneficiaries. HLFP (n=99) and LACC (n=121) participants
were largely female, Hispanic, Spanish-speaking, and a
race classified as Other; few had Medicaid. Overall, 66%
of Complex Care Community and 40% of OBTriage
patients had more than 1 social need, while more than 90%
of HLFP and LACC participants did. Sensitivity to detect
social needs was low for the 1-item screener and improved
by adding Medicaid status — 43% vs 78% for Complex
Care Community, 48% vs 75% for OBTriage, 66% vs 73%
for HLFP, and 48% vs 57% for LACC. The addition of
Medicaid status decreased specificity to less than 30% in all
except one program.
Conclusion: The 2-item screener was somewhat sensitive
but less than 80%. Specificity was low. While our 10-item
screener was successful in eliciting social needs, we failed
to find compelling evidence that either a 1- or 2-item brief
screener would adequately detect patients with social needs.

mmHg, 95% CI: -1.8, -0.04). Small but not significant
decreases in HbA1c were observed among participants with
diabetes (n=39; -0.19 mmHg, 95% CI: -0.49, 0.10). Results
from adjusted models were not substantially different.
Conclusion: Participation in the DE MLP was associated
with significant improvements in blood pressure but not
HbA1c. While no similar studies of MLPs could be found,
our findings are similar to evaluations of health system
interventions to address social needs. These findings are
encouraging, as an almost 5% reduction in relative risk
for coronary heart disease events is associated with a
2-mmHg reduction in SBP or a 1-mmHg reduction in DBP.
Our study offers evidence that addressing patients’ unmet
legal needs and their sequalae may benefit cardiovascular
health. Multisite controlled studies with larger participant
populations and additional health outcomes are needed to
elucidate and further strengthen evidence for MLP health
impact.

Addressing Unmet Legal Needs Among Vulnerable
Patients: What Is the Impact on Chronic Disease?

Samuel Savitz, Mark Nyman, Anne Kaduk, Conor
Loftus, Barbara Barry

Alicia L. Salvatore, Mathew D. Walt, Alexandra Mapp,
Elsie Evans, Christopher Moore, Erin Booker, Bettina
Tweardy Riveros, Cindy Santiago, Dawn Baker

Mayo Clinic, Rochester, MN

ChristianaCare Value Institute, Wilmington, DE
Background: Medical legal partnership (MLP), addressing
patients’ unmet legal needs through health systemlegal aid collaboration, is a well-recognized and widely
used intervention for underserved and high-need patient
populations. Yet, it remains unclear if MLPs improve
chronic disease outcomes. In this study, we examined the
effectiveness of the Delaware Medical Legal Partnership
(DE MLP), a collaboration between ChristianaCare, a MidAtlantic health system, and Delaware Community Legal
Aid Society, Inc., on improving systolic (SBP) and diastolic
blood pressure (DBP) and hemoglobin A1c (HbA1c) levels.
Methods: We used a pragmatic intent-to-treat approach
and longitudinal mixed-effects linear regression models to
examine changes in chronic disease (SBP, DBP, HbA1c)
from the period before and after MLP enrollment.
Results: A total of 215 patients participated in the DE
MLP between November 2018 and June 2020. Patients
were largely African American (53%) and White (34%),
non-Hispanic (86.4%), female (65%), and had Medicaid or
self-pay (53%). The cohort had a mean of 6.1 comorbidities
(standard deviation: 4.1). In unadjusted intent-to-treat
analyses among participants with hypertension (n=80), MLP
participation was associated with significant reductions in
SBP (-1.93 mmHg, 95% CI: -3.4, -0.39) and DBP (-0.93
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Association of Patient and System-Level Factors
in Screening for Social Determinants of Health

Background: Health systems are increasingly recognizing
the importance of social determinants of health (SDoH)
for care delivery. However, gaps remain in understanding
facilitators or barriers to screening for SDoH. In this study,
we evaluate a real-world implementation of an electronic
health record (EHR)-integrated SDoH screening. The
objective was to identify patient and system-level factors
that were associated with completion and the modality used.
Methods: The study is a retrospective analysis of the
implementation of SDoH screening at Mayo Clinic from
June 1, 2019, to October 31, 2019. The screening was
introduced enterprise-wide on June 1. We analyzed the
first instance when patients were assigned the screening.
Outcomes were completion of screening and modality
used — MyChart, filled out by patient on patient portal;
WelcomeTablet, filled out by patient in the lobby on a tablet;
or EpicCare, data obtained directly by provider and entered
directly in EHR chart. We conducted logistic regression
for completion and multinomial logistic regression for
modality. The factors of interest were race/ethnicity, use of
an interpreter, whether the visit was for primary or specialty
care, and time since implementation.
Results: We identified 500,417 patients who were assigned
the SDoH screening, of whom 307,890 (61.5%) completed
the screening. Patients who used an interpreter and racial/
ethnic minorities (compared to White patients) were less
likely to complete the screening. Primary care visits were
associated with an increase in completion compared to
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specialty care visits. Completion was highest just after
implementation and declined in the later periods. Patients
who used an interpreter, racial/ethnic minorities, and
primary care visits were associated with greater use of
WelcomeTablet.
Conclusion: Patient and system-level factors were
associated with completion and modality. The lower
completion and greater use of WelcomeTablet among
patients who use interpreters or racial/ethnic minorities
suggests that there is value in having the WelcomeTablets
available and that improving the completion rate may be
possible by increasing WelcomeTablet availability and
addressing workflow issues at the point of care. The higher
completion in primary care visits suggests that more training
or outreach is needed in specialty care. The decrease in
completion over time suggests that sustainment may require
continued engagement to support ongoing screening.

patients were more likely than Caucasian patients (RR:
1.1 [1.04–1.26]). Hispanic/Latino patients were less likely
compared to non-Hispanic/Latino patients (RR: 0.9 [0.76–
0.98]). Uninsured/self-pay patients were more likely than
patients with commercial insurance (RR: 1.3 [1.16–1.54]).
Conclusion: This evaluation reveals that many patients
attending health care have multiple social needs that can be
identified at the point of care, and patterns of need-based
referral vary by demographic characteristics. More research
is needed at the community level to assess if available
resources are utilized to address patient needs and at the
health system level to examine how addressing these needs
impacts patient outcomes.

Referrals for Social Needs in the Clinical Setting:
Pilot Data From 2500 Referrals at 3 Community
Hospitals

Cecelia Harrison, Alexandra Mapp, Mia Papas, Alicia
Salvatore

Yi Li, Alvia Siddiqi, Rasha Khatib
Advocate Aurora Research Institute, Downers Grove, IL
Background: Evidence shows that addressing social needs
in the clinical setting leads to improved health outcomes
and lower cost. However, initiatives to collect data on
social needs are limited, and little is available on the types
of community resource patients may need. This study aims
to examine referral patterns for social needs in a large
Midwestern health system.
Methods: This is a cross-sectional analysis of electronic
health records data over a 2-year period (2018–2020) from
patients visiting emergency departments or admitted to
1 of 3 community hospitals where a digital platform was
piloted to screen and refer patients with needs. The platform
includes an inventory of community resources mapped
by zip code for referrals. Referrals can be auto-selected
based on screening results or manually identified by a careteam member. Referrals were categorized into 22 types of
community resources. Patients may be referred to multiple
resources. Descriptive statistics and unadjusted risk ratio
(RR) with 95% CI were reported.
Results: Overall, 2496 patients (mean age: 51 ± 21.6 years)
were referred to at least 1 community resource during the
study period. Most patients were African American (66%)
or Caucasian (30%), and 15% were Hispanic. About 14%
were uninsured. Nearly half (48%) were referred to 3 or more
resource categories. Top referred categories included financial
stability (52%), food/nutrition (44%), and transportation
(24%). The likelihood of receiving 3 or more referral
categories was greater for English-speaking vs non-Englishspeaking patients (RR: 1.5 [1.08–2.16]). African American
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Social Determinants of Health and Psychosocial
Well-Being Since the COVID-19 Pandemic: Findings
From the Delaware COVID-19 Community Study

ChristianaCare, Newark, DE
Background: The COVID-19 pandemic is impacting the
lives of Delawareans in myriad ways that may have longlasting impacts on health and well-being. We conducted the
Delaware COVID-19 Community Study (DCCS) to assess
the pandemic’s impacts on social determinants of health
(SDoH) and health and well-being among Delaware adults.
In this study, we examined associations between SDoH
and 3 psychosocial well-being outcomes: perceived stress,
generalized anxiety, and depression.
Methods: The DCCS was an anonymous, online, crosssectional survey conducted from June 2020 to October 2020.
Participants reported sociodemographic characteristics
and 6 SDoH (food insecurity, financial insecurity, housing
insecurity, utility needs, child care needs, and inability to
see a doctor due to cost) experienced before and since the
pandemic. We used the Perceived Stress Scale 4 (PSS-4),
2-item Generalized Anxiety Disorder (GAD-2), and Patient
Health Questionnaire-2 (PHQ-2) tools to measure perceived
stress, generalized anxiety, and depression, respectively.
Descriptive and multivariate linear regression analyses were
performed; models were age-adjusted.
Results: Participants (n=341) had a mean age of 52.2
years and were mostly female (74.7%), White (76.1%),
and employed (83.3%). Most SDoH-related needs reported
were higher since the pandemic: 11.1% were food insecure,
13.8% were financially insecure, 2.1% had utility needs,
9.2% had child care concerns, 16.8% did not feel physically
or emotionally safe at home, and 5.1% could not see a doctor
when needed to due to cost. Food insecurity was positively
associated with perceived stress, generalized anxiety, and
depression; the latter was significant (PSS-4 β: 1.14, P=0.13;
GAD-2 β: 0.88, P=0.08; PHQ-2 β: 0.84, P=0.03). Financial
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insecurity had significant positive associations with all
three outcomes (PSS-4 β: 1.64, P=0.02; GAD-2 β: 0.89,
P=0.04; PHQ-2 β: 0.81, P=0.02). Child care concerns also
were associated with increases in all outcomes; associations
with generalized anxiety and depression were significant
(PSS-4 β: 0.74, P=0.40; GAD-2 β: 1.26, P=0.02; PHQ-2 β:
1.04, P=0.01).
Conclusion: In Delaware, the COVID-19 pandemic has
negatively impacted SDoH such as food insecurity, financial
security, and child care concerns, which are associated
with higher levels of perceived stress, generalized anxiety,
and depression. Interventions to address social needs and
psychosocial well-being are needed now and should be
prioritized alongside vaccination and testing.

a higher proportion of HI/H patients were frequent ED
utilizers (7% vs 0.8%), had a higher frequency of inpatient
visits (11.7% vs. 6.5%), and yet were less frequent utilizers
of outpatient care (7.9% vs 29.1%).
Conclusion: By capturing data on HI/H, we successfully
identified this issue among 4.7% of the acute-care patients
seen over the course of 1 year. The HI/H population was
disproportionately male and Black and had higher ED and
inpatient use but lower outpatient use, suggesting unmet
medical needs. These data highlight the need for health
system-designed interventions that can connect HI/H patients
to more consistent preventive care and social services and
presents an opportunity for targeted housing interventions
and linkage to community-based resources.

Housing Insecurity Among Acute-Care Patients
Within a Large Health Care System in Northern
California

Racial/Ethnic Differences in Mortality Among
Patients With COVID-19

Kristen M.J. Azar, Robert Romanelli, Satish Mudiganti,
Catherine Nasrallah, Stephanie Brown, Joyce LaMori,
Jacqueline Pesa, Anna Kiger, Alice Pressman
Sutter Health Institute for Advancing Health Equity,
San Francisco, CA
Background: As of January 2019, 27% of people
experiencing homelessness in the United States are in
California. Research has demonstrated numerous health
risks associated with housing insecurity and homelessness
(HI/H). As such, health systems have a unique opportunity to
address the unmet needs of these marginalized individuals.
Methods: We studied HI/H among acute-care patients at
Sutter Health, a large integrated health system in Northern
California. From the electronic health record, we identified
adults (18+ years old) with and without evidence of HI/H
between July 1, 2019, and June 30, 2020 and compared
their sociodemographic, clinical, and health care utilization
characteristics. HI/H data was identified from encounters,
flowsheets, and patient address. Comorbidities were
identified by ICD-10 diagnoses from problem lists,
encounters, or hospital discharge diagnosis; frequent
emergency department (ED) use was defined as >3 ED visits
in any month, or >5 ED visits within 12 months prior to the
first encounter in the study period.
Results: Among 434,286 adults assessed, 20,230 (4.7%)
had evidence of HI/H. A higher proportion of those with
evidence of HI/H were male (66.3% vs 41.8%) and Black
(24.3% vs 11.3%); the majority were 30–65 years old
(74.6%). A higher proportion in the HI/H group had a
diagnosis for serious mental illness (28.4% vs 17.2%) but
generally had fewer physical comorbidities. Among those
with HI/H, 34.7% were covered by Medicaid, and nearly
one-third (32.8%) had commercial insurance (compared to
17.5% and 51.3% without HI/H). Compared to non-HI/H,
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Suma Vupputuri, Kevin B. Rubenstein, Celeena R.
Jefferson, Sadiya S. Khan
Kaiser Permanente Mid-Atlantic States, Rockville, MD
Background: Black and Hispanic populations have
experienced an approximately 2-fold higher rate of death
due to coronavirus disease 2019 (COVID-19) compared with
White populations. However, the impact of demographic,
socioeconomic, and clinical factors on racial/ethnic
differences in death among hospitalized and nonhospitalized
patients with COVID-19 is not well known. Therefore, we
leveraged longitudinal electronic health record (EHR) data
from an integrated health system to describe differences in
mortality by race/ethnicity in patients with COVID-19.
Methods: We conducted a retrospective EHR-based cohort
study at Kaiser Permanente Mid-Atlantic States among
adults (≥18 years old) with COVID-19 between January 1,
2020, and October 31, 2020. Positive COVID-19 patients
included those identified via laboratory test or diagnosis. We
used Cox proportional hazard models to estimate the hazard
ratio (HR) for all-cause mortality in Black and Hispanic
patients compared with White patients in unadjusted and
stepwise adjusted models to control for demographics,
comorbidities, clinical, and behavioral factors.
Results: Among 19,241 patients identified with COVID-19,
40% were Black, 31% were Hispanic, 8% were Asian, and
14% were White. Mean (standard deviation) age was similar
in Black, Hispanic, and White patients (48 [17] years,
45 [14] years, and 48 [19] years). Less than 4% of Black
patients and less than 1% of White and Hispanic patients
lived in neighborhoods with median household income of
<$25,000. Prevalence of hypertension was highest among
Black patients (40%) compared with Hispanic (22%) and
White patients (28%). During follow-up, death occurred in
2.3% of all patients with COVID-19, with 75% of all deaths
occurring in Black and Hispanic patients. Crude HRs for

aah.org/jpcrr

189

mortality were 1.16 (95% CI: 0.89–1.51) and 0.44 (95%
CI: 0.31–0.60) for Black and Hispanic patients, compared
with White patients. After adjusting for age, sex, and
neighborhood income, the HRs were 1.65 (95% CI: 1.26–
2.17) for Black and 1.06 (95% CI: 0.75–1.50) for Hispanic
patients. In fully adjusted models, HRs were 1.59 (95%
CI: 1.05–2.40) for Black and 1.76 (95% CI: 1.09–2.84) for
Hispanic patients.
Conclusion: In a sample of mostly insured patients
with access to health care, Black and Hispanic patients
experienced a greater burden of COVID-19 mortality. These
strong, persistent race/ethnicity-based differences warrant
greater focus on social determinants of health as root causes
of inequities.
Virtual Recruitment Strategies for Underserved
Populations in Rural Pennsylvania
Tabitha Milliken, Kortney McBryan, Donielle Beiler,
Samantha Hoffman, Vanessa Troiani
Geisinger Research, Lewisburg, PA
Background: Participant recruitment in rural and
underserved populations can present unique challenges.
These challenges are further exacerbated by the need for
low-cost recruiting, which often leads to the utilization
of online recruitment methods (eg, email, social media).
Social media platforms are predominantly used by younger
populations and require access to internet, to which those
with lower socioeconomic means and less education are less
likely to have access. The current study highlights how a
recruitment strategy that utilizes email in combination with
a follow-up phone call produced high enrollment rates that
included a diversity of participants from rural populations in
older age brackets.
Methods: We evaluated the overall enrollment rate of one
recruitment arm of a larger study that aims to understand the
relationship between genetics and substance use disorders.
We evaluated the characteristics of the enrolled population
to determine recruitment success of a combined email and
follow-up telephonic recruitment strategy, as well as the
rate of enrollment of underserved and rural populations.
These characteristics included 1) enrollment rate before vs
after follow-up phone call, 2) zip code/county of enrollee to
determine rural status, and 3) age to verify recruitment in all
eligible age brackets.
Results: We found the email and follow-up telephonic arm
of the study had a 17.3% enrollment rate. Of those enrolled,
38% (2257) of the participants enrolled before the followup phone call (email communication only) and 62% (3730)
of the participants enrolled after a follow-up phone call
(email and phone call). Of the enrolled participants, 76%
lived in counties classified as rural and 24% lived in counties
classified as urban in Pennsylvania. Enrolled patients were
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represented in all eligible age brackets, from ages 18 to 75
years, with the 60–69 age bracket having the most enrollees.
Conclusion: Results indicate that combining an online
recruitment method with a more traditional method, such
as a phone call, yields higher enrollment rates than online
methods alone. Adding a humanizing component, such as
a live-person phone call, may be a key element needed to
establish trust and connection to encourage patients from
underserved and rural areas to enroll in studies via virtual
recruiting methods.
Implementing a Qualitative Workforce Needs
Assessment to Actualize an Equity, Inclusion,
and Diversity Workgroup in Kaiser Permanente
Southern California’s Department of Research &
Evaluation
Bhanuja Dub, Alejandra Montano, Carol Flores
Kaiser Permanente Southern California, Pasadena, CA
Background: The Kaiser Permanente Southern California
(KPSC) Department of Research and Evaluation (R&E)
established a new equity, inclusion, and diversity (EID)
workgroup in 2020 in response to the need for broad,
sustained activity to address racism and inequities in health
and health care in the United States within the workplace.
A key early step in the development of the EID workgroup
strategic plan was a survey of R&E employees to assess their
current awareness, preferences, and interest in involvement
in EID-related activities.
Methods: We developed an online survey seeking
suggestions for increasing attention to EID issues in the
workplace, enhancing a focus on health equity within
research studies and related issues. The survey was initially
fielded to a small division within R&E. After confirming
support for the EID initiative through initial responses and
after receiving leadership buy-in, the anonymous survey
was sent to the entire department (N=414 research and
administrative staff). Survey responses were analyzed using
qualitative content analysis.
Results: A total of 60 R&E staff returned completed surveys
(response rate of 14.5%). Suggestions and comments were
rich and diverse and were coded into 6 overall categories
of suggested goals and associated activities: 1) Increase
workforce diversity; 2) Increase community and stakeholder
engagement; 3) Describe and promote EID research attention
and appropriate methods; 4) Publicize EID-related funding
opportunities; 5) Measure and track health disparities and
their determinants through research; and 6) Host EID-related
training and events.
Conclusion: The needs assessment survey provided an
opportunity for employees to comment on EID issues and
offer recommendations anonymously and openly. Survey
findings plus guidance from the Institute for Healthcare
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Improvement’s framework for health care organizations to
improve health equity led to the creation of 3 subcommittees
and work streams — capacity building, research, and
training and events. Ultimately, the KPSC EID workgroup
hopes to foster a diverse and inclusive workplace culture
that welcomes open communication and dialogue around
EID, to provide department-specific guidance for research
teams related to EID issues, and to establish metrics to track
EID efforts and their impacts.
Employee-Led Grassroots Initiative in Advancing
Equity, Inclusion, and Diversity (EID) in a Health
System-Based Research Department: Emergence
of the Kaiser Permanente Southern California EID
Workgroup
Carol Flores, Bhanuja Dub, Alejandra Montano,
Angelika Alem, Brian Mittman; EID Workgroup
Steering Committee
Kaiser Permanente Southern California, Pasadena, CA
Background: The “dual pandemics” of 2020 — COVID-19
plus heightened awareness of persistent inequities and
racism in U.S. society, health care, and health research —
mandate fundamental and far-reaching changes in health
system-based research centers’ priorities, studies, and
approaches. Recognizing the urgency for action within
Kaiser Permanente Southern California’s Department
of Research and Evaluation (R&E), 7 female staff from
historically marginalized communities wrote an open letter
to R&E leadership proposing a department-wide equity,
inclusion, and diversity (EID) initiative to (a) enhance R&E
employees’ awareness and attention to EID issues, and (b)
foster appropriate responses in our organization’s research
and workplace culture.
Methods: Following an initial positive response by
leadership, the EID organizers engaged key stakeholders
(including leadership, scientists, research and administrative
staff, and others), fielded a department-wide needs
assessment survey, established a governing structure
including subcommittees, and launched a program of
activities to achieve key goals.
Results: During the initial 6 months of EID workgroup
activities, 3 subcommittees (capacity building, research,
training and events) were established, with a total of 54
R&E employees volunteering to join a subcommittee and
participate in planning calls. Multiple events were held and
a series of EID-related communications disseminated via
email. Subcommittee members facilitated 8 small group
discussions on race and racism. Two department-wide
seminars were held on health equity research and EID in the
workplace, with an average attendance of 100 R&E staff per
session. An EID Sharepoint site was established along with
an EID-focused newsletter and monthly EID events calendar
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showcasing multiple nationwide relevant activities. R&E
leadership incorporated EID trainings into departmental
goals, focusing on fostering a positive work environment.
Conclusion: Health system-based research centers possess
unique opportunities to design, evaluate, and spread
innovative solutions to inequity and racism in health, health
care, and society. The R&E EID workgroup offers a valuable
model for other research centers interested in enhancing
researchers’ awareness of, and attention to, health inequities
and racism. Supportive leadership and a committed group
of internal stakeholders are key to success in efforts to
encourage health system researchers to contribute to
meaningful efforts to counter decades of damaging policies,
practices, and beliefs.
Social Needs Data Collection for Complex Care
Members
Musu Sesay, Doraina Walker-Williams, Marni Segall,
Teaniese Davis, Drew Bradlyn
Kaiser Permanente Georgia, Atlanta, GA
Background: Addressing nonmedical needs is essential for
quality care delivery in assessing a patient’s overall health
and well-being. Nonmedical needs may be most salient
among older adults, some of whom are retired, may have
chronic health conditions or disabilities, or may have limited
financial resources. Our objective was to better understand
short-term nonmedical needs within our complex care
population.
Methods: In 2019, we invited 6021 Kaiser Permanente
(KP) Georgia members who were ≥60 years of age with ≥3
chronic comorbid conditions to complete an adapted version
of the Your Current Life Situation (YCLS) survey via email
and mail. The YCLS survey, administered at baseline and
at 6 months postbaseline, included questions about needs
related to food, housing, transportation, utilities, intentions
to seek assistance for needs if offered at no cost, and attitudes
toward sharing needs with health care providers.
Results: A total of 158 KP members participated in the study,
and 94.3% (n=149) participants completed both baseline and
follow-up surveys. Participants were predominantly nonHispanic (93.7%), White (68.4%), and female (59.5%), with
at least a high school diploma (96.2%). Mean age was 74.7
years, and Charlson score mean was 5.42. Approximately
27% of participants indicated a nonmedical need at baseline
(n=42) or follow-up (n=41). Compared to baseline, at
6-month follow-up there was an increase in participants
who indicated trouble with transportation and housing and
a decrease in reporting trouble with food and utilities. For
participants who completed both baseline and follow-up,
16.8% (n=25) indicated at least one need at both timepoints,
of which 40% (n=10) reported an increase and 40% (n=10)
reported no change in number of needs. The majority of
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participants reporting a need at baseline and follow-up
indicated they would seek assistance to address their need(s)
if offered at no cost and would want their provider to know
about their needs.
Conclusion: While the survey indicated a decrease in some
needs, there were increases in other areas for nonmedical
assistance among complex care patients. Participants want
their health care providers to know about their need(s)
and are interested in seeking assistance to address need(s)
if offered at no cost. Patients are amenable to provider
engagement in screening for nonmedical needs.
Participant Perspectives on Social Needs Data
Collection
Musu Sesay, Doraina Walker-Williams, Marni Segall,
Teaniese Davis, Drew Bradlyn
Kaiser Permanente Georgia, Atlanta, GA
Background: Addressing social (nonmedical) needs is an
important consideration for patients’ overall health and wellbeing. Screening older adults by asking about nonmedical
needs will help with gaps in quality care delivery and reduces
hesitation in discussing with health care providers. Our
objective was to understand members’ experiences, barriers,
and facilitators associated with social needs assessment and
resource referrals.
Methods: This is part of an explanatory mixed-methods
study following baseline and 6-month assessment of social
needs using an adapted version of Kaiser Permanente
(KP)’s Your Current Life Situation (YCLS) survey. We
conducted 2 focus groups and 14 interviews with select
enrolled study participants (KP Georgia members, ≥60
years of age, with ≥3 chronic comorbid conditions) to
provide feedback about the assessment of social needs,
the YCLS questions, and experiences with a social needs
resource guide. Participants were categorized based on
their YCLS responses for those who reported: 1) no needs
(n=5); 2) a need but sought no assistance (n=5); and 3) a
need and sought assistance (n=4). Discussions focused on
participants’ needs and challenges, opinions on the YCLS
survey, and usefulness of the resource guide.
Results: In all, 21 members (8 males and 13 females)
participated. Participants expressed comfort in answering
questions about their needs and found the YCLS survey
useful. They did not consider the YCLS questions to be
“prying,” with the exception of 1 participant who expressed
initial hesitancy, fearing negative consequences to health
benefits. Several participants indicated that, “If you do not
know what we need, how would you help us?” Participants
noted no preference for telephone vs online completion of
the survey, since their most important consideration was
trust of the person or organization asking the questions and
they considered KP a trusted source. Participants expressed
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openness in discussing their needs. However, they reported
reservations about reaching out for help and possibly
burdening their health care providers and a preference for
working with family members to address their needs.
Conclusion: Participants welcomed the idea of their health
care providers screening for nonmedical needs, providing
them with information to obtain assistance for those needs
if needed, and expressed receptiveness to such assistance if
provided at no cost.
Perceived Value of Resource Referral Among
Complex Care Members
Doraina Walker-Williams, Marni Segall, Musu Sesay,
Tina Davis, Derw Bradlyn
Kaiser Permanente Georgia, Atlanta, GA
Background: Providing resources to effectively address
nonmedical needs and improve the health and well-being of
communities is an important undertaking by governmental
and nonprofit agencies. This assistance is vital to older adults
who encounter social and financial limitations to receiving
necessary help. The purpose of this study was to provide and
understand the utility of providing a local resource guide for
older adults seeking nonmedical assistance.
Methods: Our team developed a resource guide using online
database resources compiled by the United Way of Greater
Atlanta and the American Association of Family Physicians.
The guide was a component of a mixed-methods social
needs study designed to examine changes in nonmedical
needs. Kaiser Permanente Georgia’s complex care members
who were 65 years of age or older and had 3 or more chronic
comorbid conditions were eligible to participate. Resource
guides were sent to 238 eligible members (irrespective of
study interest) who requested one from an initial outreach
soliciting study participation. Of the eligible members, 149
enrolled study participants completed the follow-up survey
evaluating the usefulness of the resource guide. Guides
included agencies serving 15 metro-Atlanta counties,
were tailored by zip code, and outlined agency contact
information, description, service eligibility requirements,
hours, and associated costs. Resources included assistance
with food (pantries, food delivery, soup kitchens), housing,
transportation, and utilities.
Results: Overall, 51% (n=76) of participants acknowledged
receiving the resource guide. Of those, 72.3% (n=55)
reported the guide was helpful overall; 56.6% (n=43) found
the guide helpful or very helpful for assistance; and 13.2%
(n=10) used the guide to secure assistance for their needs.
More than one-third (34%, n=26) shared the local resource
guide with someone (spouses, children, friends, others), and
10.5% (n=8) reported that person used the guide to secure
assistance for their needs.
Conclusion: Members found the resource guide helpful
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in seeking assistance for nonmedical needs. This study
highlights the utility of a more passive approach to providing
resources for patients with social needs. While approximately
half the sample acknowledged receiving the resource guide,
health systems still need to consider multiple approaches to
linking patients to resources who have social needs.

IMPLEMENTATION SCIENCE
Integration of Guideline Revisions Into Provider
Mindlines and Treatment Decisions
Arwen Bunce, James Davis, Rachel Gold
OCHIN, Inc., Aurora, CO
Background: A study examining the influence of
implementation support on adoption of guidelineconcordant cardioprotective prescribing in community
health centers (CHCs) began shortly after a major change in
guideline recommendations regarding the use of statins for
primary prevention of cardiovascular disease. This change
recommended replacing specific cholesterol treatment goals
with fixed statin doses based on individual risk. This analysis
explored how the new guidelines were integrated into
providers’ mindlines, ie, tacit and experiential knowledge
influencing their treatment decisions and prescribing
practices.
Methods: Over 3 years (2015–2018) researchers interviewed
43 providers at 20 clinics. Interviewees were asked if
their prescribing approach had shifted due to the guideline
changes, how they introduced statins to their patients,
and what might cause them to not prescribe statins; these
topics also arose organically. Interviews were transcribed
and coded in QSR NVivo; analysis followed the constant
comparative method.
Results: The extent to which the revised guidelines shifted
providers’ mindlines (and therefore prescribing practices)
fell into 3 general categories: 1) Those who incorporated
the new guidelines into their decision-making and explicitly
discussed individual risk when talking with patients; 2)
Those who believed in the new approach in theory but found
it troublesome to implement in practice; and 3) Those who
continued to prescribe based solely on cholesterol-level
targets. Providers identified multiple factors that influenced
their concordance with the revised statin guidelines (ie,
mindlines), including: a) familiarity with the new guidelines;
b) views on the applicability of population-based guidelines
to individual patients, particularly CHC patients; c) beliefs
regarding the interplay of professional autonomy and
treatment guidelines in patient care; d) intuition/gut feeling;
e) comfort with prescribing a lifelong medication to younger
or seemingly healthy patients; f) practice inertia; g) trust in
the underlying evidence; and h) deference to specialists.
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Conclusion: Evidence-based clinical guidelines are
notoriously difficult to embed into clinical practice. Enacting
new guidelines requires a shift in individual clinicians’
mindlines, which are shaped by personal experience,
training, values, and interactions with others as well as
evidence-based research. Guideline-implementation efforts
should address the multiple knowledge sources clinicians
draw on when making treatment decisions.
Supporting Community Health Center Patients in
Completing Follow-Up Colonoscopy: A Qualitative
Summary of Patient Navigation Activities
Jennifer S. Rivelli, Jennifer L. Schneider, Jamie
Thompson, Amanda Petrik, Neha Yadav, Leslie
Mosso, Edward Perez, Gloria Coronado
Kaiser Permanente Northwest, Portland, OR
Background: Fecal immunochemical tests (FITs) are an
acceptable and cost-effective way to identify patients at
risk for colorectal cancer. However, patients who receive an
abnormal FIT result must obtain a follow-up colonoscopy.
Rates of follow-up colonoscopy are low in most health care
settings, particularly in Federally Qualified Health Centers
(FQHCs). Patient navigation can provide much needed
support for patients to complete the follow-up colonoscopy.
Methods: PRECISE is a patient-randomized trial of
patient navigation vs usual care for follow-up colonoscopy
implemented within a FQHC in Washington State
(anticipated 37% Latinx). A bilingual (native Spanish
speaker) patient navigator was trained based on the New
Hampshire Colorectal Cancer Screening Program. As part
of the recruitment and data tracking tool used by the patient
navigator, open text fields are available for documenting
interactions with navigated patients. We present a qualitative
content analysis of the open text fields of navigated patients
following the first 8 months of the study. These findings
identify the range of supportive interactions engaged in by
the patient navigator to assist patients in overcoming barriers
to follow-up colonoscopy completion.
Results: A total of 52 participants had open text field
documentation, representing both decliners (n=8) and those
navigated to colonoscopy completion (n=44). Analysis of
the 44 navigated patients revealed common areas where
the navigator provided support, including contacting the
gastroenterologist office to problem-solve issues like lack
of referral, scheduling delays, or to obtain appointment
information (40 instances); assisting the patient with
obtaining, understanding, and completing the bowel
preparation (25 instances); and verifying, coordinating, and
offering transportation/escort support before and after the
colonoscopy procedure (22 instances). For the 8 decliners,
most had multiple reasons for declining, including general
resistance/fear, other health priorities, desiring a second FIT
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test, insurance challenges, and prior negative experience
with the bowel preparation formula. One participant declined
navigation due to having prior colonoscopy experience.
Conclusion: The PRECISE trial highlights the importance
of targeted patient navigation to improve colorectal
cancer screening completion. Our open text field findings
demonstrate the necessary role of patient navigation for
overcoming the multitude of educational and structural
challenges facing FQHC patients when attempting to
complete a follow-up colonoscopy.
Comparing Two Approaches to Implementing
Suicide Risk Identification Models
Scott Stumbo, Jennifer L. Schneider, Rebecca
Rossom, Julie Richards, Bobbi Jo Yarborough
Kaiser Permanente Northwest, Portland, OR
Background: Machine learning models using electronic
health record data to identify individuals at risk for
attempting or completing suicide are being developed and
readied for implementation. A relatively new innovation
in suicide prevention efforts, the implementation of these
models warrants study; guidelines for acceptable and safe
implementation do not yet exist.
Methods: Guided by the Consolidated Framework for
Implementation Research, we interviewed 40 clinicians and
health care administrators at 3 integrated health systems.
Two sites are currently engaged in implementing suicide risk
identification models: one site implemented their approach as
part of a mental health visit, the other site integrated it into an
existing telephone-based case management program. Clinicians
and administrators at the third site, planning for future suicide
risk identification model implementation, also were interviewed
about their concerns and hopes for this technology.
Results: Content analysis of interviews revealed clinicians
across sites broadly support the use of suicide risk
identification models as another important tool in the suicide
prevention toolkit. Clinician recommendations included
early engagement of clinicians in decision-making and
planning, establishing a clear clinic workflow, and providing
appropriate, thorough, and ongoing training. Studying two
different implementation approaches elicited different
strengths and challenges. For example, the strength of an
established patient-provider relationship in a visit-based
approach could be compared to the opportunity to reach
patients with an outreach approach and the accompanying
barrier of not having a history with the patients. Other
barriers included competing demands and time and lack
of comfort/training in suicide risk assessment. Clinicians
across sites called for consolidating all suicide-related risk
information into a standardized and easy-to-access module
in the electronic health record to enhance efficiency for
risk identification follow-up. Finally, clinicians expressed

194 JPCRR • Volume 8, Issue 2 • Spring 2021

concern that some patients would still be missed, and they
were not sure what to do with patients with chronic suicide
ideation who are continuously identified.
Conclusion: Lessons from two sites provided several areas
of opportunity for improving implementation of machine
learning models that identify suicide risk.
Using Qualitative Comparative Analysis in
Implementation Science: Findings and Challenges
Inga Gruß, Arwen Bunce, James Davis, Joanna
Bulkley, Rachel Gold
Kaiser Permanente Northwest, Portland, OR
Background: Identifying determinants of practice change in
health care is central to implementation science. Qualitative
comparative analysis (QCA) offers a rigorous approach to
identify determinants, or “conditions,” of practice change
by systematically comparing cases (units of analysis) as
configurations of conditions of desired outcomes. Using data
from a trial comparing implementation support strategies’
impact, we performed crisp-set QCA to identify sets of
conditions associated with significant improvements in the
targeted outcome (guideline-concordant cardioprotective
prescribing) in the study clinics. We also reflect on challenges
involved when using this methodology.
Methods: Qualitative (staff interviews, observations) and
quantitative (electronic health record, surveys) data were
collected over 3 years from 29 community health centers
across 12 service areas in the United States. Performing QCA
involved 4 steps: building a configurational model by selecting
4 conditions of interest; constructing the empirical sample
to include all relevant cases (each service area); calibrating
the data by translating data into binary categories (present
and absent); and analyzing the “truth table” created during
calibration to calculate consistency (extent to which a given
configuration of conditions is associated with outcome) and
coverage scores (empirical relevance of sets of conditions).
Results: The QCA identified 2 conditions as necessary for
achieving significant change in the targeted outcome —
the presence of a study champion (consistency score: 1.00;
coverage score: 0.72) and the absence of a perceived culture
of quality improvement (consistency score: 1.00; coverage
score:1.00). No other conditions were necessary or sufficient.
Further exploring the finding that the absence of a perceived
culture of quality improvement was a necessary condition was
challenging because 1) it was not feasible to meaningfully
operationalize all conditions that might explain this finding,
and 2) adjusting the configurational model post hoc would
have required including additional conditions that were not
assessed systematically during data collection.
Conclusion: QCA methods can support empirical
explanation of implementation research findings, with
limitations. In implementation science, important conditions
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that contribute to implementation success or failure often
are only understood upon completion of a trial. This poses
a challenge for systematically collecting data for designing
the most appropriate configurational model.
Using Implementation Science to Identify
Clinician-Reported Barriers to Discussing Safe
Fish Consumption During Routine Prenatal Care
Meghan JaKa, Jennifer Dinh, Thomas Kottke, Jacob
Haapala, Patricia McCann, Jeanette Y. Ziegenfuss
HealthPartners, Bloomington, MN
Background: Fish consumption during pregnancy is
beneficial for mothers and developing fetuses; however, care
should be taken to choose low-mercury fish. The complexity
and importance of this message make it ideal for clinician
discussions during routine prenatal care. This project
measures clinician-reported behaviors and barriers related to
fish consumption conversations, guided by implementation
science theory (the Capability, Opportunity, and Motivation
Behaviour, or COM-B, model).
Methods: A representative sample of 400 obstetrics/
gynecology and family medicine clinicians across Minnesota
were surveyed using a sequential, mixed-mode design
with a small token incentive. Questions asked how often
clinicians discussed fish consumption and the prevalence
of various barriers to these discussions. Reported behaviors
and barriers were categorized into the COM-B model.
Descriptive and chi-squared statistics were used to report
prevalence and differences across clinician characteristics.
Responses to open-ended items were coded into COM-B
categories using content analysis.
Results: A total of 219 clinicians completed the survey
(55% response rate), with no differences by specialty or
geography. Most clinicians reported the “behavior” of
discussing nutrition generally, but the most common topic
was weight management (89%), with only 35% discussing
the benefits of fish and 27% discussing risks. Aligning with
other COM-B constructs, commonly reported “capability”
barriers included knowledge (67% did not strongly
agree it was important for pregnant women to eat fish);
“opportunity” barriers related to context and resources
(82% said not enough time, 63% said topic not built into
encounters, 41% said topic was not a leadership priority),
and “motivation” barriers included lack of perceived
professional role (91% said dietitians were an ideal
source for patient diet information). Qualitative responses
reiterated these findings, adding additional context, “It’s
not prioritized by my employer, perhaps because it’s not
related to insurance company compensation.” Differences
by clinician characteristics also will be presented.
Conclusion: Opportunities exist to increase clinician
recommendation of healthy and safe fish consumption during
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pregnancy, but a number of barriers across all COM-B model
domains constrain the frequency of these conversations. This
presentation will discuss the implications of this work and how
results may be used to develop theory-informed intervention
strategies to facilitate effective, high-quality informationsharing about fish consumption around the point of care.
Impact of a Multilevel Acute Kidney Injury
Rehabilitation Program on Postdischarge Mortality
and Rehospitalization
Gurmukteshwar Singh, Yirui Hu, Steven Jacobs, Jason
Brown, Jason George, Maria Bermudez, Kevin Ho,
Jamie Green, H. Lester Kirchner, Alex Chang
Geisinger Research, Danville, PA
Background: Hospitalization-associated acute kidney injury
(AKI) is common and associated with markedly increased
mortality and morbidity. The objective of this study was
to examine the impact of a multilevel AKI rehabilitation
program on postdischarge outcomes.
Methods: An AKI rehabilitation program was piloted at an
academic center in central Pennsylvania from September 19,
2019, to February 29, 2020. Hospitalized patients with stage
2–3 AKI were identified in real-time using an electronic
health record-embedded algorithm and offered enrollment
into an AKI rehabilitation program. Patients who had hospice/
comfort care status, unclear goals of care at discharge,
or significant cognitive impairment were excluded. The
intervention included patient education, case manager
services, and expedited nephrology appointments starting
within 2–4 weeks of discharge. We examined the association
between AKI rehabilitation program participation and
risks of rehospitalization or mortality in logistic regression
analyses adjusting for comorbidities, discharge disposition,
sociodemographics, and kidney parameters. Sensitivity
analysis was performed using propensity score matching.
Results: In total, 52 high-risk AKI patients were enrolled
and compared to 400 nonparticipants. Crude postdischarge
rates of rehospitalization or death were significantly lower
for participants vs nonparticipants at 30 days (15.4% vs
34.2%; P=0.01) and at 90 days (32.7% vs 50.5%; P=0.023).
After multivariable adjustment, AKI rehabilitation program
participation was associated with lower risk of rehospitalization
or mortality at 30 days (odds ratio: 0.42, 95% CI: 0.17–0.95),
with similar findings at 90 days (odds ratio: 0.54, 95% CI:
0.25–1.14). In propensity score-matched sensitivity analyses of
46 participants and nonparticipants, risks of rehospitalization
or mortality were not significantly different at 30 days (15% vs
26%; P=0.3) or at 90 days (37% vs 35%; P=1.0).
Conclusion: Participation in an AKI rehabilitation
program was associated with decreased 30-day risk of
rehospitalization or death. Randomized trials are needed to
evaluate the efficacy of this strategy.

aah.org/jpcrr

195

Assessing Challenges to Implementing Tobacco
Cessation Guidelines in Dental Offices
Mark W. Jurkovich, Steve E. Asche, Chris J. Enstad,
Anjali R. Truitt, Emily C. Durand, Kimberly S.
Johnson, Lauryn M. Davin, Heiko Spallek, Jeanette Y.
Ziegenfuss, D. Brad Rindal

Developing a Prototype to Promote Data Collection
of Sexual Orientation and Gender Identity Through
Education and Electronic Health Record Feedback
Reports
Christopher Kabir, Cynthia Lira-Crame,
Benitez, Brooke Pichen, Oscar Zambrano

Belinda

HealthPartners, Bloomington, MN

Advocate Aurora Health, Chicago, IL

Background: Tobacco use has a negative impact on oral
health. Practice guidelines encourage dental providers to
provide tobacco using patients with cessation counseling. In
order to improve adherence to these guidelines, it is important
to understand the factors that make implementation difficult.
As part of a clinical trial testing a clinical decision support
tool to support guideline compliance in dental practice, we
examined baseline factors that could serve as barriers to
guideline implementation.
Methods: We enrolled 29 dental providers into a tobacco
cessation trial. At baseline we administered a questionnaire
based on key theoretical domains relevant to implementation
behaviors of health care providers. The online baseline
survey was collected from 10 dentists and 19 hygienists
at 10 private practice dental offices from July 2019 to
August 2020. Descriptive statistics compare endorsement
of individual survey items (response scale: 1 = strongly
disagree, 5 = strongly agree) and patterns of differences in
dentist and hygienist responses are described.
Results: Clinicians believe there is value in (mean: 4.1),
and that their role includes provision of (mean=4.3) tobacco
cessation services. Hygienists were directionally more
likely than dentists to agree that their role involved assisting
patients to stop tobacco use (means: 4.6 vs 4.0). Clinicians
had a moderate level of confidence in how to assess patients
in efforts to stop tobacco use (mean: 3.5) and that they knew
the right questions to ask patients (mean: 3.2). Clinicians
were less confident in prescribing medications for those
ready to quit (mean: 1.9) and had moderate levels of
understanding the risks and benefits of nicotine replacement
therapy (mean: 2.8). Clinicians lack a system to cue/prompt
counseling against tobacco use (mean: 2.1) and report that
clinics had done little to remove barriers to the provision of
tobacco use counseling (mean: 2.3). Directional differences
in dentist vs hygienist item means indicated that receipt of
sufficient reimbursement for promoting tobacco abstinence
was more of a concern for dentists than hygienists (means:
2.4 vs 3.6).
Conclusion: Dental providers believe they have a valuable
role in tobacco cessation. Opportunities to enhance tobacco
cessation include providing tools to prompt counseling and
assist prescribing medications. Dentists more than hygienists
identify reimbursement as insufficient. More could be done
to remove barriers.

Background: Collecting sexual orientation and gender
identity (SOGI) information is essential to improving
patient-centered care, according to the Centers for Disease
Control and Prevention. However, obtaining SOGI data in
the electronic health record (EHR) is often difficult within
large health systems, and information on sexual and gender
minority patients remains largely uncaptured and unused
by health systems. One reason for this may be a gap in
cultural competence in discussing SOGI information with
patients. A solution identified by our Lesbian, Gay, Bisexual,
Transgender, and Queer (LGBTQ) Task Force was to
integrate education with SOGI data extracted from the EHR.
In this presentation, we describe the implementation and
results of a quality improvement project designed to address
barriers in documentation and improve data quality.
Methods: An interdisciplinary committee was established
within the LGBTQ Task Force with the mission to reinforce
the importance of SOGI information and promote data
collection and education throughout the institution. To
accomplish this, education material is coupled with
visualizations of the institution’s SOGI data and shared
with nursing leadership at one metropolitan Level 1 trauma
center. We also received feedback through anonymous
surveys to examine barriers in collecting SOGI information.
Results: Our transition to a unified EHR system provided
an opportunity to develop and demonstrate a prototype for
a standard and user-friendly reporting function that can be
accessible throughout the health system. Once this work
is complete, we hope to better understand and overcome
barriers, as well as improve SOGI data completeness. The
committee garnered support from institutional leaders
and multiple departments to transition the project into the
future state.
Conclusion: To identify and address health disparities, we
need to provide ongoing feedback and reinforce the priority
of collecting SOGI data at multiple points of care within
the clinical workflow. Improved access and flexibility in
data visualization to unit-level granularity of EHR data
is the first step to identifying gaps and target areas for
education. Furthermore, high completion rates of SOGI
information throughout the health system is needed and can
lead to improved compassionate care for sexual and gender
minority patients.
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Beyond Implementation: Developing and Utilizing
a 5-Factor Scale to Measure Optimization of Lynch
Syndrome Tumor Screening Programs in Health
Systems
Zachary Salvati, Deborah Cragun, Victoria Schlieder,
Jamie Atondo, Ilene Ladd, Jasmine Burton-Akright,
Jessica Ezzell Hunter, Mara Epstein, Christine Y. Lu,
Pamala A. Pawloski, Ravi Sharaf, Su-Ying Liang,
Andrea Burnett-Hartman, Alanna Kulchak Rahm
Geisinger Research, State College, PA
Background: Implementation of universal tumor screening
(UTS) programs for Lynch syndrome remains variable
when comparing health systems nationwide. The IMPULSS
study aims to better understand this variability and identify
elements that facilitate or impede program optimization.
Methods: The IMPULSS study utilized purposive sampling
of 9 health systems (7 in HCSRN, 1 academic, 1 national
system) with variability in UTS implementation. Semistructured interviews with 44 relevant stakeholders were
conducted. Data collection and thematic analyses were
guided by the Consolidated Framework for Implementation
Research (CFIR) with the intent to identify domains and
constructs differing across sites that have successfully
implemented and optimized UTS using cross-case
comparisons of the data matrices generated.
Results: Some sites had multiple unique UTS operations
under the same organizational umbrella, each considered
separate analytic units (AUs). To date, we have identified
14 distinct AUs within 6 health systems. Of these, 10
AUs had implemented a UTS program, represented by 31
interviewed stakeholders involved in direct-patient care
and/or administrative leadership; 13 stakeholders were
interviewed from the 4 AUs without a program. Thematic
coding guided by CFIR found differences primarily in
constructs within the “Innovation Characteristics” CFIR
domain. A 5-point UTS optimization scale was created to
indicate presence or absence of each of the following factors
important to program optimization: 1) systematic tracking;
2) procedural uniformity; 3) process for “bridging the gap”
between tumor screening and germline testing; 4) automatic
ordering of appropriate reflex testing; and 5) using data
and quality assurance methods to determine and improve
program efficacy. By scoring each factor as 1-present or
0-absent, progress toward UTS program optimization was
calculated and areas that need improvement were identified.
AUs that scored a 4 or 5 on optimization demonstrated high
quality and consistency in “Networks & Communication.”
Conclusion: Identification and stratification of CFIR
domains and constructs allowed the study team to separate out
the processes and factors pertinent to initial implementation
and program optimization. We subsequently identified 5 key
factors important to UTS program optimization. This will
allow us to tailor toolkits to assist with both implementation
and optimization of UTS programs.
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MATERNAL, CHILD, AND FAMILY HEALTH
Understanding the Time Costs of Caring for
Children With a Chronic Health Condition: A Report
From the r-Kids Study
Frances Lynch, Alexandra Varga, Joanna Bulkley, Lisa
Croen, Eric Fombonne, Brigit Hatch, Yihe Daida, April
Lee, Maria Massolo, John Dickerson
Kaiser Permanente Northwest, Portland, OR
Background: All families experience time demands
related to caring for their child’s health. However, families
of children with autism spectrum disorder (ASD) or other
chronic health conditions may face a higher burden.
Methods: We used electronic health records from 3 Kaiser
Permanente regions (Northwest, Hawaii, and Northern
California) and several community health clinics to identify
children between 3 and 16.5 years of age with ASD, asthma,
or neither (ie, control group). We oversampled racial and
ethnic minorities and matched asthma and control groups
to the age and gender distribution of the ASD group.
Parents or guardians completed online surveys 3 times over
12 months in English or Spanish. Surveys included the
Family Economic Impact Inventory (measuring financial,
time, and employment costs of caring for a child’s health)
and instruments measuring the child’s quality of life (per
PedsQL) and symptom severity for children with ASD (per
SRS) or asthma (per PROMIS Asthma), parenting stress,
and parent physical and mental health.
Results: In all, 1461 families enrolled in the study (n=564
ASD, n=468 asthma, n=429 control). The children had a
mean age of 9.1 years and were predominantly male (79%)
and ethnically diverse (21% Hispanic, 43% non-Hispanic
White, and 35% non-Hispanic Asian, Black, Native
Hawaiian, or other race/ethnicity). Families of children
with ASD spent more time coordinating with and attending
meetings with schools (mean [standard deviation]: 28 [55]
hours in ASD group vs 23 [54] hours in asthma group or
10 [32] hours in control group; P<0.0001) and child care
providers (mean [standard deviation]: 19 [66] hours in
ASD vs 7 [31] hours in asthma or 3 [24] hours in control;
P<0.0001). Families of children with ASD also spent much
more time in caregiving tasks at home (eg, managing
insurance, coordinating with schools) related to their child’s
health compared to either group (mean [standard deviation]:
93 (151) hours in ASD vs 13 [59)] hours in asthmas or 10
[46] in control; P<0.0001).
Conclusion: Families of children with ASD experience
significant time costs related to caring for their child’s health.
These time demands can have a profound effect on parent
stress and ability to function in work and other activities.
More attention to these costs could improve policies to
support families of children with ASD.
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Association of Adverse Perinatal Outcomes With
Maternal Obesity and Gestational Diabetes
Vani Movva, Kajal Angras, Amanda Young, A. Dhanya
Mackeen

Romantic Relationship and Parenting Distress
Associations With Emotional Eating and Alcohol
Consumption During COVID-19
Megan Ferriby Ferber, Stephanie Malzahn, Dixie Meyer

Geisinger Research, Danville, PA

Saint Louis University / SSM Health, St. Louis, MO

Background: The risk of development of gestational
diabetes mellitus (GDM) increases with maternal body
mass index (BMI). Several adverse perinatal outcomes are
associated with both maternal obesity and GDM. The aim
of this study was to investigate the concomitant effects of
GDM and maternal obesity on adverse perinatal outcomes
at term.
Methods: This is an institutional review board-approved
retrospective cohort study of women who delivered a
singleton at a tertiary care center between 2010 and 2019.
We excluded patients with pregestational hypertension or
diabetes. Women were categorized by their pregravid BMI
(underweight and normal: <25.0, overweight: 25.0–29.9,
obese: >30.0 kg/m2) and presence/absence of GDM. To
determine if there is an association between obesity and
GDM with perinatal outcomes, general linear models were
applied for the continuous outcomes and logistic regression
for the binary outcomes. Test of trend P-values were reported
for all outcomes.
Results: Of the 30,632 included women, 25.1% were
overweight and 31.7% were obese prior to pregnancy.
The risk of GDM was 3.6%, 6.1%, and 11.2% among the
underweight/normal, overweight, and obese BMI categories,
respectively. Maternal outcomes, including incidence of
hypertensive disorders of pregnancy and cesarean delivery,
and neonatal outcomes, including APGAR score of <7 at
5 min, intensive care unit (ICU) admission, and neonatal
jaundice and hypoglycemia, increased with increasing
BMI and presence of GDM, with the highest risk in obese
patients with GDM (P<0.01). The gestational age at delivery
decreased as BMI increased (P<0.01); however, it was not
clinically significant. Incidence of preterm delivery, shoulder
dystocia, length of neonatal ICU admission, and respiratory
distress syndrome did not show a significant trend. The risk
of stillbirth could not be assessed with only 1 fetal demise
in the cohort.
Conclusion: Obesity increases the risk of GDM and
worsens outcomes as compared to GDM alone. The test
of trend indicated that an increase in BMI class in addition
to GDM increased the risk of both maternal and neonatal
morbidity. Preventive strategies for risk reduction, such as
healthy weight loss prior to pregnancy, should be strongly
encouraged by health care providers.

Background: The COVID-19 pandemic shifted work
and home life for many American couples and families.
Changes such as added demands and responsibilities may
elicit coping strategies and, for many, can overwhelm
coping skills. Prior research suggests maladaptive coping
mechanisms are utilized when negative interactions are
triggered between partners and when emotional distress
becomes too great to tolerate. This study aimed to examine
how individuals are coping with the stressors associated with
the COVID-19 pandemic within the relational context. We
specifically assessed association of the maladaptive coping
mechanisms alcohol use and emotional eating with romantic
and family relationship interactions and stress.
Methods: This longitudinal study, part of a larger ongoing
study, utilized ecological momentary assessment. A total of
88 participants completed surveys examining relationship
satisfaction, daily distress, negative partner interactions,
parenting stress, emotional eating, and alcohol use on both
weekday and weekend days. Data were analyzed using
4 multiple linear regressions for each maladaptive coping
mechanism and for each day assessed.
Results: Results revealed greater use of emotional
eating was associated with higher perceived relationship
satisfaction (t=2.19, P=0.03) and parenting distress (t=2.68,
P=0.01) during weekdays. Weekend data showed parenting
distress (t=2.52, P=0.02) and daily distress (t=2.13, P=0.04)
were significantly related to greater use of emotional eating.
Greater use of alcohol use was associated with parenting
distress (t=2.44, P=0.02) on weekends only.
Conclusion: These results highlight the taxing impact of
the COVID-19 pandemic on couples’ and families’ ability to
cope with parenting stress. The limited resources currently
available to couples and families require alternate coping
strategies be implemented to reduce stress activation.
Greater emotional eating (both days) and alcohol use were
found to be related to parenting distress, indicating parents
may be a particularly vulnerable group to the stress of
COVID-19. With the frequency of emotional eating and
alcohol use to cope with stress comes increased health risks
and the necessity for implementing health care interventions
and behavioral approaches that result in more adaptive
stress-coping strategies.
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Improving Lead Screening in the Era of COVID-19:
Development of a Lead Screening Program in an
Integrated Health System Serving Predominantly
Rural and Suburban Pediatric Patients
Karina Phang, Jennifer Vodzak, Stacey Cummings,
Heather Mosley, Keith Boell
Geisinger Research, Pittston, PA
Background: Lead exposure remains a common, preventable
environmental health threat to children. Lead screening
with blood lead level (BLL) testing is recommended as
part of well-child examinations. COVID-19 has adversely
affected identification of children with elevated BLL, lead
exposure elimination, and linkage to community services and
interventions in the United States. Geisinger is a large integrated
health system with an outpatient pediatric network serving
predominantly suburban and rural children in more than 40
Pennsylvania counties, many with high risk for lead exposure.
Methods: We assembled a multidisciplinary team
representing general pediatrics, quality and safety,
informatics, laboratory medicine, pharmacy, patient
experience, and population health. Our overall aim was to
develop a comprehensive pediatric lead screening program
that 1) systematically performs lead screening, 2) delivers a
standardized guideline-adherent response to results, and 3)
communicates lead screening and interventions to families
using health literacy-informed approaches. We utilized
mixed-method quality improvement and implementation
science methodologies. We validated lead screening
completion metrics utilizing the Cerner HealtheIntent
Registry tool. Primary measures included completed BLL at
1-year well visit, completed BLL in 2-year-olds with public
insurance, and documentation of lead risk assessment.
We completed qualitative assessments of existing patient
education and communication strategies.
Results: A key driver diagram outlined stages of program
development and intervention strategies. The improvement
model and Plan-Do-Study-Act cycles enabled testing
of changes on small scale in specific pediatric clinics/
regions before system-level implementation. Geisinger’s
pediatric network lead screening completion rate was
49% in Medicaid patients in 2019 (national Healthcare
Effectiveness Data and Information Set rate of 70%). Initial
data showed substantial variation in percentages of both
children tested for BLL and with confirmed elevated BLL
across sites. As the program is in early development phases,
key performance indicator data will be forthcoming.
Conclusion: Multidisciplinary team involvement and system
process changes can create pathways to address adherence
to complex lead screening guidelines in an integrated health
system. During the COVID-19 pandemic, it is important
that health systems utilize diverse strategies to prioritize
lead testing, especially for children who missed routine BLL
screening, are at high risk for lead exposure, and have prior
elevated levels needing follow-up testing and intervention.
Supplement

Trends in Human Papillomavirus Vaccination
Among Insured Adolescents in Georgia
Courtney McCracken, Natalie Hernandez, Belkis
Pimentel, Ianthia Smith, Hsien-lin Hsieh, Teaniese
Davis
Kaiser Permanente Georgia, Atlanta, GA
Background: The human papillomavirus (HPV) is the most
common sexually transmitted infection in the United States
and has been linked to several forms of cancer. Fortunately,
the majority of HPV-related cancers are preventable through
vaccination. Despite the safety of HPV vaccination, HPV
vaccination rates are lower than many other adolescent
vaccines. The goal of this study was to evaluate trends in
HPV vaccination among insured adolescents 11–17 years
of age and to identify characteristics associated with HPV
vaccination.
Methods: We performed a retrospective cohort study of
11–17-year-old adolescents who were insured by Kaiser
Permanente Georgia (KPGA) between January 1, 2012,
and December 31, 2019. Patient demographics and medical
history were extracted from KPGA’s virtual data warehouse.
HPV vaccination information was ascertained from medical
records, claims, and state immunization registry records.
HPV vaccination coverage was defined as the proportion
of adolescents that had more than 1 HPV dose prior to or
during a given calendar year. HPV vaccine completion was
defined as receipt of either 2 or 3 doses based on the age of
the adolescent and the year vaccination was initiated. Trends
over time were examined using the Cochran-Armitage test
for trend, and rates were compared between demographic
subgroups using chi-squared tests.
Results: There were a total of 74,488 adolescents during
the study period. HPV vaccine coverage increased over
time (P<0.001) from 40% in 2012 to 61% in 2019, while
completion rates only modestly increased from 31% to 41%
(P<0.001). HPV vaccination coverage was slightly higher
among females compared to males; however, there was a
significant decrease in the gender gap over time (P<0.001).
Asians and African Americans had the highest coverage
rates (66% and 61%, respectively), while Whites had the
lowest (52%, P<0.001). Prior flu vaccination was strongly
associated with HPV vaccine coverage (74% vs 37%;
P<0.001).
Conclusion: While HPV vaccination rates have risen over
time, vaccination rates still fall well below the Healthy
People 2020 benchmark of 80%. These findings suggest the
need for continued efforts and interventions to improve HPV
vaccination rates and series completion among adolescents.
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MENTAL HEALTH
Developing a Prospective Cohort of Prescription
Opioid Users: Challenges and Lessons Learned
Jeffrey Scherrer, Lisa Matero, Scott Secrest, Kirsti
Autio, Joanne Salas, Lauren Wilson, Mark Sullivan,
Lynn DeBar, Brian Ahmedani, Patrick Lustman
Saint Louis University / SSM Health, St. Louis, MO
Background: Opioid analgesic use (OAU) is associated
with an increased risk for depression even after controlling
for the contributions from pain. Herein, we describe a
research collaboration between Saint Louis University
(SLU) and Henry Ford Health System (HFHS) that aims
to determine the risk factors, either preceding or following
OAU, that increase risk for incident depression and to
systematically characterize the depression profile (ie, major
depressive episode, dysthymia, bipolar, anhedonia, and vital
exhaustion) associated with OAU.
Methods: This is a prospective cohort study of 1500 (750
SLU, 750 HFHS) adult (age range: 18–70 years) prescription
opioid users invited to participate when they have completed
a new period (no OAU in previous 3 months) of 30day OAU and have prescriptions allowing for 60 days of
continuous opioid use. Targeted subject recruitment using
electronic health record data is being used to identify
eligible subjects. Baseline, 6-month, and 12-month web or
telephone survey are being used to obtain data on lifetime
and current psychiatric diagnoses, trauma, sleep disorder,
social support, noncancer pain, and OAU. Subjects will be
asked to complete 12 monthly assessments measuring painrelated functioning, depression symptoms, and OAU.
Results: Efforts to reduce morbidity and mortality associated
with the opioid epidemic have led to significant declines in
the number and duration of new opioid prescriptions written
in the United States. These changes have challenged our
ability to identify eligible subjects and required adapting
the eligibility criteria to reflect current prescribing patterns.
We now allow tramadol to count as an eligible opioid and
do not require a chronic pain diagnosis. We have completed
programming of a diagnostic interview in REDCap, making
it the first available web-based, lay-administered, psychiatric
diagnostic survey. Approximately 500 participants have
been enrolled since November 2019.
Conclusion: Restrictions on type of opioid and duration
of new opioid prescriptions have dramatically increased
the difficulty involved in obtaining eligible patients. Fewer
eligible subjects per week has led to allowing for a 24-month
baseline enrollment period. Allowing tramadol to count
toward OAU greatly increased the number of subjects
eligible for study and ensures that results will be relevant
to current prescribing practices. Preliminary recruitment
information and lessons learned will be discussed.
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Increasing Nurse Satisfaction While Decreasing
Compassion Fatigue: A Quality Improvement Pilot
Project
Alexandra Myers, Ashleigh Boyd
Treat The Nurse, St. Louis, MO
Background: The purpose of this quality improvement
project was to identify and reduce the level of compassion
fatigue in emergency department (ED) nurses by
implementing a self-guided intervention. Compassion
fatigue was the largest concern for nurse vacancy rates by
administration, and it was confirmed that ED nurses were
in the moderate-risk category for compassion fatigue via
Professional Quality of Life (ProQOL-5) survey results.
Methods: A Plan-Do-Study-Act method of quality
improvement was used for this project. The self-guided
intervention of Real-Time Transformative Response© (RTR)
was used. ProQOL-5 was used to measure and determine if
it was effective in reducing levels of compassion fatigue in
ED nurses.
Results: A total of 34 ED nurses completed RTR training
and ProQOL-5 surveys. Overall mean (standard deviation)
score was 107 (1.1385) for the pre-RTR training survey
and 106.613 (1.1677) for the post-RTR training survey
(t=1.6924, df=66; P=0.0476). Mean scores pre-and postRTR training for compassion satisfaction increased from
3.59 (0.9521) to 3.95 (0.7766) (t=1.997, df=66; P<0.0001),
for burnout decreased from 2.71 (1.1501) to 2.36 (0.9120)
(t=1.997, df=66; P<0.0001), and for secondary traumatic
stress decreased from 2.45 (1.0002) to 2.25 (0.9143)
(t=1.997, df=66; P=0.0017).
Conclusion: Increasing compassion satisfaction and having an
overall decrease in compassion fatigue, burnout, and secondary
traumatic stress from using the self-guided RTR methods
concluded that it is a valid coping mechanism for nurses.
Patient Perspectives on Acceptability of, and
Implementation Preferences for, Use of Electronic
Health Records and Machine Learning to Identify
Suicide Risk
Bobbi Jo Yarborough, Scott Stumbo
Kaiser Permanente Northwest, Portland, OR
Background: Suicide rates in the United States have steadily
increased over the past two decades. With recognition that
traditional clinical assessments of suicide risk perform only
slightly better than chance, attention has turned to the promise
of identifying at-risk patients using existing electronic health
record data and automated machine learning methods.
However, suicide risk identification, being a relatively
new application of this technology, lacks implementation
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guidelines or practice standards. While health systems are
increasingly interested in use of this technology, we know
very little about how patients feel about its use.
Methods: Focus groups informed a web-based survey sent
to 11,486 Kaiser Permanente Northwest members in April
2020. Likert-type and bipolar visual analog scales (means
of the latter scored -50 to 50) assessed patient understanding
of, potential concerns with, and implementation preferences
related to automated suicide risk identification using
electronic health record data and machine learning.
Descriptive statistics summarized findings.
Results: Overall, 1357 (12%) participants responded to the
survey. Most (84%) found machine learning-derived suicide
risk identification an acceptable use of electronic health
record data; however, 67% objected to use of externally
sourced data. Participants felt consent (or opt-out) should
be required (mean: -14). The majority (69%) supported
outreach to at-risk individuals by a trusted clinician through
care messages (57%) or telephone calls (47%–54%).
Highest endorsements were for psychiatrists/therapists
(99%) or a primary care clinician (75%–96%); less than half
(42%) supported outreach by any clinician, and participants
generally felt only trusted clinicians should have access to
risk information (mean: -16).
Conclusion: We found patient support for use of electronic
health record data (but not externally sourced risk
information) to inform automated suicide risk identification
models. A patient-centered approach to implementation of
these models would involve the option to consent or optout of inclusion and telephone or care message outreach to
individuals identified at risk by patients’ trusted clinicians.
A Stakeholder-Informed Ethical Framework to
Guide Implementation of Suicide Risk Identification
Models Using Machine Learning Applied to
Electronic Health Records
Bobbi Jo Yarborough, Scott Stumbo, Gregory Simon
Kaiser Permanente Northwest, Portland, OR
Background: Given the pressing need for adequate
prevention efforts to arrest the escalating suicide rate in the
United States, there has been an urgent focus on suicide risk
detection using novel methods including machine learning
applied to electronic health records (EHR). Relative to
clinical assessment, machine learning algorithms have
demonstrated superior accuracy in identifying patients at
risk for suicide. Consequently, interest in their use in health
care has expanded. A growing body of literature calls for an
anticipatory examination of ethical concerns relevant to risk
model implementation. In light of active implementation
already occurring, and increasing interest in further
deployment of suicide risk identification models, there is an
urgent need for a practical resource focused on the ethical
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application of these models in health care delivery settings.
Methods: In this multimethods study, patient advisors,
a bioethics consultant, and patients and family members
participating in formative focus groups (4 focus groups,
n=23 participants) collectively informed the development
of a web-based survey; survey results (n=1357 respondents)
and themes from interviews with key informants were
used to draft a stakeholder-informed ethical framework to
provide practical guidance to health systems considering
implementation of suicide risk identification models.
Results: Clinical, ethical, operational, and technical issues
reiterated by multiple stakeholder groups and corresponding
questions for risk identification model adopters to consider
prior to and during suicide risk identification model
implementation are organized within 6 ethical principles in
the resulting stakeholder-informed framework.
Conclusion: Enthusiasm for machine learning in the context
of suicide is understandable given the significance of the
suicide epidemic in the United States. Attention to ethical
and practical concerns in advance of automated suicide
risk identification model implementation may help avoid
unnecessary harms that could thwart the promise of this
innovation in suicide prevention. An ethical framework can
help to anticipate and reduce potential for harms, keeping
the safety and welfare of the patients and their trust at the
center of health care decision-making.
Universal Screening for Suicidal Thoughts and
Behaviors in a Large Health System’s Hospital and
Emergency Departments
Ellis C. Dillon, Kristen M.J. Azar, Ernell De Vera,
Martina Li, Qiwen Huang, Sien Deng, Anna Kiger,
Daniel Becker, Tam Nguyen, Jacqui Pesa, Jennifer
Voelker, Giacomo Salvadore
Sutter Health, Palo Alto, CA
Background: Suicide is the 10th-leading cause of death in
the United States. The Joint Commission recently revised
its National Patient Safety Goal requirements to include
standardizing suicide screening. In response, Sutter Health,
a large system serving 3 million patients in Northern
California, launched systemwide standardized use of the
Columbia Suicide Severity Rating Scale (C-SSRS) in acute
care facilities in July 2019. Our goal was to describe and
compare characteristics of adult patients screening positive
for suicidal thoughts or behaviors (STB), including those
with major depressive disorder (MDD).
Methods: Electronic health record-based observational
cohort study describing and comparing sociodemographic
and clinical characteristics of adult patients screening
positive for STB (July 1, 2019–October 4, 2020),
including those with MDD. Patients with STB and MDD
(STB+MDD) were compared to those with STB without
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MDD (STB-MDD) and on risk categories (no risk vs any
risk). Wilcoxon rank-sum tests for continuous variables and
χ2 tests for categorical variables were used. Results reported
are statistically significant at 0.05.
Results: Of 478,143 adults identified, 410,302 (85.8%) were
screened by C-SSRS. Among those screened, 8416 (2.05%)
had STB; in that group, 914 (10.9%) were STB+MDD and
7502 (89.1%) were STB-MDD. Of those with STB, 3278
(38.9%) were low risk, 1314 (15.6%) moderate risk, and
3824 (45.4%) high risk. Any risk vs no risk comparisons by
characteristic were: male gender (46.6% vs 42.3%), White race
(55.5% vs 47.9%), mean age (41.6 vs 50.3 years), homeless in
last 12 months (12.0% vs 2.5%), index encounter in psych unit
(10.3% vs 0.2%), mental health diagnoses (22.2% vs 4.9%),
and MDD (10.9% vs 1%). STB+MDD patients vs STB-MDD
comparisons by characteristic were: mean age (38.8 vs 41.9
years), female gender (58.6% vs 52.8%), Asian race (9.7%
vs 6.6%), income of $75,000+ (45.5% vs 34.0%), index
encounter in psych units (46.5% vs 5.9%), substance abuse
(12.1% vs 3.9%), anxiety (16% vs 2.2%), and documented
prior suicidal ideation (3.7% vs 0.5%).
Conclusion: Screening for STB identified 2.05% with any
STB, 10.9% of which were STB+MDD. Characteristics
differed based on risk and MDD status. Highlighting
demographic and clinical differences between these
patient groups can guide efforts to provide mental health
consultation and referrals. Future research may establish if
universal screening in acute care settings leads to improved
follow-up care for those with STB.
Weight Loss Improves Mental Health Status in a
Behavioral Weight Loss Trial
Cody Goessl, Jeff VanWormer, Ram Pathak, Ed
Ellerbeck, Christie Befort
Marshfield Clinic, Marshfield, WI
Background: Obesity, depression, and anxiety often cooccur, but there is limited prior research on weight change
and mental health status. The purpose of this study was to
examine how Short-Form 12 Health Survey mental health
(SF-12MH) scores changed over 24 months between obese
adult trial participants with vs without a baseline mental
condition, as well as those who lost or gained weight.
Methods: There were 1407 participants enrolled in a 3-arm
behavioral weight loss trial based in rural primary care practices
across Kansas, Nebraska, and Wisconsin. All participants
received a lifestyle intervention with different delivery models,
including in-clinic individual, in-clinic group, or telephone
group counseling visits. In this analysis, the 1148 participants
with complete data were stratified by those with vs without
a baseline mental health condition (receiving medication or
counseling for depression, anxiety, or adjustment issues), as
well as by 24-month weight-change quintiles. Mixed models
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were used to estimate SF-12MH scores by mental health
condition and weight-change categories.
Results: There was a significant group-by-time interaction
at 24-month follow-up. The largest 0–24-month increase
in SF-12MH scores (+5.3 points [12%]) was observed in
participants with a baseline mental health condition who
lost the most weight (quintile) during the trial, while the
largest decrease in SF-12MH scores (-1.8 points [-3%]) was
observed in participants without a baseline mental health
condition who gained the most weight (P<0.001).
Conclusion: Mental health status modestly improved in
this trial with obese adults but particularly increased among
participants with a baseline mental health condition who
experienced significant weight loss. Those without baseline
mental health concerns who gained weight, however,
actually experienced a decline in mental health status over
24 months. Although the causal direction cannot be firmly
established given our analytical design, study findings
support the mental health benefits of weight loss in obese
adults with depression or anxiety. They also suggest that
failure to achieve weight loss could be psychologically
consequential for at least some participants.
Medication Patterns for Patients With Depression,
Anxiety, and Sleep Disorders
Jennifer M. Boggs, Erica Morse, Kathleen Albers,
Arne Beck
Kaiser Permanente Colorado, Denver, CO
Background: Depression, anxiety, and sleep disorders are the
most common mental health disorders and highly comorbid.
Despite a wide range of pharmacological treatments
informed by numerous randomized clinical trials, real-world
medication patterns to treat these comorbidities involve
significant adaptations. Treatment is further complicated by
safety concerns for benzodiazepines, including addiction,
falls, and dementia. We used a mixed-methods approach to
understand real-world prescribing patterns and to identify
relevant research questions for future study.
Methods: Kaiser Permanente Colorado patients were
identified with new medication treatment episodes (4-month
washout) initiated by dispensing of antidepressants (selective
serotonin reuptake inhibitor, serotonin-norepinephrine
reuptake inhibitor, norepinephrine-dopamine reuptake
inhibitors, tricyclic), benzodiazepines, z-drug, or atypical
antipsychotics. Patients had at least one comorbidity for
anxiety, depression, or sleep within a 1-year period (2009–
2018) and no bipolar, psychosis, dementia, or attentional
disorders. Dispensing data (from Virtual Data Warehouse)
were evaluated to determine frequencies of the following
medication patterns: stabilization (no changes for 90 days),
medication changes (stopping one, starting another), stopping
(all medications stopped for 60 days), and co-prescribing.
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Results: A total of 56,862 patients were prescribed
medications by primary care providers (PCP) or psychiatrists,
with 11% receiving prescriptions from the latter. More than
half (57%) reached stabilization, with an average of 1.1
changes before stabilization. Patients treated by psychiatric
providers were more likely to reach stabilization (70% vs
55%). Those who stopped all medications were less likely
to have medication changes (average number of changes:
0.5). Nine providers (6 PCP, 3 psychiatry) were interviewed;
all indicated they rarely prescribed benzodiazepines, but
one-third of their patients received them. All providers
discussed challenges with managing patient expectations for
effectiveness and medication side effects with variation in
counseling strategies. Providers indicated having a handful of
patients they “couldn’t get off” benzodiazepines, which was
observed in the electronic health record data. Approximately
8% of patients who started a benzodiazepine remained on it
beyond 90 days, indicating likely physical dependence.
Conclusion: These findings showed several important areas
for future research on comorbid depression, anxiety, and sleep
disorders: 1) understanding risk factors for benzodiazepine
dependence; 2) differences in treatment patterns between
psychiatric and nonpsychiatric providers; and 3) counseling
strategies that emphasize the importance of trial and error
with medication switching to achieve stabilization.
Understanding the Role of Mental Health and
Substance Abuse in Perpetrating Violent Acts: In
the Presence of Unmet Needs for Mental Health
Services
Ruaa Al Juboori, Divya Subramaniam, Leslie Hinyard
Saint Louis University / SSM Health, St. Louis, MO
Background: Less is known about how the association
between substance use, mental health, and violent acts might
vary depending on perceptions of unmet needs for mental
health services. This study aimed to explore the association
between unmet need for mental health services, health
insurance, substance abuse, and mental health problems
and the perpetration of violent acts. Its second aim was to
determine if unmet need for mental health services is an
effect modifier in the relationship between predictors and
violence perpetration.
Methods: Year 2019 data from adults (≥18 years old) in
the National Survey on Drug Use and Health (n=42,567)
was used. Logistic regression was conducted to examine
the relationship between attacks intended to seriously hurt
others and unmet needs for mental health services, health
insurance, major depressive episode (MDE), suicidal
ideation, and substance abuse. Interaction terms between
unmet needs for mental health services and predictors were
created to test for the effect-modifying role of unmet needs
for mental health services between predictors and outcome.
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Results: In this adult population, 469 (1.1%) reported
attacking someone with the intent to seriously hurt in the last
12 months. Unmet needs for mental health services, suicidal
ideation, MDE, alcohol, and other illicit drug abuse were
associated with higher likelihood of violence perpetration.
The interaction terms showed that in the presence of unmet
need for mental health services, there were amplified
associations for suicidal ideation (adjusted odds ratio [aOR]:
5.34, 95% CI: 4.10, 6.59) MDE (aOR: 1.95, 95% CI: 1.46,
2.60), and alcohol abuse (aOR: 3.10, 95% CI: 2.49, 3.85)
with violence perpetration.
Conclusion: Study results highlight the importance of
providing mental health coverage for individuals experiencing
substance abuse and mental health disorders in order to prevent
violence. Therefore, it is valuable to have mental health
experts highly involved in violence risk assessment among
patients with mental health and substance abuse disorders. Yet,
prospective studies are needed to assess causal pathways.
Health Service Utilization Among Children and
Adolescents With Posttraumatic Stress Disorder:
A Case-Control Study
Frances Lynch, Pauline Goger, Argero Zerr, John
Dickerson, Phillip Crawford, Stacy Sterling, Yihe Daida,
Brian Ahmedani, Robert Penfold, Robin Weersing
Kaiser Permanente Northwest, Portland, OR
Background: Trauma exposure is widely prevalent, with
over 60% of adolescents having experienced at least one
traumatic event and one-third of those at high risk to develop
posttraumatic stress disorder (PTSD). Data on the services
youths with PTSD receive are scarce and out of date,
impeding efforts to improve care and outcomes. This study
examines health services use for a large and diverse sample
of youths with and without a diagnosis of PTSD.
Methods: Utilizing a matched case-control study, we gathered
information from 4 large health systems participating in
the Mental Health Research Network (MHRN): Kaiser
Permanente Northwest; Henry Ford Health System; Kaiser
Permanente Northern California; and Kaiser Permanente
Hawaii. Data from each site’s electronic medical records
and claims data on diagnoses, encounters, and demographics
were analyzed. A total of 955 youths (age range: 4–18 years)
with a diagnosis of PTSD were identified and matched on
an approximately 1:5 ratio to 4770 controls. We compared
cases to controls on frequency of service use in primary care,
medical specialty care, acute care, and in mental health care.
We also assessed psychotropic medication use.
Results: Youths diagnosed with PTSD utilized care in nearly
all physical and mental health service categories at a higher
rate than control youths. In particular, youth with PTSD are
more likely to use outpatient mental health (odds ratio: 9.09;
P<0.001) and psychotropic medication (odds ratio: 6.56;
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P<0.001). However, one-third of youths did not receive even
one outpatient mental health visit (36.86%) during the yearlong observation window.
Conclusion: Only about two-thirds of youth with PTSD
received outpatient mental health services, while half
received medications. Per practice parameters for youth
with PTSD, psychotropic medications such as selective
serotonin reuptake inhibitors can be an important adjunct
to psychotherapy, especially for youth with comorbid
conditions or more severe symptoms. Thus, this rate of
medication dispensing may indicate unmet need. Most
critically, more than one-third of youth diagnosed with PTSD
did not receive any mental health services at all during the
study period. Youths with PTSD are high utilizers of health
services overall but lower utilizers of the treatment sectors
that may be most helpful in resolving their symptoms.
Health Diagnoses and Service Utilization in the
Year Prior to Youth and Young Adult Suicide
Jordan Braciszewski, Ana Lanier, Hsueh-Han Yeh,
Kelsey Sala-Hamrick, Gregory Simon, Rebecca
Rossom, Frances Lynch, Stephen Waring, Christine
Y. Lu, Ashli Owen-Smith, Arne Beck, Beth Waitzfelder,
Melissa Maye, Cathrine Frank, Melissa Hendriks, Nina
Fabian, Brian Ahmedani
Henry Ford Health System, Detroit, MI
Background: Suicide rates among adolescents have
risen steadily since 2007, creating a dire need to expand
prevention protocols. Health care visits have been identified
as key opportunities for identification and intervention. To
date, studies of youth and young adult health conditions
and service utilization have been limited by small or
circumscribed samples.
Methods: A case-control study was conducted using records
from 9 health systems nationwide. Data from 450 members,
10–24 years of age, who died by suicide between the years
2000 and 2015 were matched with data from 4500 controls
based on health system and time period of membership. We
examined past-year recorded diagnoses, patterns of visit
types, and frequency of those visits.
Results: Adolescents who died by suicide were more likely
to have at least one recorded mental health diagnosis (51%
vs 16%; adjusted odds ratio: 5.74, 95% CI: 4.60–7.18) and
higher rates of each individual mental health condition
except for autism. Adjusting for age and gender, odds
ratios ranged from 2.85 (ADHD) to more than 16 (eating
disorders, other psychoses). Recorded diagnoses of brain
injuries, epilepsy, and sleep disorders also were more likely
among cases. Close to half (49%) and nearly all (89%) youth
who died by suicide had a health care visit in the month
and year prior to their death, respectively. Across all visit
types and time frames (30, 90, and 365 days), cases were
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more likely to visit the health system than controls. Visits
for outpatient specialty care were most common in the past
year, with suicide decedents making an average of 8 visits in
the year before death, only 4 of which were associated with
a recorded mental health diagnosis.
Conclusion: With nearly half (49%) of adolescents who
died by suicide lacking a recorded mental health diagnosis
in the year prior to their death, relying only on mental health
services to identify at-risk adolescents may not be sufficient.
High rates of health care utilization among those who died
by suicide indicate a strong need for improving identification
of youth while they are seeking services, thereby preventing
future deaths.
Demographic and Psychosocial Factors Associated
With Suicide Mortality Among Childbearing-Age
Individuals: A Case-Control Study
Leah Hecht, Amy M. Loree, Hsueh-Han Yeh, Lyubov
Gavrilova, Katerina Furman, Joslyn Westphal, Gregory
Simon, Frances Lynch, Arne Beck, Ashli Owen-Smith,
Rebecca Rossom, Yihe G. Daida, Christine Y. Lu,
Jennifer M. Boggs, Cathrine Frank, Stephen Waring,
Brian Ahmedani
Henry Ford Health System, Detroit, MI
Background: Depression is common among individuals of
childbearing age, particularly during the perinatal period.
Although suicide rates tend to be lower among those who
are pregnant, potential risk factors of maternal suicide
need to be better understood. The goal of this study was to
examine demographic and psychosocial factors, including
pregnancy and postpartum status and perinatal loss (eg,
stillbirth, abortion) associated with suicide among a large
diverse sample of childbearing-age individuals.
Methods: The study sample was obtained from 9 health
systems in the Mental Health Research Network. This study
used a case-control study design, with 290 childbearing-age
individuals who died by suicide (cases) during 2000–2015
each matched to 10 childbearing-age individuals from the
same health system and enrolled during the same time
period who did not die by suicide (n=2900). Conditional
logistic regression was used to investigate the relationship
between pregnancy/postpartum status and suicide death in
this matched case-control study.
Results: Childbearing-age individuals who died by suicide
were more likely to have mental health disorder diagnoses
including substance use disorders (adjusted odds ratio [aOR]:
2.69, 95% CI: 1.69, 4.26) and more likely to have visited
the emergency department in the year prior to index date
(ie, date of suicide death) (aOR: 3.44, 95% CI: 2.50, 4.73).
Childbearing-age individuals who were pregnant (aOR: 0.14,
95% CI: 0.03, 0.63) or gave birth (aOR: 0.38, 95% CI: 0.16,
0.87) within a year before the index date had a lower risk
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of dying by suicide compared to individuals who had not
experienced any pregnancy events. However, individuals
who experienced perinatal loss were more likely to die by
suicide (aOR: 1.43, 95% CI: 0.51, 4.00), although due to the
small number of patients with this event (n=6 cases, n=21
control), the result was not statistically significant.
Conclusion: While pregnancy and delivery may be
protective against suicide, perinatal loss may be associated
with higher suicide rate. Routine screening and monitoring
for anxiety, depression, substance use disorders, and prior
emergency department encounters among individuals who
experience pregnancy loss is warranted given their increased
risk for suicide. Future studies should further examine
associations between type of perinatal loss (eg, early infant
death, miscarriage, abortion, stillbirth) and suicide mortality.
Visual and Ocular Phenotypes Associated With
Autism and Atypical Neurodevelopment Using
Electronic Health Records
Antoinette DiCriscio, Jaclyn Smith, Julie-Anne Little,
Anthony Seiwell, Brian Harry, Vanessa Troiani
Geisinger Research, Lewisburg, PA
Background: Atypical visual perception, such as “seeing
the trees instead of the forest,” has been frequently
documented in autism spectrum disorder (ASD) and is
generally attributed to atypical brain function. However,
relatively little research has characterized optometric
anomalies in ASD, which may indicate atypical morphology
and/or malfunction of the eye rather than the brain.
Increased prevalence of refractive errors and optic nerve
abnormalities in ASD have been found in studies with small
sample sizes, but this work has yet to be completed at a
large scale. The current study leverages existing optometry
and ophthalmologic records to establish visual and ocular
phenotypes in patients with and without known genetic
causes of ASD and atypical neurodevelopment.
Methods: We evaluated the presence of atypical ocular
features via manual chart review of electronic health record
data in 563 patients (age range: 3–21 years), including
ophthalmologist/optometrist visits across 3 groups: n=210
neurodevelopmental probands with a genetic syndrome
associated with ASD; n=156 with ASD diagnoses with no
known genetic cause; and n=197 age- and sex-matched
controls. We characterized structural and functional ocular
symptoms using a rubric based on the presence or absence of
symptoms across 6 domains: 1) visual acuity; 2) refractive
error, accommodative disorders, and near visual function;
3) eye movements; 4) stereopsis and oculomotor function;
5) retinal function and structure; and 6) photoresponse,
photosensitivity, and pupil response.
Results: We found increased documentation of visual and
ocular symptoms in neurodevelopmental probands and ASD
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with no genetic cause as compared to healthy controls,
including features of abnormal eye movements (P<0.0254 for
all comparisons), amblyopia (P<0.0367 for all), strabismus
(P<0.0037 for all) and esotropia (P<0.0032 for all). We also
found increased prevalence of astigmatism and atypical
accommodation in neurodevelopmental probands as compared
to both ASD and healthy controls (P<0.0140 for all).
Conclusion: Results indicate that ocular and ophthalmologic
anomalies are more frequently present in children with
neurodevelopmental differences compared to controls.
These results highlight the feasibility of retrospective chart
review to curate ocular variables acquired as part of standard
clinical care, indicate a potential path for intervention in
neurodevelopmental disorders, and lay the groundwork
for new analyses that explore the genetic underpinnings of
ocular anomalies within ASD subtypes.
Trauma Diagnoses and Risk for Suicide Mortality
in a Health System Patient Population
Kelsey Sala-Hamrick, Jordan Braciszewski, Rachel
Zelenak, Joslyn Westphal, Cathrine Frank, HsuehHan Yeh, Gregory Simon, Ashli Owen-Smith, Rebecca
Rossom, Frances Lynch, Christine Y. Lu, Stephen
Waring, Arne Beck, Yihe Daida, Brian Ahmedani
Henry Ford Health System, Detroit, MI
Background: Strong evidence exists for posttraumatic
stress disorder (PTSD) as a risk factor for suicidal thoughts
and behaviors. PTSD also has been identified as a serious
risk factor for suicide mortality in U.S. veteran populations
and in a Danish epidemiological sample. However, limited
empirical studies examine PTSD and other trauma disorders
as risk factors for suicide mortality, particularly among
non-veteran health system patients in the United States.
Additionally, this study further contributes to the field by
considering a wider spectrum of trauma conditions (not
isolated to the single diagnosis of PTSD) as risk factors
for suicide mortality by including other trauma- and stressrelated diagnostic conditions (ie, acute stress disorder and
other reactions to stress disorders [ICD-9 diagnostic codes
309.89, 309.9, 309.0–4, 309.82, and 309.83]).
Methods: Using a case-control matched design, this study
uses a dataset consisting of health plan-affiliated patients
who died by suicide between 2000 and 2015 from 9 different
U.S. health systems through participation in the Mental
Health Research Network. Patients with PTSD (n=120),
acute stress disorder (n=84), and other reactions to stress
disorders (n=331) who died by suicide were case-matched
by time period and site to a sample of controls (n=1592,
n=2218, and n=8174, respectively). Patients were identified
as having a trauma condition utilizing ICD-9 diagnostic
codes (recorded in the electronic medical records and/or
insurance claims data) at all participating health systems.
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Results: Adjusting for age and gender, individuals with
diagnosed PTSD were more likely to die by suicide (3.6%
vs 0.5%; adjusted odds ratio [aOR]: 10.10, 95% CI: 8.31–
12.27). Patients with diagnosed acute stress disorder (2.5%
vs 0.7%; aOR: 4.49, 95% CI: 3.58–5.62) and those diagnosed
with other stress reactions (9.9% vs 2.4%; aOR: 5.38, 95%
CI: 4.78–6.06) also were more likely to die by suicide.
Conclusion: This study suggests that both PTSD and other
trauma disorders in health system patient populations are
serious risk factors for suicide mortality. These findings
highlight the importance of population-level screening (ie,
across health systems) to identify individuals with trauma
diagnoses as well as providing and expanding traumainformed mental health services in a suicide prevention
strategy.
A Segmented Individual Trajectory Analysis for
Identifying Opioid Use Patterns and Examining
Their Association With Opioid Overdose
Stanley Xu, Komal Narwaney, Morgan Ford, Jason
Glanz, Ingrid Binswanger
Kaiser Permanente Southern California, Pasadena, CA
Background: Understanding how to adjust opioid dose
in patients on long-term opioid therapy (LTOT) for pain
while minimizing risk of unintentional harm is critical in
combating the opioid crisis. Researchers have assessed
the safety of limited opioid use patterns in chronic pain
populations using electronic health record (EHR) data in
observational studies. However, existing methods have
limitations. The objective of this study was to use electronic
opioid-dispensing data to develop a segmented individual
trajectory analysis for identifying opioid use patterns and
evaluating their association with opioid overdose.
Methods: Daily opioid doses in morphine milligram
equivalents (MMEs) averaged over a 30-day period were
calculated for a cohort of adult members on LTOT in an
integrated health system between January 1, 2006, and
December 31, 2019. An individual’s follow-up started upon
LTOT eligibility and ended at either disenrollment, first
overdose, death, or the end of the study, whichever occurred
first. For each individual, we used variable scan windows
and coefficient of variation to find periods with stable and
nonstable MMEs. We then categorized these periods into
11 patterns, including relatively common patterns such as
“discontinued,” “stable,” “slow tapering,” “fast tapering,”
and “increasing” periods. Incidence rates of opioid overdose
were calculated for these relatively common patterns.
Results: The study population (N=18,658) had 92,350 personyears of follow-up, including 59.0% in stable periods, 16.9%
in discontinued periods, 9.8% in increasing periods, 8.1%
in slow tapering periods, and 4.2% in fast tapering periods.
Incidence rates of overdose per 1000 person-years were
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0.13, 0.23, 0.17, 0.77, and 0.59 for discontinued, stable, slow
tapering, fast tapering, and increasing periods, respectively.
Conclusion: We developed a novel approach that identified
11 mutually exclusive opioid use patterns and showed that
“fast tapering” had the greatest incidence rate of opioid
overdose among relatively common patterns.
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Assessing the Feasibility of Collecting a Core Set
of Harmonized Depression Outcome Measures in
Multiple Real-World Care Settings
Michelle Leavy, Diana E. Clarke, Debbie Gibson,
Sarah Hajjar, Eric Bickelman, Richard Gliklich
OM1, Inc., Boston, MA
Background: Major depressive disorder is a significant
public health problem in the United States, and new research
is needed to improve diagnosis, treatment, and patient
outcomes. Real-world data sources, such as electronic health
records and patient registries, offer the potential for efficient,
large-scale studies, but variations in the data collected across
real-world care settings make it challenging to use these data
for new research studies. The purpose of this effort was to
assess the feasibility of collecting a core set of harmonized
depression outcome measures in multiple real-world care
settings.
Methods: The Agency for Healthcare Research and
Quality (AHRQ) recently supported an effort to harmonize
depression outcome measures across patient registries and
clinical practice. Implementation of these measures in patient
registries and in the clinical practice setting would support
both routine clinical care, specifically measurement-based
care using the PHQ-9, and development of data infrastructure
to address new depression-related research questions. In this
AHRQ-funded pilot study, we implemented harmonized
measures (remission, response, recurrence, suicide ideation
and behavior, adverse events related to treatment) in 2 patient
registries (the PRIME Registry sponsored by the American
Board of Family Medicine and the PsychPRO sponsored by
the American Psychiatric Association) and 1 health system
(Baystate Health).
Results: Calculation of the harmonized depression measures
was feasible in the primary care and mental health care
settings. Technical and operational efforts are necessary to
ensure that the data are recorded using structured fields in
medical records, as opposed to in clinical notes. Also, low
patient response rates impacted collection of the PHQ-9
outside of an office visit, due in part to the implementation
curve associated with measurement-based care as well as the
data collection occurring during the COVID-19 pandemic.

Supplement

Conclusion: While many efforts have developed
harmonized or core sets of outcome measures, few efforts
have undertaken pilot studies to examine the impact and
challenges of implementing the measures. This project
provides important information on potential barriers to help
inform other implementation efforts.
Constructing a Severity Index for Knee
Osteoarthritis for Use in Administrative Datasets
Sarah Gebauer, Tim Chrusciel, Joanne Salas, Jeffrey
Scherrer
Saint Louis University / SSM Health, St. Louis, MO
Background: Osteoarthritis is one of the most common
disabling conditions worldwide. Big Data approaches offer
a wealth of information to explore the clinical trajectory of
osteoarthritis and potential targets for intervention. One must
account for osteoarthritis severity because the definitive
treatment, total knee arthroplasty (TKA), is often only offered
after failure of nonsurgical management. An osteoarthritis
severity index (OSI) utilizing electronic health record (EHR)
data would allow the quantification of severity without clinical
interaction. The aim of this study was to explore methods to
develop a novel administrative OSI to predict TKA.
Methods: This retrospective cohort study used a national
EHR database of 5 million adults from 2010 to 2018. Eligible
patients were 45–80 years old with a new diagnosis of knee
osteoarthritis in 2011–2012 and no history of TKA. The
outcome was time to TKA. The OSI was a time-dependent
variable updated every 6 months in follow-up. Treatments
included X-ray, advanced imaging, intra-articular injection,
nonsteroidal anti-inflammatory drugs, and opioids. Principal
components analysis index score (PCI) and a basic sum were
explored as possible OSI indices. Extended Cox proportional
hazard models adjusted for time-dependent comorbidities
were used to calculate hazard ratios (HR).
Results: Of the 16,675 patients meeting inclusion criteria,
2119 (12.7%) underwent TKA. Follow-up time ranged from
6 to 96 months. The cohort was 44.8% 65+ years old, 63.1%
female, and 82.9% White. PCI and sum OSI indices both
showed that a unit increase doubled the risk for TKA (HR:
2.02, 95% CI: 1.95–2.10 vs HR: 1.95, 95% CI: 1.88–2.02,
respectively). Results did not differ substantially between
unadjusted and adjusted models (PCI unadjusted HR: 2.00,
95% CI: 1.93–2.07; sum OSI unadjusted HR: 1.91, 95% CI:
1.85–1.98).
Conclusion: Since PCI and sum OSI showed similar results,
using a simpler sum score would perform well at identifying
patients who would ultimately undergo TKA. The likelihood
of TKA almost doubled with each additional treatment
category received. Next steps include replication in another
administrative dataset, inclusion of pain score, and application
and evaluation of performance in geospatial models.
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A Study of the Aging Brain Using Electronic Health
Record Brain Imaging
Donielle Beiler, Arnab Roy, Vanessa Troiani
Geisinger Research, Lewisburg, PA
Background: Magnetic resonance imaging (MRI) can
be a valuable tool for understanding disease processes of
the human brain, and MRI analysis has contributed to our
understanding of brain development, aging, and cognitive
processing. Studies of the brain at the group level tend
to utilize prospective research recruitment strategies,
requiring substantial time and money for the acquisition
of substantial population cohorts. Conversely, health
systems amass large collections of MRIs as part of routine
patient care, but clinically ascertained imaging tends to
only be used for case or small cohort studies. Herein, we
examine the viability of using clinically ascertained MRIs
to establish a research cohort and assess whether we can
confirm that gray matter volumes diminish with age as an
initial experiment using the cohort.
Methods: To establish this population cohort, 12,030
brain MRI sessions from 9236 patients were identified
based on having scan sequence names consistent with
higher resolution acquisitions (ie, MPRAGE, FSPGR,
3-dimensional SPGR T1). Diagnostic history, prescribed
medications, and patient-level variables including age,
sex, and vitals recorded at the time of the scan were
exported. Patient-level variables and MRIs were deidentified using an approved data broker process, and then
MRI data were analyzed using a voxel-based morphology
pipeline. As a test experiment using this cohort, we then
compared gray matter, white matter, and cerebral spinal
fluid volumes between individuals that were either 18–22
years old (n=181) or 65–69 years old (n=193) at the time
of the scan.
Results: As expected, statistically significant differences
were detected in gray matter volume between the young
and aging cohorts when comparing individuals of the same
gender (P=1.07E-38 for females; P=4.04E-26 for males)
but not in white matter or total intracranial volume. We
also confirm known differences of total intracranial volume
within each cohort across genders (P=2.97E-10 for age 18–
22; P=5.93E-13 for age 65–69).
Conclusion: These results suggest that use of clinically
obtained, high-resolution MRIs produce results comparable
to MRIs obtained via research protocols for global gray
matter, white matter, and cerebral spinal fluid volume. This
largely untapped resource can be used to access substantial
cohorts with significantly less time and cost than traditional
prospective cohort recruitment.
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Breathing Life Into Data Using the Lives Impacted
Method: A Distinctive Approach to Estimating
Health Impact and Enhancing Health Care
Performance Data Applicability

Does Exposure to School Violence Predispose
Adolescents to Engage in Risky Sex?

Alan Bienvenida, Kate Koplan, Felipe Lobelo

Saint Louis University / SSM Health, St. Louis, MO

Kaiser Permanente Georgia, Atlanta, GA

Background: School-based violence is a public health
problem in the United States. While mortality, serious
injury, and adverse mental health outcomes are the most
severe consequences of violence, if left untreated, violenceexposed adolescents might engage in maladaptive behaviors
to cope with their traumatic experience(s). Despite that,
many adolescents are not being assessed for school violence
exposure and its implications by the educational systems
with which they frequently interact. Hence, we investigated
the association between school-based violence (being
threatened/injured on school property) and having last sex
under the influence of alcohol/drugs, in sexually active U.S.
high school adolescents.
Methods: Prevalence trend of having last sex under the
influence of alcohol/drugs and predictors (1991–2019) were
examined. Descriptive and multivariate logistic regression
analyses were used. Total sample used in this multivariate
analysis was 3637 sexually active adolescents. Regression
models were adjusted for demographics (age, sex, race/
ethnicity), early initiation of risky behaviors (smoking,
alcohol, and marijuana), mental health indicators (suicidal
attempt, depression), and good school performance.
Results: Analysis showed that adolescents who had sex
under the influence of alcohol/drugs accounted for 21% of
the sexually active adolescents. Adolescents who had been
threatened/injured with a weapon on school property showed
higher odds of engagement in having last sex under the
influence of alcohol/drug (adjusted odds ratio [aOR]: 1.58,
95% CI: 1.13, 2.19). Results were significant after adjusting
for potential confounders in good school performance
(aOR: 0.69, 95% CI: 0.55, 0.58); suicidal attempt (aOR:
1.34, 95% CI: 1.03, 1.74); and early initiation of the risky
behaviors drinking alcohol (aOR: 1.59, 95% CI: 1.25, 2.20),
smoking (aOR: 1.57, 95% CI: 1.20, 2.06), and marijuana
(aOR: 2.36, 95% CI: 1.79, 3.14).
Conclusion: Findings indicate that violence exposure is
associated with risky sexual behaviors. Therefore, targeted
multidimensional interventions should be developed to
combat school-based violence as a preventative measure for
risky sexual behaviors. School counseling services ought
to pay attention to adolescents who are at risk or victims
of school-based violence. Intervention programs should
consider confidential screening for risky sexual behaviors
among victims of violence to help provide referrals to
prevention services when appropriate. Further, longitudinal
research is needed to better understand school-based
violence and risky sexual behaviors.

Background: Traditional health care performance is not
expressed into easy-to-understand outcome-driven measures,
and few attempts have been made to translate these indicators
into population health impact estimations. Furthermore,
previous research studies in this area have relied on complex
modeling that may be difficult to replicate by health systems
for operational uses and quality improvement initiatives. We
developed a valid and replicable method to estimate total
cases of morbidity and mortality averted through chronic
disease prevention and control services within an integrated
health system.
Methods: This tool uses retrospective health plan
performance rates provided by the Healthcare Effectiveness
Data and Information Set (HEDIS) and number needed
to treat/screen published estimates. Patient-level data of
HEDIS-eligible Kaiser Permanente Georgia members were
used to create an adjustment factor to account for people
with multiple chronic conditions. With this approach, we
conservatively estimated the crucial population health impact
of chronic disease morbidity and mortality averted among
our integrated health system membership. We compiled and
analyzed 10-year trends (2008 to 2018) in HEDIS for 10
metrics specific to diabetes care, cardiovascular control, and
cancer screenings. We accessed both health management
organization (HMO) commercial and Medicare product line
data for each HEDIS metric. All individuals who met the
HEDIS eligibility criteria were included.
Results: For the 2008–2018 period, we conservatively
estimate a total of 15,123 lives were crucially impacted
by prevention and control services resulting in chronic
disease morbidity and mortality averted. Prospectively, we
estimate that we can impact 68 to 596 more lives annually in
scenarios with membership growth and/or improvements in
average HEDIS performance rates in the HMO commercial
and Medicare populations.
Conclusion: The Lives Impacted method is a distinctive
approach that uses HEDIS data to estimate the impact that
a health system can have on the population it serves. The
Lives Impacted method can also forecast future estimates of
health impact and enable comparisons with other publicly
reported quality data. This approach can aid health care
organizations to better communicate the crucial impact of
their prevention and control services and shape quality-ofcare objectives.

208 JPCRR • Volume 8, Issue 2 • Spring 2021

Ruaa Al Juboori, Divya Subramaniam

Supplement

Changes in Clinician Well-Being and Needs Over
Time During the COVID-19 Pandemic and the
Increased Burden on Female Clinicians
Ellis C. Dillon, Cheryl Stults, Sien Deng, Meghan
Martinez, Amaka Agodi, Nina Szwerinski, P.T. Koenig,
Melissa Hanley, Sarina Le Sieur, Jill Kacher Cobb,
Laurie Gregg, Suzanne Pertsch

OTHER
Saint Louis University and SSM Health Virtual Data
Warehouse (VDW): Lessons Learned From the
Creation of a Multi-Institutional VDW in the U.S.
Midwest
Leslie Hinyard, Katie Sniffen, Jeffrey Scherrer

Sutter Health, Palo Alto, CA

Saint Louis University / SSM Health, St. Louis, MO

Background: COVID-19 has dramatically changed
clinicians’ personal and professional lives. At Sutter
Health, the Joy of Work team sought to support clinicians
by conducting repeated surveys that were used to ask about
well-being, gather actionable information, and identify
improvement opportunities.
Methods: We developed 5 core questions about leadership,
safety at work, caregiving, what can be done to support
clinicians, and burnout (using a validated single-item
measure) and asked them on surveys distributed by our
research team and by NRC Health in June–August and again
in October–December of 2020. A total of 10,916 surveys
were distributed in summer and 9318 in fall to clinicians
in 8 affiliated medical groups and 17 Sutter hospitals across
Northern California.
Results: Overall, 3470 (31.8%) surveys were returned in
summer and 4556 (48.9%) in fall. The burnout rate was 30.1%
in summer and 29.0% in fall. Burnout was more common
among women than men (summer: 38.4% vs 24.6%; P<0.001;
fall: 35.1% vs 21.7%; P<0.001). Between summer and fall,
the proportion of clinicians concerned about safety decreased
(42.7% to 21.7%; P<0.001) and the proportion who believed
their concerns would be acted on increased (53.9% to 60.7%;
P<0.001). Of participants with caregiving responsibilities,
the proportion indicating that childcare/caregiving impacted
work was 32.6% (summer) vs 31.7% (fall) and more women
reported this than men (summer: 42.2% vs 23.7%; P<0.001;
fall: 36.7% vs 26.0%; P<0.001). When asked “What can
be done to better support you?” the most frequent response
was “more personal protective equipment (PPE)” (37.1%
in summer vs 26.6% in fall; P<0.001) and “provide more
flexibility with schedules” (26.5% in summer vs 21.9% in
fall; P<0.001). More women than men wanted flexibility
with schedules (summer: 32.5% vs 22.6%, respectively;
fall: 25.3% vs 18.4%, respectively; P<0.001) and support for
mental health needs (summer: 16.9% vs 10.7%, respectively;
fall: 19.1% vs 11.1%, respectively; P<0.001).
Conclusion: Over time, in this population, the pandemic
has disproportionally impacted women who reported more
burnout, caregiving challenges, and desire for mental health
support. The Joy of Work team worked with organizational
leadership and operations teams to respond to these concerns,
which may have influenced decreased rates of concern about
safety, requests for more PPE, flexibility with schedules, and
mental health needs.

Background: HCSRN membership can lead to
transformative growth in research collaboration and funding.
Saint Louis University (SLU) has funded the development
of a Virtual Data Warehouse (VDW) containing electronic
health record (Epic) data from approximately 4 million
patients who have received care in SLU’s academic medical
practice or our partner system SSM Health. Herein, we
describe the development of a unique, comprehensive
VDW encompassing data from two organizationally distinct
collaborative entities.
Methods: A merged instance of Epic between SSM
Health and the SLUCare medical practice provided a
unique opportunity for the development of an SLU-SSM
Health VDW. Working collaboratively with both medical
organizations, SLU researchers obtained a data use
agreement (DUA) for shared data use across the institutions.
Upon obtaining institutional support for the project, we
recruited an experienced HCSRN VDW developer and
established a phase 1 goal to extract a limited database with
monthly updates.
Results: This unique academic-private health system
collaboration began after DUA completion. The VDW build
began in June 2019, with projected completion in March
2021, and SLU successfully applied for membership into the
HCSRN in September 2020. The SLU-SSM Health VDW
includes 23 hospitals, nearly 300 ambulatory care sites,
and approximately 4 million patients who received care in
Missouri, Illinois, Oklahoma, and Wisconsin from 2015 to
2021. Of those, 1.7 million have established primary care
within SSM Health. Patient demographics include sufficient
samples of African American and White urban and rural
populations of low income to offer a unique resource for health
disparities research. Challenges to development included
identification and inclusion of key stakeholders in both
organizations, conforming to data security and compliance
policies at two separate organizations, timing of data
transfer from SSM Health to SLU, and interorganizational
collaboration during the COVID-19 pandemic.
Conclusion: The SLU-SSM Health partnerships allows
for novel health services and outcomes research comparing
academic to private sector delivery of care. Bridging two
independent organizations with shared data resources
presents both challenges and advantages during resource
development.
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Lessons Learned From a Pilot Study on Cognitive
Behavioral Therapy for Chronic Pain: Qualitative
Findings
Dea Papajorgji-Taylor, Alison Firemark, Meghan
Mayhew, Sara Gille, Lynn DeBar, Carmit McMullen
Kaiser Permanente Northwest, Portland, OR
Background: Approximately 10% of adults are affected
by chronic pain, for which cognitive behavioral therapy for
chronic pain (CBT-CP) is an effective and accepted alternative
to pharmacotherapy treatments. Making CBT-CP widely
available in medically underserved populations, in addition
to delivering these services at low cost, would reduce access
barriers for a significant portion of the U.S. population.
Methods: A comparative effectiveness study is currently
underway in 4 integrated health systems and is evaluating the
delivery of CBT-CP via 2 low-cost scalable modalities: an
established web-based intervention, and a virtual coach-led
intervention covering similar content. Formative research was
conducted to pilot test both interventions and gather feedback
for refining the trial protocol. In-depth semi-structured
interviews conducted by telephone with 8 health system
leaders and 7 patients explored feasibility, acceptability,
alignment of interventions with existing pain management
programs, and opportunities for improvement of study
procedures. Thematic analysis and comparative qualitative
data visualization techniques helped to synthesize results.
Results: Health system stakeholders emphasized support
for the trial and anticipated valuable results from it. They
anticipated likely adoption of the interventions and saw
these as aligned with existing pain management initiatives.
Several concrete suggestions about recruitment and
information-sharing between the trial and health systems
were offered. Patients in both arms reported similar
motivators for enrolling in the study, including outreach
through the health system, an opportunity to gain new pain
management skills, having an open mind, potential for pain
relief, and a desire to help others through research. Common
motivators for intervention completion included dedication
to the commitment made to participate and familiarity with
the material presented. Both groups had mixed experiences
of learning valuable skills but generally anticipated
sustained skill use postintervention. Web-based intervention
participants stated that convenience and flexibility supported
intervention completion. They were less likely to report
that the intervention met their expectations compared
to participants in the coach-led intervention. Coach-led
intervention participants valued engagement with trained
professionals.
Conclusion: Findings resulted in modest protocol changes
and confirmed that the trial design was feasible and
welcome, especially for medically underserved areas. Data
visualization techniques greatly enhanced communication
of pilot study findings to the study team.
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Adults Exposed to Tear Gas Report Physical
and Psychological Health Issues and Health
Care Utilization: A Cross-Sectional Survey From
Portland, Oregon
Britta Torgrimson-Ojerio, Karen Mularski, Madeline
Peyton, Erin Keast, Jason Scott, Ilya Ivlev
Kaiser Permanente Northwest, Portland, OR
Background: Although banned in international warfare,
U.S. civilians are being subjected to chemical munitions by
law-enforcement agencies. Interest in health policy on the
use of these chemical agents on the general population is
increasing; as of August 2020, lawmakers in 9 states had
introduced bills that would ban or limit the use of tear gas
on civilians. This study was designed to describe the health
effects and subsequent health care utilization in civilians
who were exposed to tear gas agents by law-enforcement
agencies during protests of racial and social injustice in
2020 in Portland, Oregon.
Methods: We conducted a cross-sectional online survey
administered July 30–August 20, 2020, in a convenience
sample of 2257 adults exposed to tear gas.
Results: The majority of respondents self-identified as
female/cisgender women (n=1151, 51.0%) and White/
non-Hispanic (n=1615, 71.6%). Of the 2257 persons who
reported tear gas exposure, 2116 (93.8%) reported physical
(n=2114, 93.7%) and/or psychological (n=1635, 72.4%)
health issues immediately or within days after being
exposed. Most (n=2105, 93.3%) reported eye (88.4%), nose
(79.3%), lungs/chest (69.5%), mouth (66.9%), and/or skinrelated (54.9%) issues immediately after exposure. Notably,
we report ongoing health issues 1 to 2 days after exposure in
lungs and/or chest (n=1063, 47.1%), gastrointestinal (n=638,
28.3%), head (n=626, 27.7%), and eye issues (n=594,
26.3%). Of 1650 persons who identified as female/cisgender
woman, transgender male, genderqueer (not exclusively
female or male), or did not specify sex or gender identity, the
majority (n=899, 54.5%) reported menstrual disruption (ie,
increased bleeding, abnormal spotting, increased menstrual
cramping) and/or breast/chest tenderness. Most respondents,
1635 (72.4%), reported increased anxiety, startle response,
fear, fatigue, or sadness/depressive feelings after the
exposure. The majority of respondents (n=1233, 54.6%)
received or planned to seek health care for their physical
and/or psychological tear gas-related health issues. Of the
2257 exposed to tear gas, 944 (41.8%) reported receiving
medical care immediately after exposure.
Conclusion: We report tear gas-related health issues
affecting multiple body systems, sometimes persisting for
days to weeks, and often requiring medical attention that
could potentially be avoided otherwise. Our findings may
further inform policy on the public health impact of using
of these chemical agents on the general population.
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Using Survey Data to Assess Clinician Perspectives
on Comparative Performance Feedback Interventions
on Opioid Prescribing
Zijun Shen, Farah Refai, William Isenberg, Amol
Navathe, Mitesh Patel, Joshua Liao, Xiaowei (Sherry)
Yan
Sutter Health, Walnut Creek, CA
Background: We surveyed 437 clinicians from emergency
departments and urgent care clinics across Sutter Health on
their perspectives on an email-based opioid intervention.
The 4-arm randomized intervention involved sending
clinicians comparative performance feedback on their opioid
prescribing, and was live from September 2019 to February
2020. We analyzed survey responses to understand clinician
perspectives on the email intervention and to determine
the impact on clinical decision-making when prescribing
opioids to patients.
Methods: A pre- and a postintervention survey were sent in
April 2019 and September 2020, respectively. We compared
clinicians’ perspectives of comparative performance feedback
before and after the intervention and assessed clinicians’
feelings regarding the intervention using descriptive statistics.
Results: A total of 139 clinicians responded to both pre- and
postintervention surveys, compared to 167 clinicians who
responded to one survey and 157 clinicians who did not respond
to either. The baseline opioid prescription rate is slightly higher
for nonrespondents (14.2%) compared to those who responded
to both (12%). Compared to the preintervention survey, fewer
clinicians agreed on the effectiveness of receiving comparative
performance feedback on their opioid prescribing than in the
postintervetnion survey (49% to 42%), and the perception
of another clinician’s prescribing practices influencing one’s
own prescribing behavior increased from 21% to 29%. Most
clinicians claimed to trust the data in the feedback email,
varying by intervention arm (46% to 62%), and most (67%
to 76%) also agreed that receiving the feedback via email was
convenient. Clinicians in certain arms (46% in combination
and 48% in peer comparison) felt that the email intervention
was a critique of their clinical decision-making compared to
the individual feedback arm (11%; P<0.001). About 30% of
clinicians in the peer comparison and combination arms felt
that their autonomy as a clinician was threatened by receiving
the feedback email. A significant amount of clinicians (35%
in peer comparison and 30% in combination arms) reported
that the email intervention impacted their opioid prescribing
behavior.
Conclusion: Though evidence demonstrated that the peercomparison intervention improves clinicians’ practice
behavior, the clinicians’ perspectives of being monitored
and critiqued on their clinical decisions cannot be ignored.
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Designing Educational Mailings to Motivate
Patient-Caregiver-Provider Conversations About
Deprescribing
Mary Antonelli, Sam Cox, Cassie Saphirak, Abir Kanaan,
Jerry Gurwitz, Kathleen M. Mazor, Sonal Singh
Meyers Primary Care Institute, Worcester, MA
Background: Inappropriate prescribing includes the use of
unnecessary medications or medications that increase the
risk of adverse events. Sedative-hypnotic, antipsychotic,
and anticholinergic agents pose risks for older adults,
especially those with Alzheimer’s disease and Alzheimer’s
disease-related dementias (AD/ADRD). Educating patients
and caregivers about the potential for inappropriate
prescribing and prompting them to talk with their health
care provider about their medications may help stimulate
deprescribing of inappropriate medications. We sought to
create educational mailings for patients with AD/ADRD,
with the goal of motivating the patient or their caregiver to
initiate a conversation with their provider about potentially
inappropriate medications.
Methods: We drafted cover letters and educational brochures
for sedative-hypnotics, antipsychotics, and anticholinergics,
drawing on existing tested materials. We conducted semistructured interviews with patients and caregivers via Zoom
and telephone to elicit their reactions to the materials and
to explore whether they would bring the materials to their
next health care visit as the materials suggested. Interview
transcripts were analyzed qualitatively. An advisory
panel and stakeholder panel also provided feedback and
suggestions. Materials were iteratively adapted and refined
based on feedback from the interviewees and panelists.
Results: We conducted 14 interviews, involving 9
caregivers, 2 independent patients, and 3 patient-caregiver
dyads (total N=17). Interviewees were receptive to the ideas
of bringing the materials to their next health care visit and
initiating a conversation with their provider. Most patients
indicated the materials would be shared with the caregiver.
Major recommendations included: 1) keep materials specific
to the patient, concise, understandable, and with clear
action steps; 2) use color to highlight key information and
emphasize importance; 3) align text with visuals to reinforce
understanding; 4) convey warmth and empathy; and 5) be
mindful that patients want to avoid offending the provider
or disrupting their relationship. Final materials were more
concise than the originals, with a sharper focus on medication
risks and the importance of talking with the provider.
Conclusion: We successfully engaged diverse participants
to create specific, concise, and easily understandable
educational mailings intended to encourage patients and
caregivers to engage in conversations with their provider.
We are planning a small pilot mailing to evaluate feasibility
of a large pragmatic trial.
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Systems Mapping to Understand Colorectal Cancer
Screening Underutilization in an Integrated Health
System: A Valuable Approach for Learning Health
Systems
Patricia L. Mabry, Andrew R. Zinkel, Meghan Jaka,
Jennafer Mee, Nathaniel D. Osgood, Jeanette Y.
Ziegenfuss, Nico Pronk, Anne Book, Ann Werner,
Kristen Kopski, Greg Fedio, Gary Kitching, Kody
Donahue, Matt Flory, Charles R. Rogers
HealthPartners, Bloomington, MN
Background: Learning health systems are health systems
that engage in self-study to improve quality, efficiency,
and effectiveness of the care they deliver. HealthPartners,
a nonprofit integrated health system in the U.S. Midwest,
used systems mapping to understand barriers to member/
patient underutilization of colorectal cancer (CRC)
screening and identify strategies to address these barriers.
Methods: Semi-structured interviews were conducted with
HealthPartners members 50+ years of age (n=40); thematic
content analysis revealed barriers to CRC screening.
Barriers from a recent national survey of unscreened
adults 45–75 years of age (n=1021) also were considered.
Stakeholders within and outside of HealthPartners (n=40)
familiar with CRC screening constructed causal maps
of the identified barriers and strategies to address them.
HealthPartners members’/patients’ attitudes toward barrierreduction strategies were assessed in an online survey (age
range: 45–75 years; n=261). Lastly, 14 modeling experts
and 6 subject matter experts added extensive detail and
logic to the barrier/strategy causal maps, transforming
them into interconnected systems maps that informed the
development of a dynamic simulation model (model results
presented elsewhere).
Results: 1) Perceived barriers to CRC screening:
invincibility to CRC; unpleasantness/fear of the prep/
test/results; lack of time/resources to get screened; and
financial challenges. 2) Surveyed attitudes toward barrierreducing strategies: a majority of respondents would not
be motivated by incentives (64%); many preferred evening
(28%) or weekend (41%) colonoscopies; and some would
utilize a ride program (37%). 3) Causal maps of barriers/
strategies and model structures and their advantages,
limitations, and recommendations were delivered for use
in simulation model development.
Conclusion:
Multimethod,
multistakeholder
data
collection and systems mapping provided participant
stakeholders with a deeper understanding of CRC screening
underutilization at HealthPartners and identified strategies
to improve participation. A beneficial byproduct of the
mapping process was new communication/collaboration
pathways across the organization. Uncovering patient/
member opposition to incentives for CRC screening
prevented implementation of a potentially flawed strategy,
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while discovering patient/member enthusiasm for evening/
weekend scheduling and rides led HealthPartners to
reconsider these strategies. Systems mapping informed
the development of a dynamic simulation model. By
enabling virtual experimentation, the model can be used to
systematically examine trade-offs between different CRC
barrier-reducing strategies, thereby informing strategy
adoption at HealthPartners. In sum, systems mapping can
be a valuable tool for learning health systems.
Randomized Trial of Variable Performance
Feedback and Its Effects on Influenza Vaccination
at Kaiser Permanente Georgia
Felipe Lobelo, Alan Bienvenida, Belkis Pimentel,
Henry Eyring, Kate Koplan
Kaiser Permanente Georgia, Atlanta, GA
Background: Provision of performance feedback to
health care providers (HCPs) can improve overall rates of
delivering screening and other preventive services. However,
researchers have yet to examine whether targets can change
individual HCP performance in health care settings. In this
study, we assessed how varying performance target designs
can produce improvements in the successful provision of
influenza (flu) vaccinations.
Methods: Between September 23, 2019, and December
31, 2019, we conducted a randomized controlled trial to
assess the effectiveness of variable performance target
designs on provider flu vaccination performance, defined
as the number of successful flu vaccinations over their
total patients counseled (opportunities). A total of 595
HCPs at Kaiser Permanente Georgia (62.0% female, 84.7%
physicians) were enrolled and categorized into 4 groups
(primary care, medical specialty, procedural & surgical, and
other) based on their specialty and randomly assigned to 1
of 3 performance target design conditions: 1) organizational
control target (CT), defined as 50% success static target
(n=204); 2) achievable target (AT), defined as static target
10 percentage points higher than the providers’ baseline
performance (n=197); and 3) variable target (VT), defined
as a dynamic target set 10 percentage points higher than the
individual best and rising another 10 points in the 2-week
period after the provider achieves it (n=194).
Results: Over the study period, there were 117,230 unique
flu vaccination opportunities among all participating
HCPs. Overall, HCPs who received VT (22.3%, 95% CI:
20.5–24.1) or AT (21.4%, 95% CI: 19.5–23.2) performance
feedback designs had significantly higher (P<0.05) average
flu vaccination success rates, as compared to HCPs in the
CT condition (19.5%, 95% CI: 17.5–21.9). When stratified
by provider demographics, VT resulted in significant flu
vaccination success rate improvements for younger HCPs
(4.3%; P<0.001), male HCPs (1.1%; P<0.05), and shorter-

Supplement

tenured HCPs (3.5%; P<0.05). Additionally, HCPs who
received the VT had higher flu vaccination success rates
with older (2.7%; P<0.05), White (4.8%; P<0.05), and Black
patients (3.2%; P<0.05) compared to HCPs in the CT.
Conclusion: Alternative performance feedback designs
such as variable and achievable targets led to significant
improvements in flu vaccination success rates across a
variety of provider and patient demographics.

POPULATION HEALTH IMPROVEMENT
“I Would Never Have Done It on My Own” —
Patient Satisfaction With Advanced Notifications
and Reminders as Part of a Mailed Fecal
Immunochemical Test Colorectal Cancer Screening
Program
Jennifer L. Schneider, Jennifer S. Rivelli, Katie Vaughn,
Jamie Thompson, Amanda Petrik, Gloria Coronado
Kaiser Permanente Northwest, Portland, OR
Background: Colorectal cancer (CRC) screening by annual
fecal immunochemical test (FIT) is an accessible and costeffective strategy to lower CRC incidence and mortality.
Mailed FIT outreach programs have been shown to improve
CRC screening rates in community health centers, with
improvements ranging from 22% to 45%. Despite use of
primers (advanced notifications) and reminders for mailed
FIT programs, less is known about patient satisfaction of
these communications for motivating FIT completion.
Methods: To improve rates of CRC screening, the
Participatory Research to Advance Colon Cancer
Prevention (PROMPT) trial studied the effectiveness of an
enhanced mailed FIT outreach program that adds primers
(text messages or live phone calls) and automated phone
call reminders. The program was administered at a Los
Angeles-based community health center that provides
medical services to 280,000 patients annually (82% are
Latinx). As part of PROMPT, we conducted telephone
interviews with a subset of English-language (EL) and
Spanish-language (SL) participants who experienced the
enhanced mailed FIT program and primers. Our goal was
to assess acceptability, helpfulness, and advice for program
improvement.
Results: We completed 25 interviews (n=13 SL, n=12
EL) with 15 females and 10 males, 68% (n=17) of whom
were 50–60 years of age, and 15 with no identified prior
experience completing a FIT. Most patients found the
frequency and content of the primers and reminders
appropriate and professional. SL patients were less
likely to recall receipt of primer texts, with a few
indicating technology challenges. The majority of patients
preferred the live call primer for increasing awareness
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of the importance of CRC screening and creating patient
accountability for completion. This theme was endorsed
more often by SL patients and those who had never
completed a FIT in the past. Primer texts also were found
satisfactory to patients, viewed as less intrusive than calls,
and less likely to be ignored. Automated reminders, while
recognized as helpful for overcoming inertia, were leastpreferred due to being impersonal and lacking clear caller
identification. All participants felt the program should
continue.
Conclusion: An enhanced mailed FIT program with
primers and reminders is acceptable to patients and helpful
for overcoming common barriers such as lack of awareness,
completion confusion, and procrastination.
Cardiometabolic Health Gaps: How Precisely
Can Therapeutic Care Gaps Be Identified From
Electronic Health Records?
Xiaowei (Sherry) Yan, Walter Stewart, Hannah
Husby, Jake Delatorre-Reimer, Satish Mudiganti,
Farah Refai, Andrew Hudnut, Kevin Knobel, Karen
MacDonald, Frangiscos Sifakis, J.B. Jones
Sutter Health, Walnut Creek, CA
Background: Demand is increasing for efficient, higherquality management of cardiometabolic health. Because
cardiometabolic health outcomes are mediated by cliniclevel (eg, knowledge, communication) and individuallevel factors (environment, health behaviors, genetics,
etc), the ability to more precisely identify the root cause
of a health gap may help drive actions to close them. We
sought to understand the utility of structured electronic
health record (EHR) data to precisely identify the gaps in
therapeutic care processes (eg, physician ordering) that
underlie cardiometabolic health gaps.
Methods: Using structured EHR data (2015–2017)
from 249,659 primary care patients, 35+ years of age,
we identified cardiometabolic health gaps for guidelinedefined control of blood pressure, low-density lipoprotein
cholesterol (LDL-C), and hemoglobin A1c, as well as
corresponding guideline-based therapeutic care gaps.
Logistic regression models were applied to determine if
cardiometabolic health gaps were explained by 1) lack of
medication retrieval or low treatment adherence, 2) lack of
health gap closure by the physician, or 3) uncertain.
Results: EHR data identified cardiometabolic health
gaps in 44% of individuals with hypertension, 33%
with hyperlipidemia, and 57% with diabetes. Failure
to fill medication was common in hypertension (39%),
hyperlipidemia (27%), and diabetes (27%) but was not
strongly related to cardiometabolic health gaps (odds
ratios [OR] of 1.23 to 1.76). By comparison, a provider’s
lack of medication prescription (ie, therapeutic inertia)
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was common for hypertension (16%), hyperlipidemia
(40%), and diabetes (27%) and was strongly related to
hyperlipidemia (OR: 5.8) and diabetes (OR: 5.7) health
gaps. In 9% (hyperlipidemia) to 21% (diabetes) of patients,
we could not determine if a cardiometabolic health gap
was explained by patient adherence or a physician-related
therapeutic care gap.
Conclusion: Cardiometabolic health gaps and related
therapeutic care gaps can be identified from structured
EHR data. Therapeutic inertia is highly correlated to health
gaps and could represent an actionable target for health
systems. The underlying cause of persistent care gaps for
hyperlipidemia and diabetes is difficult to identify in up to
20% of patients, suggesting that better structured data and/
or more sophisticated decision support is needed to help
close these gaps in care settings.

networks, adjusting the questionnaire to account for
cultural differences and include social determinants of
health, and offering more follow-up. In exploring KP’s role
in the primary prevention of ACEs, key findings showed
investment in multiple prevention-focused strategies, but
they often focused at one medical center or one community.
Conclusion: Health care has both a downstream (treatment)
and upstream (prevention) role to play in addressing
pediatric ACEs. From a downstream perspective, KP can
use ACEs screening as a tool (not a diagnostic) but within
the context of trauma/resilience-informed care. From an
upstream perspective, KP can continue to collaborate across
sectors, invest in key environments, and leverage data to
pinpoint investment and collaboration. This developmental
evaluation provides a draft blueprint for KP’s role in the
screening, treatment, and prevention of pediatric ACEs.

A Developmental Evaluation of the Screening,
Treatment, and Prevention of Pediatric Adverse
Childhood Experiences at Kaiser Permanente
Southern California

Evaluation of the National Diabetes Prevention
Program Among Adults With Prediabetes in the
Southeastern United States, 2018–2020

Kelly Dumke

Tina Davis, Courtney McCracken, Ann Whitaker,
Cristina Bozocea, Felipe Lobelo, Belkis Pimentel

Kaiser Permanente Southern California, Los Angeles, CA

Kaiser Permanente Georgia, Atlanta, GA

Background: More than 20 years ago, Kaiser Permanente
(KP) partnered with the Centers for Disease Control and
Prevention and uncovered the devastating impacts that
adverse childhood experiences (ACEs) can have across the
life course. While frameworks for treating or preventing
ACEs exist, there is limited practice-based guidance on
the role of the health care sector, especially when it comes
to pediatric populations. This study capitalized on 3 key
opportunities: a new California initiative seeking to cut
ACEs in half in one generation (ACEs Aware); a lack of
practice-based research on pediatric ACEs; and an ongoing
pediatric screening pilot at KP Southern California.
Methods: A mixed-methods developmental evaluation
of KP Southern California’s Pediatric ACEs Pilot
Program was conducted to explore 4 research aims: 1)
understand the current burden of pediatric ACEs (through
quantitative analysis); 2) evaluate pilot efforts from
multiple perspectives, including pediatricians, nurses,
social workers, and community organizations (through
semi-structured interviews); 3) compare pilot efforts to
recommendations for trauma-informed care (through
semi-structured interviews); and 4) explore opportunities
for KP’s role in primary prevention (through focus group).
Results: Among pediatric members screened at KP
(n=8473), 1 in 5 had an ACE score of 1+ with statistically
significant differences across age, race/ethnicity, pilot site,
and income. Key findings when examining perceptions of
the pilot included the need for more training on traumainformed care, strengthening resources and referral

Background: While 34.2 million Americans have diabetes,
88 million adults in the United States have prediabetes.
Without lifestyle changes, people with prediabetes have
increased risk of developing type 2 diabetes, stroke, and
heart disease. Lifestyle changes decrease risk of developing
type 2 diabetes by as much as 58%. The National Diabetes
Prevention Program (National DPP) lifestyle change
program is a 12-month evidence-based intervention
developed in 2010 to address increasing burden of
prediabetes and type 2 diabetes. Adults in National DPP
were one-third less likely to develop diabetes. Kaiser
Permanente Georgia (KPGA) achieved full recognition
for their National DPP lifestyle change program, which is
offered to members at no cost. This study is an evaluation
of members from 2018 to 2020 who participated in the
National DPP at KPGA.
Methods: Members were eligible to participate if they
were 18 years old or older, not pregnant, not diagnosed
with diabetes, currently enrolled at KPGA, and met at least
1 of the following criteria: hemoglobin A1c of 5.7–6.4,
previous prediabetes or gestational diabetes diagnosis, and
a score of >5 on the prediabetes risk test. A total of 254
members participated in National DPP during 2018–2020.
The primary outcome was weight loss at 12 months postbaseline session; participants were included in the analysis
of weight trajectory based on having at least 1 follow-up
time point.
Results: National DPP participants at KPGA were
predominately female (85.1%, n=217) and Black (69.8%,
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n=178). Median age at program start was 59 years, and
43.1% (n=110) had a college degree. Most participants
(79.6%, n=203) had a hemoglobin A1c recorded to confirm
their prediabetes status. Among members with multiple
weights (n=191), 69% (n=132) lost more than 1 pound per
month and 31% (n=59) showed a stable weight trajectory
with weight change within ±1 pound per month. Results
from the mixed model showed estimated weight loss was
1.59 pounds per month (95% CI: 1.33, 1.88). The average
minutes of physical activity per week was 150 minutes.
Conclusion: Members with prediabetes in the National
DPP lost weight while participating in the lifestyle change
program. Future research should look at a maintenance
phase of weight loss and hemoglobin A1c 6–12 months
after completing the program to understand longer-term
program outcomes for program participants.

TECHNOLOGY AND DIGITAL HEALTH
Effect of a Web-Based Medication Reconciliation
Tool on Medication Discrepancies in a Primary
Care Population
Michael Gionfriddo, Vanessa Duboski, Melissa Kern,
Bhumika Maddineni, Yirui Hu, Eric Wright
Geisinger Research, Forty Fort, PA
Background: Having an accurate medication list is a wellrecognized patient safety issue. Unfortunately, electronically
recorded medication lists are not often reflective of actual
medications used. We developed a web-based medication
reconciliation tool (MedTrue™) to facilitate and display the
collection of accurate medication lists — through integration
of patient-collected, electronic health record (EHR), and
administrative claim medication information — within the
EHR. Effectiveness of this tool in improving the accuracy
of medication lists was evaluated.
Methods: We conducted a cluster-randomized trial within
6 primary care clinics within an integrated health delivery
system. Sites were selected in collaboration with clinic
leadership and randomized in a 1:1 fashion to intervention
(MedTrue™) or usual care using a random number
generator. Patients were eligible for inclusion if they were
seen at a participating clinic for a visit with their primary
care provider, if they were 18 years of age or older, if
they spoke English, and, for the intervention arm, if both
the patient and a health care provider were exposed to
MedTrue. After an eligible visit, patients were approached
by a trained pharmacist, consent was obtained, and a best
possible medication history was performed. The primary
outcome was the rate of medication discrepancies, defined
as a composite rate of medication additions, removals, or
modifications.
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Results: Overall, 224 patients were recruited and
underwent a best possible medication history with the
pharmacist (118 usual care, 106 MedTrue). The most
common discrepancies identified were medications the
patient was no longer taking, with a median of 2 per patient
(interquartile range: 1–3) in usual care and a median of
1 per patient (interquartile range: 1–3) among those who
used MedTrue. MedTrue use did not affect the rate of the
primary composite outcome (odds ratio: 1.01, 95% CI:
0.38–2.70; P=0.982).
Conclusion: MedTrue did not reduce the rate of medication
list discrepancies among a population of patients seen in
primary care.
Cross-Organization Data Sharing Using MDClone
Platform
Gabriel Chodick, Tal Tova Patalon, Brosh Yinon, Ben
Gross
Maccabi Institute for Health Services Research, Tel
Aviv-Jaffa, Israel
Background: At present, most health care providers
rely only on data from their facilities, which is many
times lacking and telling a misleading story. It is clear
that integration of information from different health care
providers can dramatically improve patient quality of care,
research, organization financial savings, etc.
Methods: MDClone platform is a Big Data system for
health care, enabling broad use of data inside and across
health systems to rapidly deliver information to improve
patients’ health. During the COVID-19 pandemic, MDClone
platform is used to share data between two leading health
care providers in Israel: Maccabi, the second-largest health
management organization (HMO) in Israel (~30% of
Israel population) and Sheba Medical Center, the biggest
governmental hospital in Israel. As part of this collaboration,
both organizations shared data on a daily/weekly basis,
enabling researchers to draw a complete picture of
COVID-19 continuum of care and statistics.
Results: Full historical data of 800 Maccabi COVID-19
patients that were admitted to emergency department
or hospitalized in Sheba was shared between the two
organizations. The vast data-sharing allowed both
organizations to work on varied research. Two papers are
already published, and recently the data collaboration was
extended to include vaccination data, as Israel becomes the
world leader, allowing the identification of side effects and
long-term outcomes.
Conclusion: Following the success of this pilot collaboration,
we now aim to extend this collaboration to additional areas
such as oncology, neurology, and obstetrics data.
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Engaging Parents and Health Care Providers to
Inform Development of a Behavioral Intervention
Technology to Promote Pediatric Behavioral
Health: Mixed-Methods Study

Pulse Rate Variability as a Digital Biomarker of
Low-Grade Inflammation and Its Regulation

Sean M. O’Dell, Heidi R. Fisher, Victoria Schlieder,
Tracey Klinger, Rachel Kininger, McKenna Cosottile,
Stacey Cummings, Kathy DeHart

NeurodigitX, Syracuse, NY

Geisinger Research, Danville, PA
Background: Behavioral intervention technologies (BITs)
hold potential to transform primary care behavioral health
by empowering parents to take charge of their child’s
behavioral health care. However, research is needed to
understand parental needs in a BIT as well as current parent
self-help practices and parent-provider collaboration to
identify and address behavioral health challenges.
Methods: We conducted a convergence-validation mixedmethods study in which parent quantitative surveys (N=385)
on preferences and current practices related to behavioral
health themes to be addressed in a BIT were integrated
with focus group interview data on internal and external
contextual factors contributing to parental unmet needs
and current practices with 48 health care stakeholders in
9 child-serving clinics within a large, predominantly rural
health system. We integrated these data using joint displays
and synthesized areas of confirmation, expansion, and
discordance between parents and health care stakeholders.
Results: Parents frequently endorsed about half of the
available themes, indicating that BITs may not be the
preferred modality for all targeted prevention. Additionally,
parents frequently endorsed themes that were not related
to child psychopathology (eg, parenting stress and family
communication), indicating parents are interested in
guidance on parenting beyond challenging child behavior.
Health care stakeholders indicated that an online platform
aligns with how parents already seek behavioral health
guidance and suggested that a BIT may connect families
with evidence-based guidance sooner. We identified areas
of convergence related to overt behavior problems and
areas of divergence related to internalizing problems and
cross-cutting issues that may be more difficult for health
care providers to detect. Data integration expanded our
understanding of factors enabling effective parent-provider
partnerships, including the impact of time pressure during
office visits and insights on how parenting stress influences
parent help-seeking behavior.
Conclusion: These findings provide a rich understanding
of the complexity involved in meeting parents’ needs
for behavioral health guidance in a primary care setting
using BITs. Further triangulation of these findings in usertesting studies for BIT prototypes is needed to refine our
understanding of how to successfully develop and implement
an effective BIT to guide parents in taking charge of their
child’s behavioral health care.
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Background: While acute inflammation is critical to
survival, chronic low-grade inflammation (LGI) is now
appreciated to be a major factor in mental and physical
disease, with potential onset in early development. While
acute inflammation is assessed from blood samples
(eg, C-reactive protein), LGI status requires repeated
assessments to characterize its longitudinal evolution.
Herein, we examine the use of pulse rate variability (PRV)
as a noninvasive digital biomarker of LGI correlates in the
brain and body.
Methods: LGI is controlled by the brain through the
vagal nerve (cranial nNerve X) and is 1) associated with
older age, 2) associated with lower neuroplasticity, and
3) regulated by the vagal anti-inflammation reflex. In 65
adults across the lifespan, we assessed these 3 factors
and their relation to the variability in timing between
heart beats (3-lead electrocardiogram) and fingertip pulse
(photoplethysmography). All participants performed
measures of cognitive plasticity (learning and cognitive
flexibility) and 2 minutes of an autonomic vagal maneuver
(slow breathing at 0.1 Hz, 6 breaths per minute) to engage
the vagal anti-inflammation response.
Results: Consistent with LGI, lower baseline PRV was
reliably associated with age, lower cognitive functional
status (including decreased learning), and cognitive
flexibility. Consistent with an anti-inflammation response,
0.1 Hz breathing transiently enhanced PRV. This was
greatest for those with lower baseline PRV and thus
higher LGI, lowering PRV indices of LGI equivalent to
a reduction of approximately 30 years. Finally, PRV was
able to capture vagal influences on heart contractions equal
to electrocardiogram.
Conclusion: Acute and unresolved LGI is a critical feature
of COVID-19 and its potential long-term consequences,
and it is known to contribute to future noncommunicable
disease burden in the young. We present evidence that PRV,
by assessing and regulating vagal control of inflammation,
captures critical associations between LGI with mental and
physical function. PRV may serve as a noninvasive digital
biomarker of the evolution of LGI and its resolution.
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Patient
Considerations
When
Selecting
Telemedicine Versus In-Office Care: A Qualitative
Study
John W. Morgan, Mandy K. Salmon, Maya Ambady,
Kirstin A. Manges, Corrine M. Rhodes, Nwamaka
Eneanya, Judy Shea, David Grande
University of Pennsylvania, Philadelphia, PA
Background: The COVID-19 pandemic has dramatically
increased adoption of telemedicine. However, how patients
choose between in-office and telemedicine visit modalities
remains largely unknown. Given the impact of patient
choice on use of and access to telemedicine, we sought
to understand how high-risk primary care patients choose
between in-office, synchronous audiovisual, or audio-only
telemedicine.
Methods: Between July 13, 2020, and September 30,
2020, we interviewed 29 high-risk patients who had been
invited to schedule primary care visits for chronic disease
management via in-office, audiovisual, or audio-only visits.
Semi-structured interviews were conducted over phone.
Using constant comparison, enabled by NVivo 12.1, we
utilized a grounded theory approach to explore factors
influencing participants’ selection of visit type.
Results: Participants were predominantly female (55.2%),
Black (65.5%), low-income (85.7% with household income of
<$50,000), and elderly (mean age of 64.6 ± 11 years). Among
interviewees, 43% had had a prior video visit. Reasons for
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choice of visit type were compiled into a comprehensive
decision framework comprising the following factors: 1)
perceptions of utility, 2) perceptions of costs, 3) choice
modifiers, and 4) underlying drivers. Patients were especially
sensitive to office visits’ perceived superiority at revealing
unexpected medical problems. Despite lower transportation
“costs” with telemedicine, these were often offset by reduced
ease of task-clustering (ie, inability to complete labwork
or schedule appointments subsequent to the televisit).
Patients’ particular clinical situations, awareness of choice,
and behavioral phenotype (risk aversion, assertiveness)
modified decisions irrespective of cost/benefit assessments.
Underlying drivers comprised global life experiences and
experience with local telehealth environments.
Conclusion: Our results stand to aid health systems seeking
to understand, anticipate, and inform telemedicine use. For
example, by leveraging choice-framing and replicating
in-person remote task-clustering efficiencies (ie, nurses
in virtual “waiting rooms” prior to visit), health systems
can affect telehealth utilization more effectively than by
exclusively addressing low technology literacy and lack
of access to technology or by focusing on more immutable
factors such as distrust. The underlying drivers we identified
highlight telemedicine’s risk of exacerbating disparities in
access and underscore the importance of alternative methods
of engaging high-risk patients, including using telephoneonly services and bringing conveniences of telemedicine to
in-office care (ie, direct phone lines).
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